
<html lang="en"     class="pb-page"  data-request-id="8e569c60-f83a-4f12-813a-a706b69bb47e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;article:article:10.1021/jm301020q;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors" /></meta><meta name="dc.Creator" content="Anthony A.  Estrada" /></meta><meta name="dc.Creator" content="Xingrong  Liu" /></meta><meta name="dc.Creator" content="Charles  Baker-Glenn" /></meta><meta name="dc.Creator" content="Alan  Beresford" /></meta><meta name="dc.Creator" content="Daniel J.  Burdick" /></meta><meta name="dc.Creator" content="Mark  Chambers" /></meta><meta name="dc.Creator" content="Bryan K.  Chan" /></meta><meta name="dc.Creator" content="Huifen  Chen" /></meta><meta name="dc.Creator" content="Xiao  Ding" /></meta><meta name="dc.Creator" content="Antonio G.  DiPasquale" /></meta><meta name="dc.Creator" content="Sara L.  Dominguez" /></meta><meta name="dc.Creator" content="Jennafer  Dotson" /></meta><meta name="dc.Creator" content="Jason  Drummond" /></meta><meta name="dc.Creator" content="Michael  Flagella" /></meta><meta name="dc.Creator" content="Sean  Flynn" /></meta><meta name="dc.Creator" content="Reina  Fuji" /></meta><meta name="dc.Creator" content="Andrew  Gill" /></meta><meta name="dc.Creator" content="Janet  Gunzner-Toste" /></meta><meta name="dc.Creator" content="Seth F.  Harris" /></meta><meta name="dc.Creator" content="Timothy P.  Heffron" /></meta><meta name="dc.Creator" content="Tracy  Kleinheinz" /></meta><meta name="dc.Creator" content="Donna W.  Lee" /></meta><meta name="dc.Creator" content="Claire E.  Le Pichon" /></meta><meta name="dc.Creator" content="Joseph P.  Lyssikatos" /></meta><meta name="dc.Creator" content="Andrew D.  Medhurst" /></meta><meta name="dc.Creator" content="John G.  Moffat" /></meta><meta name="dc.Creator" content="Susmith  Mukund" /></meta><meta name="dc.Creator" content="Kevin  Nash" /></meta><meta name="dc.Creator" content="Kimberly  Scearce-Levie" /></meta><meta name="dc.Creator" content="Zejuan  Sheng" /></meta><meta name="dc.Creator" content="Daniel G.  Shore" /></meta><meta name="dc.Creator" content="Thuy  Tran" /></meta><meta name="dc.Creator" content="Naimisha  Trivedi" /></meta><meta name="dc.Creator" content="Shumei  Wang" /></meta><meta name="dc.Creator" content="Shuo  Zhang" /></meta><meta name="dc.Creator" content="Xiaolin  Zhang" /></meta><meta name="dc.Creator" content="Guiling  Zhao" /></meta><meta name="dc.Creator" content="Haitao  Zhu" /></meta><meta name="dc.Creator" content="Zachary K.  Sweeney" /></meta><meta name="dc.Description" content="There is a high demand for potent, selective, and brain-penetrant small molecule inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentia..." /></meta><meta name="Description" content="There is a high demand for potent, selective, and brain-penetrant small molecule inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentia..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 15, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301020q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301020q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301020q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301020q" /></link>
        
    
    

<title>Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301020q" /></meta><meta property="og:title" content="Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0019.jpeg" /></meta><meta property="og:description" content="There is a high demand for potent, selective, and brain-penetrant small molecule inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson’s disease patients. Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compounds. High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro–in vivo correlations. Guided by this data, optimal design parameters were established. Effective incorporation of these guidelines into our molecular design process resulted in the discovery of small molecule inhibitors such as GNE-7915 (18) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species. Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="There is a high demand for potent, selective, and brain-penetrant small molecule inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson’s disease patients. Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compounds. High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro–in vivo correlations. Guided by this data, optimal design parameters were established. Effective incorporation of these guidelines into our molecular design process resulted in the discovery of small molecule inhibitors such as GNE-7915 (18) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species. Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0019.jpeg" /></meta><meta name="twitter:title" content="Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301020q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301020q">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301020q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301020q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301020q&amp;href=/doi/10.1021/jm301020q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9416-9433</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301460x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/jm3005306" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+A.++Estrada">Anthony A. Estrada</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xingrong++Liu">Xingrong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Baker-Glenn">Charles Baker-Glenn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan++Beresford">Alan Beresford</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Burdick">Daniel J. Burdick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Chambers">Mark Chambers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+K.++Chan">Bryan K. Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huifen++Chen">Huifen Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao++Ding">Xiao Ding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio+G.++DiPasquale">Antonio G. DiPasquale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>●</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sara+L.++Dominguez">Sara L. Dominguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennafer++Dotson">Jennafer Dotson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Drummond">Jason Drummond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Flagella">Michael Flagella</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Flynn">Sean Flynn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reina++Fuji">Reina Fuji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Gill">Andrew Gill</a></span><span class="author-xref-symbol author-aff-symbol"><sup>×</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janet++Gunzner-Toste">Janet Gunzner-Toste</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seth+F.++Harris">Seth F. Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+P.++Heffron">Timothy P. Heffron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tracy++Kleinheinz">Tracy Kleinheinz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donna+W.++Lee">Donna W. Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire+E.++Le+Pichon">Claire E. Le Pichon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Lyssikatos">Joseph P. Lyssikatos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+D.++Medhurst">Andrew D. Medhurst</a></span><span class="author-xref-symbol author-aff-symbol"><sup>×</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+G.++Moffat">John G. Moffat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susmith++Mukund">Susmith Mukund</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Nash">Kevin Nash</a></span><span class="author-xref-symbol author-aff-symbol"><sup>×</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Scearce-Levie">Kimberly Scearce-Levie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zejuan++Sheng">Zejuan Sheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+G.++Shore">Daniel G. Shore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thuy++Tran">Thuy Tran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naimisha++Trivedi">Naimisha Trivedi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shumei++Wang">Shumei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuo++Zhang">Shuo Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaolin++Zhang">Xiaolin Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guiling++Zhao">Guiling Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haitao++Zhu">Haitao Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zachary+K.++Sweeney">Zachary K. Sweeney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Discovery Chemistry, <sup>‡</sup>Department of Neurosciences, <sup>§</sup>Department of Biochemical and Cellular Pharmacology, <sup>∥</sup>Department of Drug Metabolism and Pharmacokinetics, <sup>⊥</sup>Department of Safety Assessment, and <sup>#</sup>Department of Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>∞</sup>Department of Chemistry, <sup>×</sup>Department of Biochemical and Cellular Pharmacology, and <sup>○</sup>Department of Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">●</span> <span class="aff-text">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis Hall, Berkeley, California 94720, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 650-225-4934. Fax: 650-742-4943. E-mail: <a href="/cdn-cgi/l/email-protection#34514740465550551a555a405c5b5a4d7453515a511a575b59"><span class="__cf_email__" data-cfemail="9bfee8efe9fafffab5faf5eff3f4f5e2dbfcfef5feb5f8f4f6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301020q&amp;href=/doi/10.1021%2Fjm301020q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9416–9433</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 17, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 July 2012</li><li><span class="item_label"><b>Published</b> online</span>15 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301020q" title="DOI URL">https://doi.org/10.1021/jm301020q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9416%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnthony%2BA.%2BEstrada%252C%2BXingrong%2BLiu%252C%2BCharles%2BBaker-Glenn%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm301020q%26title%3DDiscovery%2Bof%2BHighly%2BPotent%252C%2BSelective%252C%2Band%2BBrain-Penetrable%2BLeucine-Rich%2BRepeat%2BKinase%2B2%2B%2528LRRK2%2529%2BSmall%2BMolecule%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9433%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301020q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6123</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">85</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301020q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;A. Estrada&quot;},{&quot;first_name&quot;:&quot;Xingrong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Baker-Glenn&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;Beresford&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Burdick&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Chambers&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;K. Chan&quot;},{&quot;first_name&quot;:&quot;Huifen&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xiao&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;G. DiPasquale&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;L. Dominguez&quot;},{&quot;first_name&quot;:&quot;Jennafer&quot;,&quot;last_name&quot;:&quot;Dotson&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Drummond&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Flagella&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Flynn&quot;},{&quot;first_name&quot;:&quot;Reina&quot;,&quot;last_name&quot;:&quot;Fuji&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Gill&quot;},{&quot;first_name&quot;:&quot;Janet&quot;,&quot;last_name&quot;:&quot;Gunzner-Toste&quot;},{&quot;first_name&quot;:&quot;Seth&quot;,&quot;last_name&quot;:&quot;F. Harris&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;P. Heffron&quot;},{&quot;first_name&quot;:&quot;Tracy&quot;,&quot;last_name&quot;:&quot;Kleinheinz&quot;},{&quot;first_name&quot;:&quot;Donna&quot;,&quot;last_name&quot;:&quot;W. Lee&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;E. Le Pichon&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Lyssikatos&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;D. Medhurst&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;G. Moffat&quot;},{&quot;first_name&quot;:&quot;Susmith&quot;,&quot;last_name&quot;:&quot;Mukund&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Nash&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Scearce-Levie&quot;},{&quot;first_name&quot;:&quot;Zejuan&quot;,&quot;last_name&quot;:&quot;Sheng&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;G. Shore&quot;},{&quot;first_name&quot;:&quot;Thuy&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Naimisha&quot;,&quot;last_name&quot;:&quot;Trivedi&quot;},{&quot;first_name&quot;:&quot;Shumei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Shuo&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xiaolin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Guiling&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Haitao&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Zachary&quot;,&quot;last_name&quot;:&quot;K. Sweeney&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9416-9433&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301020q&quot;},&quot;abstract&quot;:&quot;There is a high demand for potent, selective, and brain-penetrant small molecule inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson’s disease patients. Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compounds. High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro–in vivo correlations. Guided by this data, optimal design parameters were established. Effective incorporation of these guidelines into our molecular design process resulted in the discovery of small molecule inhibitors such as GNE-7915 (18) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species. Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early devel&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301020q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301020q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301020q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301020q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301020q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301020q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301020q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301020q&amp;href=/doi/10.1021/jm301020q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301020q" /></input><a href="/doi/pdf/10.1021/jm301020q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26pmid%3D22985112%26genre%3Darticle%26aulast%3DEstrada%26date%3D2012%26atitle%3DDiscovery%2Bof%2BHighly%2BPotent%252C%2BSelective%252C%2Band%2BBrain-Penetrable%2BLeucine-Rich%2BRepeat%2BKinase%2B2%2B%2528LRRK2%2529%2BSmall%2BMolecule%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D9416%26epage%3D9433%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Volume 55, Issue 22"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Volume 55, Issue 22"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There is a high demand for potent, selective, and brain-penetrant small molecule inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson’s disease patients. Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compounds. High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro–in vivo correlations. Guided by this data, optimal design parameters were established. Effective incorporation of these guidelines into our molecular design process resulted in the discovery of small molecule inhibitors such as <b>GNE-7915</b> (<b>18</b>) and <b>19</b>, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species. Advancement of <b>GNE-7915</b> into rodent and higher species toxicity studies enabled risk assessment for early development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>▽</span> Author Present Address</h4><p class="last">Novartis Institutes for Biomedical Research (NIBR), 4560 Horton Street, Emeryville, CA 94608-2916.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD) is the second most common neurodegenerative disease and affects approximately 1 in 100 people over the age of 60. A disease-modifying or neuroprotective therapy is highly desired, as the current standard of care is limited to symptomatic treatment.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">In the past decade, the LRRK2 gene, which encodes a large, multidomain protein, has been linked to familial PD.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2-6)</a> Furthermore, the autosomal dominant G2019S kinase domain variant has been associated with both familial and idiopathic PD.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Numerous reports have been published that suggest that the kinase activity of LRRK2 is involved in Parkinson’s disease pathophysiogenesis.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17">(10-17)</a> Some of the small molecule inhibitors disclosed in these reports are highly selective for LRRK2 and could serve as useful tool compounds for examination of LRRK2 function in the periphery.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> This is critical as LRRK2 is expressed in kidney, lung, spleen, monocytes, etc., and roles in immunology, inflammatory bowel disease, cancer, and leprosy have been proposed.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> However, the utility of these inhibitors for studying the role of LRRK2 in PD is limited, as they either do not sufficiently cross the blood–brain barrier or do not demonstrate inhibition of kinase activity in rodent brains.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Our group has demonstrated the in vivo inhibition of LRRK2 autophosphorylation of serine 1292 (Ser1292) in the brains of transgenic mice using a potent, selective, and brain-penetrable tool compound (<b>7</b>); the discovery and characterization of this autophosphorylation site are described elsewhere.<a onclick="showRef(event, 'ref24 ref125'); return false;" href="javascript:void(0);" class="ref ref24 ref125">(24, 26)</a> The moderate total plasma (∼150 nM) and brain (∼100 nM) concentrations of <b>7</b> required to significantly inhibit LRRK2 kinase activity in vivo provide further support for LRRK2 as a potentially druggable target for PD.</div><div class="NLM_p">We recently reported the construction of a JAK2-based LRRK2 homology model that was used to detect several binding site residues that impart general kinase selectivity.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Through a matched molecular pair activity cliff analysis we were able to identify an amino acid near the hinge binding region (Leu1949) as a selectivity hotspot.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30 ref31">(27-32)</a> As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, small ortho-substituents, such as the methoxy group in 2,4-diaminopyrimidine <b>1</b>, are well tolerated in LRRK2 but are disfavored in JAK2 and approximately 290 other kinases that contain a larger Phe or Tyr residue in this binding site region near the hinge.<a onclick="showRef(event, 'ref25 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref25 ref32 ref33">(25, 33, 34)</a> This finding allowed us to use structure-based drug discovery to successfully optimize a series of diaminopyrimidine inhibitors that led to the identification of <b>1</b> as a potent, selective, and brain penetrable LRRK2 small molecule inhibitor.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Compound <b>1</b>, originally disclosed in a 2011 Genentech patent application,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(35)</a> was subsequently used to demonstrate in vivo inhibition of Ser910 and Ser935 phosphorylation in mouse brain.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(36)</a> In this contribution we report the expanded profiling of <b>1</b> and our subsequent lead optimization efforts to identify a LRRK2 small molecule inhibitor suitable for progression to higher species toxicity studies and early development evaluation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Docking model of <b>1</b> (cyan) in LRRK2 (green with L1949 in yellow). The side chain of Y931 of JAK2 is also shown (magenta). Intermolecular hydrogen bond interactions are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As previously reported,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>1</b> has a LRRK2 biochemical potency of 3 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), a JAK2 biochemical selectivity index of >1067× and only inhibits wild-type and G2019S mutant LRRK2 at greater than 50% inhibition at 1 μM (345-fold over <i>K</i><sub>i</sub>) in a representative Invitrogen panel of 63 kinases. At this stage of lead optimization, the JAK2 biochemical assay proved to be a useful barometer for general kinase selectivity. In order to determine the cellular activity of <b>1</b>, we measured the inhibition of LRRK2 autophosphorylation in HEK293 cells using our LRRK2 cellular assay.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the phospho-LRRK2 (pLRRK2) cellular IC<sub>50</sub> of <b>1</b> was 29 nM, translating into an enzyme-to-cell shift of approximately 10-fold. With the cellular assay in place, we explored structure–activity relationships (SARs) of the aminopyrimidine C-4 and C-5 positions. The examples shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> demonstrate good biochemical (<10 nM) and cellular activities (<70 nM) with the exception of aminopyrimidine C-5 fluoro (<b>5</b>) and C-5 cyano (<b>6</b>) analogues. The rationale for this observation was that C-5 groups with increased lipophilicity and size are able to interact more favorably with the gatekeeper Met1947 residue. Furthermore, all of the examples in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> possess desirable CNS MPO scores<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(37)</a> and are highly efficient as measured by lipophilic ligand efficiency (LLE)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(38)</a> and ligand-efficiency-dependent lipophilicity (LELP)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(39)</a> parameters with scores that are in line with CNS marketed drugs and clinical candidates.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(40)</a> The optimal C-4/C-5 combination proved to be the C-4 aminomethyl/C-5 trifluoromethyl substituted aminopyrimidine (i.e., <b>7</b>, pLRRK2 IC<sub>50</sub> of 9 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Representative Aminopyrimidine SAR for C-4/C-5 Substitution Combinations</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">CNS MPO score</th><th class="colsep0 rowsep0" align="center" char=".">LRRK2 <i>K</i><sub>i</sub> <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">LLE</th><th class="colsep0 rowsep0" align="center" char=".">LELP</th><th class="colsep0 rowsep0" align="center" char=".">JAK2 selectivity lndex<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">pLRRK2: IC<sub>50</sub> <a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">>1067</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">>360</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">1546</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="char" char=".">>661</td><td class="colsep0 rowsep0" align="char" char=".">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">>55</td><td class="colsep0 rowsep0" align="char" char=".">418</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">>288</td><td class="colsep0 rowsep0" align="char" char=".">105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">>1928</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Biochemical assay.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">(JAK2 <i>K</i><sub>i</sub>)/(LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Cellular assay.</p></div></div></div><div class="NLM_p">The rationale for installing the aminopyrimidine C-5 trifluoromethyl group in <b>7</b> was not limited to increasing the activity for LRRK2 by providing optimal lipophilic contact with the Met gatekeeper. We also hypothesized that the trifluoromethyl group would impart a more favorable DMPK profile in comparison to other C-5 substituents because of the relative decreased oxidation potential of the pyrimidine ring system. The increased lipophilicity of the trifluoromethyl group should also favor blood–brain barrier penetration.</div><div class="NLM_p">In order to test this hypothesis, the DMPK profiles of selected analogues from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were assessed (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Rat was employed as the primary rodent species for exploratory in vivo pharmacokinetic (PK) studies. In order to accurately assess the brain penetration of multiple compounds, we utilized a cassette dosing approach that provided brain, plasma, and CSF AUC ratios at 0.25, 1, and 3 h time points.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(41)</a> Using in vitro PPB and BPB values, we then converted total brain/plasma (<i>B</i>/<i>P</i>) and total CSF/plasma (CSF/<i>P</i>) to unbound brain/unbound plasma (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub>) and CSF/unbound plasma (CSF/<i>P</i><sub>u</sub>) ratios. This methodology proved to be an extremely critical resource for our program and enabled the rapid generation of meaningful in vitro MDR1 efflux ratio–in vivo unbound brain concentration correlations for medicinal chemistry design and inhibitor evaluation (vide infra).</div><div class="NLM_p">In initial rat pharmacokinetic experiments, the previously reported aminopyrimidine lead (<b>1</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> was cleared rapidly from plasma and demonstrated substantial brain penetration impairment (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.17, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The reduced CNS penetration was consistent with a moderate MDR1 efflux ratio (ER (B–A)/(A–B) = 2.8). While this stands in contrast to the previously reported mouse <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> ratio of 0.61, studies with P-gp/Bcrp knockout mice also suggested that <b>1</b> was an efflux substrate.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Additionally, <b>1</b> exhibited potent time-dependent inhibition (TDI) of CYP1A2. By converting the C-4 aminomethyl in <b>1</b> to a C-4 methoxy (<b>2</b>), we were able to remove one hydrogen bond donor (HBD) and achieve a 5-fold reduction in total clearance and also eliminate TDI concerns. Additionally, this modification improved the passive permeability (A–B of 4.4 to 8.2 × 10<sup>–6</sup> cm/s, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and attenuated P-gp efflux (ER of 2.8 to 0.8, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Unfortunately, we quickly discovered that most C-4 methoxy analogues suffered from high brain protein binding and suboptimal <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> ratios. For inhibitor <b>6</b>, despite the extremely low Cl<sub>u</sub> (27 mL min<sup>–1</sup> kg<sup>–1</sup>), the lack of brain exposure (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.08) as predicted by in vitro MDR1 data (ER = 6.8) and poor cellular activity (105 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) resulted in deprioritization of C-5 cyano analogues.</div><div class="NLM_p">Finally, as we had hypothesized (vide supra), <b>7</b> provided a desirable balance between in vivo stability, oral exposure, and brain penetration. Good CNS penetration for this compound was achieved despite the presence of two HBDs and an amide functionality, both of which may be considered undesirable for crossing the blood–brain barrier. However, the small molecule X-ray crystal structure of <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) suggests that intramolecular hydrogen bonds are formed between a fluorine of the C-5 trifluoromethyl group and the C-4 aminomethyl <i>N</i>-H,<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(42, 43)</a> as well as the aniline <i>N</i>-H and the methoxy group. These interactions likely increase passive permeability and reduce the susceptibility to efflux by P-gp and/or other transporters.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(44)</a> The crystal structure also confirms the role of the amide group in reducing planarity, which is important for improving solubility and minimizing CYP inhibition.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(45, 46)</a> Inhibitor <b>7</b> is also stable in human hepatocytes (Cl<sub>hep</sub> = 1.8 mL min<sup>–1</sup> kg<sup>–1</sup>) and the rat CSF levels correlate well with the measured unbound brain concentration.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(47, 48)</a> These data, along with the PK/PD analysis for <b>7</b> illustrating robust in vivo inhibition of LRRK2 autophosphorylation at Ser1292 in the brains of G2019S transgenic mice,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> provided strong support for additional profiling of <b>7</b> and structurally related compounds.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Rat in Vitro and in Vivo PK Profiles of Aminopyrimidines<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hepatocytes Cl<sub>hep</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a>(mL min<sup>–1</sup> kg<sup>–1</sup>),h/r<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">% rat PPB</th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">MDR1<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a><i>P</i><sub>app</sub>, A–B<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a>(×10<sup>–6</sup>cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">MDR1 P-gp ER<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a>(B–A<a class="ref internalNav" href="#t2fn8" aria-label="h">h</a>/A–B<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a>)</th><th class="colsep0 rowsep0" align="center" char="."><i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t2fn9" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center" char=".">CSF/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t2fn10" aria-label="j">j</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">4.9/24.3</td><td class="colsep0 rowsep0" align="left">91.8</td><td class="colsep0 rowsep0" align="left">51 (616)</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">1.8/4.4</td><td class="colsep0 rowsep0" align="left">94.6</td><td class="colsep0 rowsep0" align="left">9.8 (183)</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">0.84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">12/16</td><td class="colsep0 rowsep0" align="left">96.6</td><td class="colsep0 rowsep0" align="left">5.7 (167)</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2.1/5.4</td><td class="colsep0 rowsep0" align="left">83.5</td><td class="colsep0 rowsep0" align="left">4.4 (27)</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">117</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">1.8/7.6</td><td class="colsep0 rowsep0" align="left">86.3</td><td class="colsep0 rowsep0" align="left">24 (156)</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">18.2</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Compound dosed po (1 mg/kg) as a suspension in MCT and iv (0.5 mg/kg) as a 60% PEG solution or 20–60% NMP solution for systemic PK and iv as a 60% NMP solution for brain PK.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">In vitro stability in cryopreserved hepatocytes.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">h/r = human/rat.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/[(100 – % rat PPB)/100].</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">A–B, apical-to-basolateral.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Efflux ratio.</p></div><div class="footnote" id="t2fn8"><sup>h</sup><p class="last">B–A, basolateral-to-apical.</p></div><div class="footnote" id="t2fn9"><sup>i</sup><p class="last">Unbound brain/unbound plasma AUC ratio.</p></div><div class="footnote" id="t2fn10"><sup>j</sup><p class="last">CSF/unbound plasma AUC ratio.</p></div></div></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Small molecule X-ray crystal structure of <b>7</b> with suggested intramolecular hydrogen bonds in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initial Invitrogen kinase selectivity profiling of <b>7</b> at 0.1 μM (178 kinases, 60-fold over LRRK2 <i>K</i><sub>i</sub>; 0 kinases at >50% inhibition) and 1 μM (63 kinases, 600-fold over LRRK2 <i>K</i><sub>i</sub>; 0 kinases at >80% inhibition) demonstrates that <b>7</b> is likely to be a highly selective inhibitor for LRRK2. In order to ensure that we were including all structurally related kinases in our screening panels, we re-evaluated the ATP binding site sequences of all human kinases to identify those that have either a high ATP binding site sequence identity to LRRK2 or a combination of a Met gatekeeper and a small residue such as Leu, Val, Cys, or Ala at the Leu1949 position. We found 41 kinases that met these criteria. Of the 11 of these that were available at Invitrogen and were not represented in our original panels, only TTK (MPS1) was inhibited by several of our lead compounds. Compound <b>7</b>, for example, inhibited TTK activity by 55% at 0.1 μM and 98% at 1 μM. A TTK Lanthascreen assay provided a <i>K</i><sub>i</sub> of 25 nM for <b>7</b>, which translates to a biochemical TTK selectivity index of 13×.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(49)</a> Because of the structural homology between LRRK2 and TTK, as well as potential toxicity concerns (vide infra), it was decided that an increased TTK selectivity index was desirable.</div><div class="NLM_p">In an attempt to introduce additional TTK selectivity while maintaining the desirable attributes of <b>7</b>, we examined the inhibitor binding site residue differences between a published TTK crystal structure (magenta, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3GFW">3GFW</a>)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(50)</a> and the LRRK2 homology model (green) with <b>7</b> (cyan) docked in TTK (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The Cys604 TTK residue is smaller than Leu1949, supporting the lack of selectivity imparted by the <i>o</i>-methoxy group that serves as the key selectivity handle for many kinases with larger residues at this position. Additionally, both TTK and LRRK2 have Met gatekeepers. However, our analysis suggested that we may be able to exploit the Ser1954 (LRRK2) to Asp608 (TTK) residue difference by adding substituents at C-5′ of the front pocket phenyl ring (para to the methoxy group) and introducing unfavorable steric and electrostatic interactions with the bulkier, negatively charged Asp608 side chain. The estimated distance from C-5′ of docked <b>7</b> (cyan) to the Asp608 side chain carboxyl oxygen is approximately 3.9 Å. Thus, relatively small substituents were anticipated to clash with the Asp608 side chain and provide an increased TTK selectivity index.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key residue differences between LRRK2 homology model (green) and TTK X-ray structure (magenta) with <b>7</b> (cyan) docked in TTK. Hydrogen bond interactions between the TTK hinge residue Gly605 and <b>7</b> are shown as yellow dashed lines. The red arrow shows the measured distance between C-5′ of <b>7</b> and the side chain carboxyl oxygen of Asp608.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the lack of TTK selectivity, we also discovered that <b>7</b> induced micronuclei formation at low concentrations in a human peripheral blood lymphocyte in vitro assay and in a mouse in vivo micronucleus study at multiple doses. While TTK has not been previously implicated in in vitro genotoxicity findings,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(51)</a> the role of TTK in cell-cycle checkpoint assembly raised some concern that in vitro genotoxicity could be linked to TTK inhibition and further supported our decision to identify compounds with greater TTK selectivity.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(52)</a> Guided by the structural insight described above, we therefore designed the phenyl C-5′ substituted small molecule inhibitors shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_p">Phenyl C-5′ chloro (<b>8</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) and methoxy (<b>9</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) substituted matched pairs of <b>7</b> provided clear support for the TTK selectivity hypothesis as the biochemical TTK selectivity index increased from 13× in <b>7</b> to 53× and 275×, respectively. These compounds also maintained desirable LRRK2 cellular activities (7 and 21 nM). Desirable selectivity indices over JAK2 and TTK were also achievable with chlorine as the C-2′ JAK selectivity handle and methoxy at C-5′ (<b>10</b> and <b>11</b>). Expanded kinase profiling (189 kinases) at 1 μM demonstrated excellent selectivity for both <b>10</b> (250-fold over LRRK2 <i>K</i><sub>i</sub>; 0 kinases at >75% inhibition) and <b>11</b> (345-fold over LRRK2 <i>K</i><sub>i</sub>; only two kinases at >80% inhibition). Thus, TTK and JAK2 biochemical assays were incorporated into our screening cascade as off-target counterscreens and served as robust indicators of general kinase selectivity for new compounds.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Preliminary Investigation of Phenyl 2′,5′-Substitution for Increased TTK Selectivity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0015.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">LRRK2 <i>K</i><sub>i</sub> <a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">JAK2 selectivity index<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">TTK selectivity index<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">pLRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">>1928</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">>1368</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">>2540</td><td class="colsep0 rowsep0" align="char" char=".">275</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">>808</td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">>1096</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Biochemical assay.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">(JAK2 <i>K</i><sub>i</sub>)/(LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">(TTK <i>K</i><sub>i</sub>)/(LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Cellular assay.</p></div></div></div><div class="NLM_p">After the TTK selectivity issues were addressed, the in vitro and in vivo DMPK profiles of phenyl 2′,5′ substituted analogues <b>8</b>–<b>12</b> were assessed (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The plasma protein binding of <b>8</b> was unexpectedly high, resulting in an unbound clearance (551 mL min<sup>–1</sup> kg<sup>–1</sup>) 3.5-fold higher than <b>7</b> and an unacceptable <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> ratio of 0.11. Despite showing slight MDR1 efflux with the human P-gp cell line, dimethoxy analogue <b>9</b> demonstrated an in vivo profile comparable to that of <b>7</b>. While <b>9</b> did not reveal any covalent adducts from in vitro trapping studies with glutathione, we ultimately decided not to pursue this compound because of concerns regarding electrophilic metabolites that might be formed from oxidation of the electron-rich phenyl ring. The excellent brain penetration of <b>10</b> was promising (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.77); however, a large in vitro–in vivo (iviv) disconnect resulted in a clearance higher than liver blood flow. As a result of significant N-demethylation observed from in vitro metabolite identification studies, the aminoethyl analogue of <b>10</b> (<b>11</b>) was prepared and successfully reduced the total clearance while maintaining comparable brain penetration. Both <b>10</b> and <b>11</b> also demonstrated significant in vitro oxidative metabolism of the morpholine ring. Thus, in an attempt to further reduce the metabolic turnover, the morpholine-<i>d</i><sub>8</sub> analogue (<b>12</b>) of <b>11</b> was synthesized and reduced the clearance significantly, presumably because of kinetic deuterium isotope effects.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(53)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Rat in Vitro and in Vivo PK Profiles of Phenyl 2′,5′-Substituted Aminopyrimidines <b>8</b>–<b>12</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hepatocytes Cl<sub>hep</sub> <a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>(mL min<sup>–1</sup> kg<sup>–1</sup>),h/r<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">% rat PPB</th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">MDR1<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a><i>P</i><sub>app</sub>, A–B<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a>(×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">MDR1 P-gp ER<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a>(B–A<a class="ref internalNav" href="#t4fn8" aria-label="h">h</a>/A–B<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a>)</th><th class="colsep0 rowsep0" align="center" char="."><i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t4fn9" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center" char=".">CSF/P<sub>u</sub> <a class="ref internalNav" href="#t4fn10" aria-label="j">j</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2.8/22</td><td class="colsep0 rowsep0" align="char" char=".">99.1</td><td class="colsep0 rowsep0" align="left">4.7 (551)</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">0.8/15.2</td><td class="colsep0 rowsep0" align="char" char=".">91.4</td><td class="colsep0 rowsep0" align="left">15<a class="ref internalNav" href="#t4fn11" aria-label="k">k</a>(170)</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">0.8/3.7</td><td class="colsep0 rowsep0" align="char" char=".">90.8</td><td class="colsep0 rowsep0" align="left">59<a class="ref internalNav" href="#t4fn11" aria-label="k">k</a>(640)</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.9/26</td><td class="colsep0 rowsep0" align="char" char=".">96.3</td><td class="colsep0 rowsep0" align="left">19<a class="ref internalNav" href="#t4fn11" aria-label="k">k</a>(514)</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a class="ref internalNav" href="#t4fn12" aria-label="l">l</a></td><td class="colsep0 rowsep0" align="left">5.7/14</td><td class="colsep0 rowsep0" align="char" char=".">95.5</td><td class="colsep0 rowsep0" align="left">10<a class="ref internalNav" href="#t4fn11" aria-label="k">k</a>(227)</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Compound dosed po (1 mg/kg) as a suspension in MCT and iv (0.5 mg/kg) as a 60% PEG solution or 20–60% NMP solution for systemic PK and iv as a 60% NMP solution for brain PK.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">In vitro stability in cryopreserved hepatocytes.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">h/r = human/rat.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/[(100 – % rat PPB)/100].</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">A–B, apical-to-basolateral.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">Efflux ratio.</p></div><div class="footnote" id="t4fn8"><sup>h</sup><p class="last">B–A, basolateral-to-apical.</p></div><div class="footnote" id="t4fn9"><sup>i</sup><p class="last">Unbound brain/unbound plasma AUC ratio.</p></div><div class="footnote" id="t4fn10"><sup>j</sup><p class="last">CSF/unbound plasma AUC ratio.</p></div><div class="footnote" id="t4fn11"><sup>k</sup><p class="last">Blood clearance is reported.</p></div><div class="footnote" id="t4fn12"><sup>l</sup><p class="last">Morpholine-<i>d</i><sub>8</sub> analogue of <b>11</b>.</p></div></div></div><div class="NLM_p">As previously mentioned, <b>7</b> demonstrated genotoxicity at low concentrations. This is a concern for an indication that potentially requires chronic dosing from an early age. Therefore, <b>10</b> and <b>11</b> were chosen for in vitro analyses in a human peripheral blood lymphocyte genotoxicity assay. While we were pleased to find that both parent molecules did not induce micronuclei formation, incubation of <b>11</b> with S9 fraction revealed the formation of potentially clastogenic metabolites. Since the in vitro metabolite profile of deuterated morpholine analogue <b>12</b> was similar to that of <b>11</b>, these molecules were deprioritized.</div><div class="NLM_p">At this point in our program, we had established reliable metabolic stability and permeability iviv correlations with a wide range of aminopyrimidines, including those already illustrated. These relationships were used to rapidly triage newly synthesized molecules prior to in vivo evaluation, and their associated physicochemical property ranges provided useful guidelines at the design stage. For example, retrospective analysis revealed that analogues with a cLogD between 1.8 and 3.3 had the highest probability (60%) of being metabolically stable in human hepatocytes (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). While inhibitors with a cLogD < 1.8 also demonstrated good stability, most of these compounds were P-gp efflux substrates. Most analogues with TPSA < 90 showed a low propensity for P-gp efflux (85% exhibited an efflux ratio of <3, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Thus, the application of refined design parameters (1.8 < cLogD < 3.3 and TPSA < 90)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(54)</a> for future analogues in this series was adopted to increase our probability of success and ultimately reduce the number of compounds synthesized prior to nomination for development.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Vortex charts illustrating (A) binned cLogD (pH 7.4) values for aminopyrimidines colored by in vitro human hepatocyte stability measured from cryopreserved hepatocytes and (B) binned TPSA values for aminopyrimidines colored by MDCK-MDR1 efflux ratios (ER), Vortex, version 2012.02.13219.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With several molecules already demonstrating fairly optimized activity, selectivity, and ADME profiles within the aminopyrimidine scaffold, our goal was to make subtle improvements while staying within the desirable property ranges. This focus led to the alternative phenyl substitution patterns shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. C-5′ methyl analogues <b>13</b> and <b>14</b> displayed good TTK selectivity, with the latter also possessing good LRRK2 cellular activity. In an attempt to maintain acceptable selectivity indices while reducing both molecular weight and lipophilicity, various methoxy/fluoro combinations were targeted (<b>15</b>–<b>19</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). <b>15</b> demonstrated excellent kinase selectivity when tested against 189 kinases at 1 μM (135-fold over LRRK2 <i>K</i><sub>i</sub>; 0 kinases at >75% inhibition); however, the LRRK2 cellular activity for <b>15</b> (63 nM) was suboptimal. Inhibitor <b>16</b>, which lacked a C-5′ group, was even less selective for TTK than <b>7</b> and confirmed the necessity for a substituent at C-5′. Simply shifting the fluorine from C-3′ to C-5′ (<b>17</b>) restored the biochemical TTK selectivity index to greater than 50× while also increasing affinity for LRRK2. Maintaining the methoxy/fluoro arrangement at C-2′/C-5′ and varying aminoalkyl R<sup>1</sup> substitution resulted in single-digit nanomolar LRRK2 cellular activities for <b>GNE-7915</b> (<b>18</b>, 9 nM, R<sup>1</sup> = aminoethyl) and <b>19</b> (4 nM, R<sup>1</sup> = aminocyclopropyl). Expanded Invitrogen kinase profiling (187 kinases) at 0.1 μM for both <b>18</b> (100-fold over LRRK2 <i>K</i><sub>i</sub>) and <b>19</b> (250-fold over LRRK2 <i>K</i><sub>i</sub>) resulted in only TTK showing greater than 50% inhibition. Selectivity profiling using the DiscoverX KinomeScan<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(55)</a> competitive binding assay panel, which included 392 unique kinases, was also performed for <b>18</b> at 0.1 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Binding of >50% probe displacement was detected for 10 kinases and of >65% for only LRRK2, TTK, and ALK, further supporting the excellent LRRK2 selectivity for <b>18</b>. Cerep receptor profiling, including expanded brain panels, suggested that <b>18</b> and <b>19</b> only inhibited 5-HT<sub>2B</sub> with >70% inhibition at 10 μM. <b>18</b> and <b>19</b> were confirmed to be moderately potent 5-HT<sub>2B</sub> antagonists in in vitro functional assays.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(56)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Aminopyrimidine Phenyl 2′,3′,5′-Substitution SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0016.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char=".">LRRK2 <i>K</i><sub>i</sub> <a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">JAK2 selectivity index<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">TTK selectivity index<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">pLRRK2 IC<sub>50</sub> <a class="ref internalNav" href="#t5fn4" aria-label="d">d</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">>489</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">>1871</td><td class="colsep0 rowsep0" align="char" char=".">387</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">189</td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">>262</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">>533</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">>3200</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left"><i>c</i>Pr</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">>3200</td><td class="colsep0 rowsep0" align="char" char=".">118</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Biochemical assay.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">(JAK2 <i>K</i><sub>i</sub>)/(LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">(TTK <i>K</i><sub>i</sub>)/(LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Cellular assay.</p></div></div></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. KinomeScan selectivity tree for <b>18</b> at 0.1 μM (100-fold over LRRK2 <i>K</i><sub>i</sub>). Of 451 profiled kinases, only LRRK2, TTK, and ALK demonstrated <35% inhibition of % control (>65% probe displacement).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The DMPK profiles of the most promising compounds from Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were then assessed (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Inhibitor <b>14</b> was moderately cleared as predicted by in vitro measurements and demonstrated good metabolic stability in human hepatocytes. It also displayed good in vivo brain penetration. Compound <b>17</b> also showed a strong iviv correlation with respect to metabolic clearance; however, the <i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> ratio of 0.15 was suboptimal. Both <b>18</b> and <b>19</b> demonstrated excellent in vitro DMPK and in vivo rat PK profiles: (a) minimal turnover in human hepatocytes; (b) low total and unbound clearance values as predicted by rat hepatocytes; (c) long half-lives and good oral exposure; (d) high passive permeability, no human P-gp efflux, and good brain penetration in rats. Having established the lead profiles of <b>14</b>, <b>18</b>, and <b>19</b> as benchmarks, additional SAR exploration was carried out to address specific areas that we felt could potentially be improved upon.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat in Vitro and in Vivo PK Profiles of Phenyl 2′,5′-Substituted Aminopyrimidines <b>14</b> and <b>17</b>–<b>19</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hepatocytes Cl<sub>hep</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>(mL min<sup>–1</sup> kg<sup>–1</sup>),h/r<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">% rat PPB</th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">MDR1<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a><i>P</i><sub>app</sub>, A–B<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a>(×10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">MDR1 P-gp ER<a class="ref internalNav" href="#t6fn7" aria-label="g">g</a>(B–A<a class="ref internalNav" href="#t6fn8" aria-label="h">h</a>/A–B<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a>)</th><th class="colsep0 rowsep0" align="center" char="."><i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t6fn9" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center" char=".">CSF/<i>P</i><sub>u</sub> <a class="ref internalNav" href="#t6fn10" aria-label="j">j</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">4.2/22</td><td class="colsep0 rowsep0" align="char" char=".">95.8</td><td class="colsep0 rowsep0" align="left">28 (667)</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">3.9/11</td><td class="colsep0 rowsep0" align="char" char=".">95.7</td><td class="colsep0 rowsep0" align="left">12 (279)</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3.2/14</td><td class="colsep0 rowsep0" align="char" char=".">96.6</td><td class="colsep0 rowsep0" align="left">8.3 (244)</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">10.4</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">4.9/15</td><td class="colsep0 rowsep0" align="char" char=".">97.6</td><td class="colsep0 rowsep0" align="left">6.8 (296)</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">10.9</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Compound dosed po (1 mg/kg) as a suspension in MCT and iv (0.5 mg/kg) as a 60% PEG solution or 20–60% NMP solution for systemic PK and iv as a 60% NMP solution for brain PK.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">In vitro stability in cryopreserved hepatocytes.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">h/r = human/rat.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/[(100 – % rat PPB)/100].</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line.</p></div><div class="footnote" id="t6fn6"><sup>f</sup><p class="last">A–B, apical-to-basolateral.</p></div><div class="footnote" id="t6fn7"><sup>g</sup><p class="last">Efflux ratio.</p></div><div class="footnote" id="t6fn8"><sup>h</sup><p class="last">B–A, basolateral-to-apical.</p></div><div class="footnote" id="t6fn9"><sup>i</sup><p class="last">Unbound brain/unbound plasma AUC ratio.</p></div><div class="footnote" id="t6fn10"><sup>j</sup><p class="last">CSF/unbound plasma AUC ratio.</p></div></div></div><div class="NLM_p">As amides are often substrates for P-gp, one approach to improve brain penetration of our current leads was to introduce amide isosteres such as tetrazole <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Indeed, <b>20</b> did exhibit good brain exposure (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.65); however, poor solubility, relatively modest LRRK2 cellular activity, and mild CYP1A2 TDI precluded further advancement. Similar tetrazoles, triazoles, pyrazoles, and other heterocyclic replacements showed promising brain exposure, but most suffered from a combination of poor solubility and time-dependent inhibition of CYP1A2. Alkylsulfones were also investigated as amide replacements. Representative of this series, <b>21</b> showed good in vivo stability and brain PK (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.70); however, the alkylsulfones were compromised by time-dependent inhibition of CYP1A2, poor solubility, and interestingly, inadequate kinase selectivity. These observations are consistent with the notion that the morpholinoamide functionality of the primary series of inhibitors is optimal for decreasing inhibitor planarity and improving solubility.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(57, 58)</a> Pyridine replacement of the phenyl ring was also conducted to improve solubility and gauge whether or not the C-5′ nitrogen lone pair could serve as a suitable TTK selectivity handle. <b>22</b> provided support for this hypothesis, as it showed a 63-fold selectivity TTK index. Unfortunately, although <b>22</b> exhibited optimal cellular activity, unbound clearance, and bioavailability, poor brain penetration prevented further profiling. Scission of the amide bond in <b>22</b> and removal of the morpholine nitrogen to avoid bis-aniline formation afforded <b>23</b>. Unfortunately, while <b>23</b> and various other saturated heterocycles enhanced brain penetration, inadequate levels of TTK selectivity were obtained. Finally, several morpholine derivatives were targeted, as the morpholine ring had been identified as a major site of metabolism and an altered metabolic profile for unpredictable toxicity/genotoxicity could prove desirable. This strategy is exemplified by <b>24</b> and <b>25</b> where the intent was to minimize P-gp recognition of the introduced polarity through steric congestion (tertiary alcohols) and intramolecular hydrogen bonding (secondary amide <i>N</i>-H and arylfluorine). Good LRRK2 activity and in vivo metabolic clearance was achieved, but a combination of poor solubility and insufficient unbound brain levels again precluded further progression.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. SAR and DMPK Profiles of Aminopyrimidines <b>20</b>–<b>25</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0017.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0018.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">Compound dosed po (1 mg/kg) as a suspension in MCT and iv (0.5 mg/kg) as a 60% PEG solution or 20–60% NMP solution for systemic PK and iv as a 60% NMP solution for brain PK.</p></div><div class="footnote" id="t7fn2"><sup>Table b</sup><p class="last">Biochemical assay.</p></div><div class="footnote" id="t7fn3"><sup>Table c</sup><p class="last">(TTK <i>K</i><sub>i</sub>)/(LRRK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t7fn4"><sup>Table d</sup><p class="last">Cellular assay.</p></div><div class="footnote" id="t7fn5"><sup>Table e</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/[(100 – % rat PPB)/100].</p></div><div class="footnote" id="t7fn6"><sup>Table f</sup><p class="last">MDCK-MDR1 human P-gp transfected cell line.</p></div><div class="footnote" id="t7fn7"><sup>Table g</sup><p class="last">efflux ratio.</p></div><div class="footnote" id="t7fn8"><sup>Table h</sup><p class="last">A:B, apical-to-basolateral; B:A, basolateral-to-apical.</p></div><div class="footnote" id="t7fn9"><sup>Table i</sup><p class="last">Unbound brain/unbound plasma AUC ratio.</p></div><div class="footnote" id="t7fn10"><sup>Table j</sup><p class="last">Blood clearance is reported.</p></div></div><div></div></div><div class="NLM_p">Lead compounds <b>14</b>, <b>18</b>, and <b>19</b> were further evaluated in PK/PD studies. Thus, BAC transgenic mice expressing human LRRK2 protein with the G2019S Parkinson’s disease mutation were given either a single oral dose (po) or intraperotineal (ip) injection. Brain (hippocampus) and peripheral (spleen) tissues were harvested 1–24 h postdose to assess pSer1292 levels and compound concentration.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A shows robust, concentration-dependent knockdown of pLRRK2 in the brain after oral dosing with <b>18</b> at both 15 and 50 mg/kg and after ip dosing at both 10 and 50 mg/kg (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for spleen PK/PD graphs of <b>18</b>, <b>19</b>, and <b>14</b>). By use of a pharmacodynamic inhibition model to fit the data, <b>18</b> had a calculated in vivo unbound brain IC<sub>50</sub> of 7 nM, which is consistent with the cellular IC<sub>50</sub> of 9 nM.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(59)</a> Taken together with the recently published PK/PD data for <b>7</b>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> we adopted a screening PK/PD protocol that involved ip dosing at both 10 and 50 mg/kg with tissue collection at 1 and 6 h postdose to assess future compounds with promising profiles. In these studies, <b>19</b> and <b>14</b> also demonstrated on-target reduction of brain pLRRK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B and Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C) with calculated in vivo unbound brain IC<sub>50</sub> of 27 nM for <b>19</b> and 24 nM for <b>14</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo G2019S LRRK2 transgenic mouse PK/PD results measuring brain pSer1292 autophosphorylation. The closed circles represent the observed data, and the lines represent the predicted data from a direct inhibition model. Percent inhibition is normalized to pSer1292 levels observed in mice dosed with vehicle alone (<i>n</i> = 3). Plotted data are shown for mice treated with (A) <b>18</b> [15 mg/kg, po, at 1, 3, and 6 h (<i>n</i> = 4/dose); 50 mg/kg, po, at 1, 3, 6, and 12 h (<i>n</i> = 4/dose) and 24 h (<i>n</i> = 1); 10 mg/kg, ip, at 1 and 2.5 h (<i>n</i> = 3/dose); 50 mg/kg, ip, at 1 and 6 h (<i>n</i> = 3/dose)]; (B) <b>19</b> [10 and 50 mg/kg, ip, at 1 and 6 h (<i>n</i> = 3/dose)]; (C) <b>14</b> [10 and 50 mg/kg, ip, at 1 and 6 h (<i>n</i> = 3/dose)].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a result of their encouraging in vitro and in vivo profiles, <b>18</b> and <b>19</b> were both progressed to cynomolgus monkey PK studies. As depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, both compounds exhibited low total and unbound plasma clearance values and long half-lives. The bioavailability for <b>18</b> at 1 mpk (17%) and 20 mpk (24%) was slightly lower than expected, especially when one considers the minimal contribution from first pass hepatic extraction. It is known, however, that compounds predominantly metabolized by CYP enzymes can demonstrate higher levels of first-pass intestinal metabolism in cynomolgus monkeys than in humans.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(60)</a> The decline in oral exposure from 1 to 20 mpk with <b>19</b> is suggestive of solubility-limited absorption.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(61)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vivo Cyno PK Profiles of <b>18</b> and <b>19</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hepatocytes Cl<sub>hep</sub> <a class="ref internalNav" href="#t8fn2" aria-label="b">b</a>(mL min<sup>–1</sup> kg<sup>–1</sup>), cyno</th><th class="colsep0 rowsep0" align="center" char=".">% cyno PPB</th><th class="colsep0 rowsep0" align="center">Cl (Cl<sub>u</sub>)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">iv <i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%),1 mg/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%),20 mg/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="char" char=".">94.5</td><td class="colsep0 rowsep0" align="left">11 (200)</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="char" char=".">95.5</td><td class="colsep0 rowsep0" align="left">3.8 (84)</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Compound dosed po (1 and 20 mg/kg) with crystalline material as a suspension in MCT and iv (0.5 mg/kg) as a 20–60% NMP solution.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">In vitro stability in cryopreserved hepatocytes.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Cl<sub>u</sub> = unbound clearance = total clearance/[(100 – % cyno PPB)/100].</p></div></div></div><div class="NLM_p last">As the advancement of previous leads had been halted because of genotoxicity concerns, <b>18</b> was chosen for evaluation of in vivo genotoxic liabilities. Sprague–Dawley rats were administered <b>18</b> daily for 2 days at 100 mg/kg via oral gavage and assessed for the presence of micronucleated polychromatic erythrocytes in their bone marrow. Inhibitor <b>18</b> did not induce micronucleus formation, even with an approximate unbound AUC<sub>(0–24h)</sub> plasma concentration of 5.95 μM·h. <b>18</b> was then progressed to 7-day repeat-dose toxicity studies in rats (10, 50, and 100 mg/kg) and cynomolgus monkeys (10, 25, and 65 mg/kg). The compound was well tolerated in rats after oral administration with day 7 mean unbound plasma AUC<sub>(0–24h)</sub> concentrations of 0.8, 3.9, and 4.7 μM·h, respectively. High drug exposures were also achieved in cynomolgus monkeys with day 7 mean unbound plasma AUC<sub>(0–24h)</sub> concentrations of 0.8, 3.1, and 7.8 μM·h, respectively. Additionally, cyno terminal brain and CSF levels measured 24 h after receiving the last dose on day 7 confirmed good brain penetration (<i>B</i><sub>u</sub>/<i>P</i><sub>u</sub> = 0.6 and CSF/<i>P</i><sub>u</sub> = 0.82). Taken together, these results indicate that <b>18</b> can be used to preclinically assess the consequences of inhibiting LRRK2 kinase activity in the brain. Full disclosure of toxicity studies performed with <b>18</b> and other aminopyrimidines will be disclosed in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73540" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73540" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of aminoethyl (<b>28</b>) and aminocyclopropyl (<b>29</b>) 2,4-diaminopyrimidine rings are shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> describes the two-step syntheses of <b>2</b> and <b>4</b> from known (<b>30</b>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or commercially available (<b>31</b>) starting materials. Tetrasubstituted precursors for <b>13</b> and <b>14</b> are derived from anilines <b>33</b> and <b>34</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) via a Sandmeyer reaction to provide arylnitriles <b>35</b> and <b>36</b> followed by hydrolysis to afford carboxylic acids <b>37</b> and <b>38</b>. The precursor for <b>15</b> is generated from regioselective methoxide displacement of <b>39</b> to provide <b>40</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>), followed by hydrolysis to yield benzoic acid <b>41</b>. Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> illustrates the representative syntheses of aminopyrimidine tetra- and pentasubstituted morpholinoamides. Standard amide formation from the associated benzoic acid (<b>41</b>–<b>43</b>) followed by acid catalyzed S<sub>N</sub>Ar or Buchwald–Hartwig coupling between anilines <b>44</b>–<b>46</b> and a 4-aminoalkyl-2-chloro-5-trifluoromethylpyrimidine derivative furnished an array of products. The second method used to synthesize various aminopyrimidine targets commences from morpholine amide formation of the respective <i>p</i>-nitrobenzoic acids (<b>37</b>, <b>38</b>, <b>47</b>–<b>49</b>) followed by nitro reduction and S<sub>N</sub>Ar coupling between anilines <b>55</b>–<b>59</b> and <b>60</b>. The third protocol used to provide <b>12</b>, <b>18</b>, and <b>19</b> involved a TFA catalyzed S<sub>N</sub>Ar of anilines <b>42</b> and <b>43</b> and then peptide coupling as the final step.</div><div class="NLM_p">The synthesis of aminopyrimidine amide isosteres <b>20</b> and <b>21</b> is depicted in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. <b>20</b> is derived from Buchwald–Hartwig coupling of 4-amino-3-chlorobenzonitrile <b>64</b> and 4-aminomethyl-2-chloro-5-trifluoromethylpyrimidine (<b>60</b>), followed by tetrazole formation (<b>66</b>) and methylation. Nucleophilic arylfluorine displacement with sodium thiomethoxide, <i>m</i>-CPBA oxidation to the corresponding sulfone <b>69</b>, nitro reduction, and acid catalyzed coupling of the resulting aniline <b>70</b> with 4-aminomethyl-2-chloro-5-trifluoromethylpyrimidine (<b>60</b>) yielded <b>21</b>. Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> illustrates the independent syntheses of pyridine analogues <b>22</b> and <b>23</b> as well as morpholine amide derivatives <b>24</b> and <b>25</b>. Hence, palladium catalyzed aminocarbonylation of 6-chloro-4-methoxypyridin-3-amine <b>71</b> with morpholine and Mo(CO)<sub>6</sub> followed by Buchwald coupling afforded <b>22</b>. The synthesis of <b>23</b> commenced with palladium catalyzed cross-coupling of 2-chloro-4-methoxy-5-nitropyridine (<b>73</b>) followed by concomitant dihydropyran and nitro reduction to give <b>75</b>. Buchwald coupling then provided the final target (<b>23</b>). Amide derivative <b>24</b> was synthesized in the same manner as <b>18</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>), using 1-amino-2-methylpropan-2-ol instead of morpholine. Lastly, bromination of toluene derivative <b>76</b>, amide formation, and subsequent intramolecular lactam formation to give <b>78</b> followed by nitro reduction and standard S<sub>N</sub>Ar coupling afforded isoindolone <b>25</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 2,4-Diaminopyrimidine Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, KF, TMSCF<sub>3</sub>, DMF, Δ, 69%; (b) <i>c</i>-PrNH<sub>2</sub>, THF, 34%.</p></p></figure><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aminopyrimidine-4-methoxy Analogues <b>2</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,5-dichloro-4-methoxypyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, microwave, 15%; (b) 5-bromo-2-chloro-4-methoxypyrimidine, TFA, <i>n</i>-BuOH, microwave, 35%; (c) morpholine, HBTU, DIPEA, DMF, 56%.</p></p></figure><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Tetrasubstituted Phenyl Intermediates for the Synthesis of <b>13</b>, <b>14</b>, and <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) acetone, conc HCl, H<sub>2</sub>O, NaNO<sub>2</sub>, then CuCN, NaCN; (b) AcOH, conc H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, Δ; (c) <i>t</i>-BuOK, MeOH, THF, 80%; (d) KOH, EtOH, H<sub>2</sub>O, 68%.</p></p></figure><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aminopyrimidine Phenyl Tetra- and Pentasubstituted Morpholinoamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, HATU or HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>; (b) TFA, <i>n</i>-BuOH, Δ; (c) Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd(OAc)<sub>2</sub>, dioxane, microwave; (d) PTSA, dioxane, Δ; (e) TFA, <i>n</i>-BuOH, microwave; (f) Pd/C, MeOH, H<sub>2</sub> or SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, H<sub>2</sub>O, Δ or Fe dust, EtOH, NH<sub>4</sub>Cl, H<sub>2</sub>O, Δ; (g) <i>n</i>-BuOH, microwave; (h) 2-chloro-<i>N</i>-alkyl-5-(trifluoromethyl)pyrimidin-4-amine, PTSA, dioxane, Δ.</p><p class="last"><span class="fn-label">Scheme b</span>Morpholine-<i>d</i><sub>8</sub> analogue.</p></p></figure><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Aminopyrimidineamide Isosteres <b>20</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>60</b>, Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, Δ, 45%; (b) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, Δ, 85%; (c) MeI, K<sub>2</sub>CO<sub>3</sub>, acetone, Δ, 70%; (d) MeSNa, EtOH, Δ, 91%; (e) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 48%; (f) Pd/C, EtOH, H<sub>2</sub>, 99%; (g) <b>60</b>, TFA, 2-methoxyethanol, Δ, 19%.</p></p></figure><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyridine Analogues and Morpholinoamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mo(CO)<sub>6</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 4-DMAP, DIPEA, morpholine, dioxane, microwave, 50%; (b) <b>28</b>, BrettPhos, BrettPhos precatalyst, NaO-<i>t</i>-Bu, <i>t</i>-BuOH, Δ, 35%; (c) 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Na<sub>2</sub>CO<sub>3</sub>, KOAc, Pd(amphos)Cl<sub>2</sub>, CH<sub>3</sub>CN, degassed H<sub>2</sub>O, microwave, 79%; (d) Pd/C, EtOH, H<sub>2</sub>; (e) <b>60</b>, BrettPhos, BrettPhos precatalyst, NaO-<i>t</i>-Bu, <i>t</i>-BuOH, Δ, 52%, two steps; (f) <b>28</b>, PTSA, dioxane, Δ; (g) 1-amino-2-methylpropan-2-ol, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 95%, two steps; (h) SOCl<sub>2</sub>, MeOH, Δ, 82%; (i) NBS, CH<sub>3</sub>CN, AIBN, Δ, 31%; (j) 1-amino-2-methylpropan-2-ol, Et<sub>3</sub>N, MeOH, Δ; (k) Fe dust, EtOH, NH<sub>4</sub>Cl, H<sub>2</sub>O, Δ, 77%, two steps; (l) PTSA, dioxane, Δ, 33%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from highly ligand efficient leads <b>1</b> and <b>7</b>, the successful development of small molecule LRRK2 inhibitors suitable for higher species toxicity studies and early development evaluation is described. Optimization of LRRK2 cellular activity through appropriate C-4/C-5 aminopyrimidine substitution was achieved while imparting broad kinase selectivity, including structurally related kinases such as TTK, through strategic decoration of the phenyl ring. We were also able to effectively balance physicochemical properties, which enabled the generation of inhibitors with excellent in vitro and in vivo DMPK profiles including minimal turnover in human hepatocytes and low unbound clearance and good oral exposure in rodents and cynomologus monkeys. Of equal importance was the demonstrated ability of multiple compounds to penetrate the blood–brain barrier while maintaining such a well-balanced profile. Taken together, these efforts culminated in the discovery of <b>GNE-7915</b> (<b>18</b>) and <b>19</b>, highly potent, selective, metabolically stable and brain-penetrant LRRK2 inhibitors with potent in vivo unbound brain IC<sub>50</sub> values measured from G2019S transgenic mice PK/PD studies. <b>GNE-7915</b> achieved high exposures in the periphery and brain throughout a 7-day dosing regimen in both rat and cynomolgus monkey toxicity studies. A detailed report of toxicity studies and associated histopathology findings with <b>GNE-7915</b> and other aminopyrimidine LRRK2 inhibitors will be disclosed in a subsequent publication.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All chemicals were purchased from commercial suppliers and used as received. Flash chromatography was carried out with prepacked SiO<sub>2</sub> cartridges from either ISCO or SiliCycle on an ISCO Companion chromatography system using gradient elution or with prepacked silica gel cartridges from Biotage using a Biotage SP4 or an Isolera 4 MPLC system using gradient elution. NMR spectra were recorded on Bruker Avance 400, Bruker DPX 400M, Bruker Avance III 400, and Bruker AV III 400 or 500 NMR spectrometers and referenced to tetramethylsilane. The following abbreviations are used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet. Preparative HPLC was performed on a Polaris C<sub>18</sub> 5 μm column (50 mm × 21 mm), a Waters Sunfire OBD Phenomenex Luna phenylhexyl column (150 mm × 19 mm), or a Waters Xbridge phenyl column (150 mm × 19 mm), eluting with mixtures of water–acetonitrile or water–methanol, optionally containing a modifier (0.1% v/v formic acid or 10 mM ammonium bicarbonate). Low-resolution mass spectra were recorded on a Sciex 15 mass spectrometer in ES+ mode, a Micromass ZQ single quadrapole LCMS in ES+, ES– mode, or a Quattro Micro LC–MS–MS in ES+, ES– mode. All final compounds were purified to >95% chemical and optical purity, as assayed by (a) HPLC (Waters Acquity UPLC column, 21 mm × 50 mm, 1.7 μm) with gradient of 0–90% acetonitrile (containing 0.038% TFA) in 0.1% aqueous TFA, with UV detection at λ = 254 and 210 as well as CAD detection with an ESA Corona detector or (b) HPLC (Phenomenex Luna C18 (2) column, 4.6 mm × 100 mm, 5 μm) with gradient of 5–95% acetonitrile in water (with 0.1% formic acid in each mobile phase), with UV DAD detection between λ = 210 and 400 nm; (c) HPLC (Waters Xterra MS C18 column, 4.6 mm × 100 mm, 5 μm) with gradient of 5–95% acetonitrile in water (with 10 mM ammonium bicarbonate in the aqueous mobile phase), with UV DAD detection between λ = 210 and 400 nm; (d) HPLC (Supelco, Ascentis Express C18 or Hichrom Halo C18 column, 4.6 mm × 150 mm, 2.7 μm) with gradient of 4–100% acetonitrile in water (with 0.1% formic acid in each mobile phase), with UV DAD detection between λ = 210 and 400 nm; (e) HPLC (Phenomenex, Gemini NX C18 column, 4.6 mm × 150 mm, 3 μm) with gradient of 4.5–100% acetonitrile in water (with 10 mM ammonium bicarbonate in the aqueous mobile phase), with UV DAD detection between λ = 210 and 400 nm.</div><div class="NLM_p">The syntheses of compounds <b>1</b>, <b>3</b>, <b>5</b>, <b>6</b>, and <b>7</b> have been described previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (4-(5-Chloro-4-methoxypyrimidin-2-ylamino)-3-methoxyphenyl)(morpholino)methanone (<b>2</b>)</h3><div class="NLM_p last">To a solution of (4-amino-3-methoxyphenyl)(morpholino)methanone (<b>30</b>, 0.490 g, 2.1 mmol) in 1,4-dioxane (7 mL) were added 2,5-dichloro-4-methoxypyrimidine (0.370 g, 2.1 mmol), Cs<sub>2</sub>CO<sub>3</sub> (1.4 g, 4.1 mmol), Xantphos (0.100 g, 0.21 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (0.095 g, 0.10 mmol), and the reaction mixture was stirred at 140 °C for 25 min under microwave irradiation. The reaction mixture was filtered, concentrated, purified by flash chromatography, 0–100% EtOAc/heptane, and further purified by preparative HPLC to afford the title compound (117 mg, 15% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (m, 2H), 8.16 (d, <i>J</i> = 8.2 Hz, 1H), 7.08 (d, <i>J</i> = 1.3 Hz, 1H), 7.01 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 4.00 (s, 3H), 3.89 (s, 3H), 3.61 (br s, 4H), 3.52 (br s, 4H). LCMS, <i>m</i>/<i>z</i> = 379 [M + H]<sup>+</sup>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (4-(5-Bromo-4-methoxypyrimidin-2-ylamino)-3-methoxyphenyl)(morpholino)methanone (<b>4</b>)</h3><div class="NLM_p">To a solution of 4-amino-3-methoxybenzoic acid (<b>31</b>, 1.77 g, 10.6 mmol) in <i>n</i>-BuOH (62 mL) was added 5-bromo-2-chloro-4-methoxypyridine (2.25 g, 10.1 mmol) and TFA (0.194 mL, 2.52 mmol), and the reaction mixture was stirred at 125 °C for 30 min under microwave irradiation. The formed precipitate was collected by filtration, washing with <i>n</i>-BuOH and then Et<sub>2</sub>O to provide 1.25 g of crude <b>32</b>, which was used without further purification.</div><div class="NLM_p last">To the crude carboxylic acid from above (<b>32</b>, 365 mg, 1.03 mmol) dissolved in DMF (10 mL) were added morpholine (0.110 mL, 1.26 mmol), DIPEA (0.215 mL, 1.24 mmol), and HBTU (469 mg, 1.24 mmol), and the reaction mixture was stirred at room temperature for 1 h. The mixture was diluted with water and extracted with EtOAc (3 × 20 mL), and the combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by preparative HPLC to afford the title compound (246 mg, 56% yield, two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.38 (s, 1H), 8.30 (s, 1H), 8.16 (d, <i>J</i> = 8.2 Hz, 1H), 7.08 (d, <i>J</i> = 1.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.3 Hz, 1H), 3.98 (s, 3H), 3.89 (s, 3H), 3.61 (br s, 4H), 3.52 (br s, 4H). LCMS, <i>m</i>/<i>z</i> = 423 [M + H]<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (2-Chloro-5-methoxy-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>8</b>, Method b)</h3><div class="NLM_p last">To a solution of 2-chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>60</b>, 0.10 g, 0.47 mmol) and (4-amino-2-chloro-5-methoxyphenyl)(morpholino)methanone (<b>55</b>, 0.11 g, 0.40 mmol) in <i>n</i>-BuOH (2.0 mL) was added TFA (0.051 mL, 0.66 mmol). The mixture was stirred at 75 °C for 2 h. The reaction mixture was then concentrated. The residue was purified by preparative HPLC to afford 66 mg (37% yield, two steps) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.51 (s, 1H), 8.24 (s, 1H), 8.12 (s, 1H), 7.32 (d, <i>J</i> = 4.0 Hz, 1H), 7.06 (s, 1H), 3.89 (s, 3H), 3.49–3.71 (m, 6H), 3.15–3.24 (m, 2H), 2.94 (d, <i>J</i> = 4.3 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 446 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (2,5-Dimethoxy-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(piperidin-1-yl)methanone (<b>9</b>, Method e)</h3><div class="NLM_p last">To a solution of (4-amino-2,5-dimethoxyphenyl)(morpholino)methanone (<b>59</b>, 200 mg, 0.750 mmol) in <i>n</i>-BuOH (2 mL) were added 2-chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>60</b>, 159 mg, 0.750 mmol) and two drops of TFA. The mixture was stirred at 100 °C under microwave irradiation for 1 h. After the mixture was cooled and concentrated, the residue was purified by preparative HPLC to afford the title compound (80 mg, 24% yield, three steps). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.34 (s, 1H), 8.18 (s, 1H), 6.86 (s, 1H), 5.34 (s, 1H), 3.89 (s, 3H), 3.84 (s, 3H), 3.77–3.84 (m, 4H), 3.60–3.66 (m, 2H), 3.28–3.39 (m, 2H), 3.15 (d, <i>J</i> = 4.5 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 442 [M + H]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (5-Chloro-2-methoxy-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>10</b>, Method b)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>8</b> (22% yield, two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.59 (s, 1H), 8.20 (s, 1H), 7.88 (s, 1H), 7.32 (s, 1H), 7.25 (s, 1H), 3.81 (s, 3H), 3.60 (s, 4H), 3.53 (t, <i>J</i> = 4.3 Hz, 2H), 3.17 (s, 2H), 2.90 (d, <i>J</i> = 4.3 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 446 [M + H]<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (5-Chloro-4-(4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-methoxyphenyl)(morpholino)methanone (<b>11</b>, Method c)</h3><div class="NLM_p last">A mixture of 2-chloro-<i>N</i>-ethyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>28</b>; 0.25 g, 1.11 mmol), cesium carbonate (0.72 g, 2.22 mmol), 4-amino-5-chloro-2-methoxyphenyl)(morpholino)methanone (<b>44</b>; 0.6 g, 2.22 mmol), palladium(II) acetate (5 mg, 0.022 mmol), and Xantphos (19 mg, 0.033 mmol) in degassed dry dioxane (4 mL) was sonicated in an ultrasonic bath for 2 min. The mixture was degassed further with bubbling N<sub>2</sub> for 2 min and heated at 100 °C for 2 h. The mixture was cooled, diluted with EtOAc (25 mL), and washed with water (2 × 20 mL). The combined aqueous washes were extracted with EtOAc (2 × 25 mL). The organic extracts were combined and filtered through a phase separator, and the solvent was removed. Purification of the residue by flash chromatography, 0–100% EtOAc/isohexane, followed by trituration with Et<sub>2</sub>O/EtOAc gave the title compound (0.15 g, 30% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (s, 1H), 8.22 (s, 1H), 7.64 (s, 1H), 7.31 (s, 1H), 5.19 (br s, 1H), 3.87 (s, 3H), 3.79–3.77 (m, 4H), 3.65–3.58 (m, 4H), 3.32 (br d, <i>J</i> = 14.8 Hz, 2H), 1.30 (t, <i>J</i> = 7.6 Hz, 3H); LCMS, <i>m</i>/<i>z</i> = 460 [M + H]<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (5-Chloro-4-(4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-methoxyphenyl)(D8-morpholino)methanone (<b>12</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>18</b> (26% yield, two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (s, 1H), 8.22 (s, 1H), 7.64 (br s, 1H), 7.31 (s, 1H), 5.19 (br s, 1H), 3.87 (s, 3H), 3.65–3.58 (m, 2H), 1.30 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 468 [M + H]<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (5-Chloro-2-methyl-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>13</b>, Method d)</h3><div class="NLM_p last">A mixture of (4-amino-5-chloro-2-methylphenyl)(morpholino)methanone (<b>56</b>, 79 mg, 0.31 mmol), 2-chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>60</b>, 66 mg, 0.31 mmol), and PTSA (59 mg, 0.31 mmol) in dioxane (4 mL) was heated to 100 °C for 4 h. Saturated sodium bicarbonate solution (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were added, and the organic phase was passed through a hydrophobic frit. The solvent was removed in vacuo and the residue was purified by preparative HPLC to give the title compound (71 mg, 53% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (s, 1H), 8.21 (d, <i>J</i> = 1.1 Hz, 1H), 7.57 (s, 1H), 7.22 (s, 1H), 5.30 (br s, 1H), 3.79 (br d, <i>J</i> = 13.9 Hz, 4H), 3.60 (br s, 2H), 3.32 (br s, 2H), 3.11 (d, <i>J</i> = 4.7 Hz, 3H), 2.32 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 430 [M + H]<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5-Methoxy-2-methyl-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>14</b> Method d)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>13</b> (42% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.47 (s, 1H), 8.18 (s, 1H), 7.74 (s, 1H), 6.71 (s, 1H), 5.25 (br s, 1H), 3.88 (s, 3H), 3.80 (br d, <i>J</i> = 18.0 Hz, 4H), 3.59 (br s, 2H), 3.31 (br s, 2H), 3.12 (d, <i>J</i> = 4.7 Hz, 3H), 2.28 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 426 [M + H]<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (5-Fluoro-2-methoxy-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>15</b>, Method d)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>13</b> (20% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (d, <i>J</i> = 6.7 Hz, 1H), 8.22 (s, 1H), 7.39 (br s, 1H), 7.07 (d, <i>J</i> = 10.6 Hz, 1H), 5.30 (t, <i>J</i> = 4.7 Hz, 1H), 3.86 (s, 3H), 3.85–3.73 (m, 4H), 3.63 (br d, <i>J</i> = 11.9 Hz, 2H), 3.32 (br d, <i>J</i> = 20.3 Hz, 2H), 3.12 (d, <i>J</i> = 4.7 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 430 [M + H]<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (2-Fluoro-3-methoxy-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>16</b>, Method g)</h3><div class="NLM_p last">To a solution of (4-amino-2-fluoro-3-methoxyphenyl)(morpholino)methanone (<b>58</b>, 600 mg, 2.36 mmol) in <i>n</i>-BuOH (8 mL) was added 2-chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>60</b>, 498 mg, 2.36 mmol). The reaction mixture was stirred at 100 °C under microwave irradiation for 1 h. After the mixture was cooled and concentrated, the residue was purified by flash chromatography, 10–33% EtOAc/petroleum ether, to afford a white solid, which was triturated with 10% EtOAc/petroleum ether to afford the title compound as a white solid (700 mg, 69% yield, three steps). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.52 (s, 1H), 8.21 (s, 1H), 8.11 (d, <i>J</i> = 8.5 Hz, 1H), 7.28 (d, <i>J</i> = 4.5 Hz, 1H), 7.10–7.07 (m, 1H), 3.90 (d, <i>J</i> = 1.5 Hz, 3H), 3.64 (s, 4H), 3.55 (s, 2H), 3.29 (s, 2H), 2.91 (d, <i>J</i> = 4.0 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 430 [M + H]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (2-Fluoro-5-methoxy-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>17</b>, Method e)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>9</b> (40% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (d, <i>J</i> = 12.0 Hz, 1H), 8.25 (s, 1H), 8.11 (s, 1H), 7.35 (q, <i>J</i> = 4.3 Hz, 1H), 7.03 (d, <i>J</i> = 6.2 Hz, 1H), 3.89 (s, 3H), 3.64–3.55 (m, 6H), 3.32–3.31 (m, 2H), 2.94 (d, <i>J</i> = 4.3 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 430 [M + H]<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (4-(4-(Ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone (<b>18</b>)</h3><div class="NLM_p">A mixture of 2-chloro-<i>N</i>-ethyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>28</b>, 70 g, 310 mmol), 4-amino-2-fluoro-5-methoxybenzoic acid (<b>43</b>, 49 g, 265 mmol), and PTSA (30 g, 169 mmol) in 1,4-dioxane (400 mL) was stirred at 100 °C for 2 h (the reaction mixture remained as a suspension despite heating). The reaction mixture was then cooled to room temperature. The insoluble solids were collected by filtration, washed with 1,4-dioxane (100 mL) and Et<sub>2</sub>O (50 mL), and air-dried for 12 h to give crude 4-(4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxybenzoic acid <b>62</b>. The material (108 g) was used in the next step without further purification.</div><div class="NLM_p">To a cooled (0 °C) mixture of crude 4-(4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxybenzoic acid (<b>62</b>, 108 g, 289 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) were added HBTU (125 g, 330 mmol), morpholine (50 mL, 572 mmol), and DIPEA (150 mL, 863 mmol). The reaction mixture was stirred at 0 °C for 15 min before warming to room temperature. The reaction mixture was stirred at room temperature for an additional 45 min. The mixture was then diluted with saturated sodium bicarbonate solution, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The combined extracts were washed with saturated sodium bicarbonate solution, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated.</div><div class="NLM_p last">The crude product was first purified by SFC to give approximately 95 g of desired product. The material was then redissolved in 350 mL of refluxing <i>i</i>-PrOH. The solution was allowed to cool slowly (overnight) to room temperature with moderate stirring. The resulting suspension was cooled in an ice bath for 20 min. The solid (83.5 g) was collected by filtration. The isolated solid was redissolved in 400 mL of refluxing <i>i</i>-PrOH and allowed to cool to room temperature overnight with stirring. Again, the resulting suspension was cooled in an ice bath for 20 min. The white precipitate was collected by filtration to give a white crystalline solid. The solid was air-dried for 5 h and placed under vacuum for 3 h to give the desired product (74.5 g, 64% yield, two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 12 Hz, 1H), 8.20 (s, 1H), 7.84 (s, 1H), 6.91 (d, <i>J</i> = 5.9 Hz, 1H), 5.21 (br s, 1H), 3.74–3.85 (m, 4H), 3.69–3.71 (m, 2H), 3.58–3.68 (m, 2H), 3.44 (br s, 2H), 1.33 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 444 [M + H]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (4-(4-(Cyclopropylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone (<b>19</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>18</b> (16% yield, two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.77 (d, <i>J</i> = 12.6 Hz, 1H), 8.20 (s, 1H), 7.94 (s, 1H), 6.91 (d, <i>J</i> = 6.0 Hz, 1H), 5.48 (s, 1H), 3.92 (s, 3H), 3.84–3.76 (m, 4H), 3.68 (t, <i>J</i> = 4.5 Hz, 2H), 3.44 (br s, 2H), 2.94–2.87 (m, 1H), 1.03–0.96 (m, 2H), 0.70–0.65 (m, 2H). LCMS, <i>m</i>/<i>z</i> = 456 [M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i><sup>2</sup>-(2-Chloro-4-(1-methyl-1<i>H</i>-tetrazol-5-yl)phenyl)-<i>N</i><sup>4</sup>-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine (<b>20</b>)</h3><div class="NLM_p last">A mixture of <i>N</i><sup>2</sup>-(2-chloro-4-(2<i>H</i>-tetrazol-5-yl)phenyl)-<i>N</i><sup>4</sup>-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine (<b>66</b>, 80 mg, 0.22 mmol), K<sub>2</sub>CO<sub>3</sub> (45 mg, 0.32 mmol), and methyl iodide (15 μL, 0.24 mmol) in acetone (2 mL) was heated at 40 °C for 1 h. The mixture was cooled and filtered. The filtrate was concentrated under reduced pressure. Purification of the residue by flash chromatography, 0–100% EtOAc/isohexane, gave the title compound (10 mg, 12% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.90 (d, <i>J =</i> 8.7 Hz, 1H), 8.24 (s, 1H), 7.86 (d, <i>J =</i> 2.1 Hz, 1H), 7.79 (s, 1H), 7.68 (dd, <i>J =</i> 8.8, 2.1 Hz, 1H), 5.33 (s, 1H), 4.22 (s, 3H), 3.13 (d, <i>J =</i> 4.7 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 385 [M + H]<sup>+</sup>. The isomeric <i>N</i>-Me product <i>N</i><sup>2</sup>-(2-chloro-4-(2-methyl-2<i>H</i>-tetrazol-5-yl)phenyl)-<i>N</i><sup>4</sup>-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine (58 mg, 70% yield) was also isolated from the reaction mixture. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.76 (d, <i>J =</i> 8.7 Hz, 1H), 8.23–8.19 (m, 2H), 8.05 (dd, <i>J =</i> 8.7, 2.0 Hz, 1H), 7.72 (s, 1H), 5.29 (s, 1H), 4.40 (s, 3H), 3.12 (d, <i>J =</i> 4.7 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 385 [M + H]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i><sup>2</sup>-(5-Fluoro-2-methoxy-4-(methylsulfonyl)phenyl)-<i>N</i><sup>4</sup>-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine (<b>21</b>)</h3><div class="NLM_p last">To 5-fluoro-2-methoxy-4-(methylsulfonyl)aniline (<b>70</b>, 115.5 mg, 0.53 mmol) and 2-chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>60</b>, 117 mg, 0.55 mmol) dissolved in 2-methoxyethanol (5.0 mL, 63 mmol) was added TFA (0.04 mL, 0.53 mmol), and the reaction mixture was heated to 100 °C for 60 h. The mixture was diluted with water and saturated sodium bicarbonate solution, extracted with EtOAc (10 mL), and concentrated under reduced pressure. The residue was purified by flash chromatography, 0–50% EtOAc/heptane, followed by preparative HPLC to afford the title compound (38.9 mg, 19% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (d, <i>J =</i> 13.1 Hz, 1H), 8.3 (s, 1H), 8.30 (s, 1H), 7.50–7.40 (m, 1H), 7.30 (d, <i>J =</i> 6.4 Hz, 1H), 3.96 (s, 3H), 3.29 (s, 3H), 2.96 (d, <i>J =</i> 4.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 395 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (5-((4-(Ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-4-methoxypyridin-2-yl)(morpholino)methanone (<b>22</b>)</h3><div class="NLM_p last">To a vial were added 2-chloro-<i>N</i>-ethyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>28</b>, 41.8 mg, 0.185 mmol), (5-amino-4-methoxypyridin-2-yl)(morpholino)methanone (<b>72</b>, 41.9 mg, 0.177 mmol), BrettPhos (9.7 mg, 0.018 mmol), BrettPhos palladium(II) phenethylamine chloride (14.1 mg, 0.018 mmol), and NaO-<i>t</i>-Bu (21.0 mg, 0.212 mmol). The vial was purged with N<sub>2</sub>, and <i>t</i>-BuOH (2.0 mL) was added. N<sub>2</sub> was bubbled through the reaction mixture for 3 min. Then the vial was capped and heated to 100 °C in an oil bath for 12 h. The reaction mixture was cooled to room temperature, diluted with CH<sub>2</sub>Cl<sub>2</sub>, and filtered through Celite, eluting with CH<sub>2</sub>Cl<sub>2</sub>, and the filtrate was concentrated. The residue was adsorbed onto silica and purified by flash chromatography, 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>. The product-containing fractions were combined, concentrated and the residue was further purified by preparative HPLC to give the title compound (26.5 mg, 35% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (s, 1H), 8.37 (s, 1H), 8.17 (s, 1H), 7.31 (s, 1H), 7.15 (t, <i>J</i> = 5.5 Hz, 1H), 3.93 (s, 3H), 3.70–3.49 (m, 8H), 3.45–3.35 (m, 2H), 1.10 (t, <i>J</i> = 7.1 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 427 [M + H]<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i><sup>2</sup>-(4-Methoxy-6-(tetrahydro-2<i>H</i>-pyran-4-yl)pyridin-3-yl)-<i>N</i><sup>4</sup>-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine (<b>23</b>)</h3><div class="NLM_p">To a round-bottom flask was added 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4-methoxy-5-nitropyridine (<b>74</b>, 197 mg, 0.8286 mmol). The flask was purged with N<sub>2</sub>, and EtOH (10 mL) followed by Pd/C (20 wt %, 88 mg, 0.08 mmol) was added. H<sub>2</sub> was bubbled through the solution for 5 min, and the reaction mixture was then stirred overnight at room temperature under an atmosphere of H<sub>2</sub>. The reaction mixture was filtered through Celite, eluting with CH<sub>2</sub>Cl<sub>2</sub>, and the filtrate was concentrated to give crude 4-methoxy-6-(tetrahydro-2<i>H</i>-pyran-4-yl)pyridin-3-amine (<b>75</b>, 170 mg) that was used without further purification.</div><div class="NLM_p last">To a vial were added 2-chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>60</b>, 93 mg, 0.44 mmol), crude 4-methoxy-6-(tetrahydro-2<i>H</i>-pyran-4-yl)pyridin-3-amine (<b>75</b>, 87 mg, 0.42 mmol), BrettPhos (23 mg, 0.042 mmol), BrettPhos palladium(II) phenethylamine chloride (33 mg, 0.042 mmol), and NaO-<i>t</i>-Bu (50 mg, 0.50 mmol). The vial was purged with N<sub>2</sub>, and <i>t</i>-BuOH (3.0 mL) was added. N<sub>2</sub> was bubbled through the reaction mixture for 3 min, and the mixture was then heated to 110 °C in an oil bath for 3 h. The reaction mixture was cooled to room temperature, diluted with CH<sub>2</sub>Cl<sub>2</sub>, filtered through Celite, eluting with CH<sub>2</sub>Cl<sub>2</sub>, and the filtrate was concentrated. The residue was adsorbed onto silica and purified by flash chromatography, 0–100% EtOAc/heptane. The product-containing fractions were combined, concentrated and the residue was further purified by preparative HPLC to give the title compound (83 mg, 52% yield, two steps) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (s, 1H), 8.26 (s, 1H), 8.10 (s, 1H), 7.11–7.04 (m, 1H), 6.98 (s, 1H), 3.99–3.92 (m, 3H), 3.89–3.86 (m, 4H), 3.48–3.39 (m, 3H), 2.93–2.84 (m, 5H), 1.82–1.73 (m, 5H). LCMS, <i>m</i>/<i>z</i> = 384 [M + H]<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 4-(4-(Ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-<i>N</i>-(2-hydroxy-2-methylpropyl)-5-methoxybenzamide (<b>24</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>18</b> (95% yield, two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51 (d, <i>J =</i> 15.6 Hz, 1H), 8.21 (s, 1H), 7.93 (s, 1H), 7.58 (d, <i>J =</i> 7.2 Hz, 1H), 7.26–7.15 (m, 1H), 5.23 (br s, 1H), 3.96 (s, 3H), 3.65–3.61 (m, 2H), 3.52–3.50 (m, 2H), 1.34 (t, <i>J =</i> 7.2 Hz, 3H), 1.21 (s, 6H). LCMS, <i>m</i>/<i>z</i> = 446 [M + H]<sup>+</sup>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(4-(Ethylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-(2-hydroxy-2-methylpropyl)-6-methoxyisoindolin-1-one (<b>25</b>)</h3><div class="NLM_p last">The synthesis of <b>25</b> was carried out using the same procedure as that for <b>13</b>, method d (38 mg, 33%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.21 (s, 1H), 7.95 (s, 1H), 7.33 (s, 1H), 5.18 (br s, 1H), 4.53 (s, 2H), 3.98 (s, 3H), 3.63–3.56 (m, 4H), 3.39 (s, 1H), 1.34–1.32 (m, 3H), 1.30 (s, 6H). LCMS, <i>m</i>/<i>z</i> = 439 [M + H]<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Chloro-<i>N</i>-ethyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>28</b>)</h3><div class="NLM_p last">Into a 3000 mL four-necked round-bottom flask purged and maintained with an inert atmosphere of N<sub>2</sub> was placed copper(I) iodide (224 g, 1.17 mmol) and potassium fluoride (68 g, 1.17 mmol). The mixture was heated to 150 °C under reduced pressure for 2 h. After the mixture was cooled to room temperature, a solution of trimethyl(trifluoromethyl)silane (167 g, 1.17 mmol) in DMF (500 mL) and NMP (500 mL) was added by syringe. The mixture was stirred for 30 min, followed by the addition of a solution of 2-chloro-5-iodo-4-methoxypyrimidine (<b>26</b>, 278 g, 980.6 mmol) in DMF (500 mL) and NMP (500 mL) by syringe. The resulting solution was stirred at 35 °C for 48 h and quenched by the addition of 10 L of water. The solids were filtered out. The filtrate was extracted with EtOAc (3 × 5000 mL). The combined organic layers were washed with brine (3 × 2000 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography, 0–5% EtOAc/petroleum ether, to afford the title compound (153 g, 69% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.25 (s, 1H), 5.40 (s, 1H), 3.66–3.57 (m, 2H), 1.32–1.27 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 226 [M + H]<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Chloro-<i>N</i>-cyclopropyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>29</b>)</h3><div class="NLM_p last">To 2,4-dichloro-5-(trifluoromethyl)pyrimidine (<b>27</b>, 1.25 g, 5.8 mmol) in MeOH (4 mL) at 0 °C was added cyclopropylamine (0.69 mL, 10 mmol). The mixture was allowed to stir at room temperature for 4 h, and then CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and water (20 mL) were added. The mixture was passed through a hydrophobic frit, and the solvent was removed. Purification of the residue by flash chromatography, 0–100% CH<sub>2</sub>Cl<sub>2</sub>/isohexane, gave the title compound (472 mg, 34% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (d, <i>J</i> = 1.1 Hz, 1H), 5.56 (br s, 1H), 3.03–2.93 (m, 1H), 0.99–0.89 (m, 2H), 0.65–0.60 (m, 2H). LCMS, <i>m</i>/<i>z</i> = 238 [M + H]<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-Chloro-2-methyl-4-nitrobenzonitrile (<b>34</b>)</h3><div class="NLM_p last">To 5-chloro-2-methyl-4-nitroaniline (<b>33</b>, 5 g, 26.8 mmol) in a mixture of acetone (17.5 mL) and water (19 mL) at 0 °C was added concentrated HCl (5.6 mL). A solution of sodium nitrite (2.25 g, 32.6 mmol) in water (7.5 mL) was added dropwise, and the mixture was allowed to stir at 0 °C for 30 min. The mixture was then added dropwise to a mixture of copper cyanide (3.75 g, 42 mmol) and sodium cyanide (5.5 g, 112 mmol) in water (25 mL) and EtOAc (12.5 mL). The mixture was allowed to stir at room temperature for 1 h, and then water (50 mL) was added. The mixture was extracted with EtOAc (3 × 100 mL), and the combined organic fractions were washed with 2 M NaOH<sub>(aq)</sub> (50 mL) and brine (50 mL). The organic fraction was passed through a hydrophobic frit, and the solvent was removed in vacuo. The residue was suspended in a 1:1 mixture of diethyl ether/isohexane. The solid formed was removed by filtration and washed with isohexane and dried. Further fractions were isolated from the filtrate and combined with the initial solid fraction to give the title compound (3.22 g, 61% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80 (s, 1H), 7.80 (s, 1H), 2.63 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 197 [M + H]<sup>+</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-Methoxy-2-methyl-4-nitrobenzonitrile (<b>36</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>34</b> (90% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (s, 1H), 7.31 (s, 1H), 3.98 (s, 3H), 2.55 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 192 [M + H]<sup>+</sup>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-Chloro-2-methyl-4-nitrobenzoic Acid (<b>37</b>)</h3><div class="NLM_p last">A mixture of 5-chloro-2-methyl-4-nitrobenzonitrile (<b>34</b>, 1 g, 5 mmol) in AcOH (10 mL), water (10 mL), and concentrated H<sub>2</sub>SO<sub>4</sub> (10 mL) was heated to 120 °C for 5 h. Water (100 mL) was added and the solid was removed by filtration and dried to give the title compound (905 mg, 84% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (s, 1H), 7.76 (s, 1H), 2.70 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 214 [M + H]<sup>+</sup>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-Methoxy-2-methyl-4-nitrobenzoic Acid (<b>38</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>37</b> (58% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75 (s, 1H), 7.70 (s, 1H), 3.99 (s, 3H), 2.62 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 210 [M + H]<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 4-Amino-5-fluoro-2-methoxybenzonitrile (<b>40</b>)</h3><div class="NLM_p last">To a stirred solution of MeOH (26 mL) in THF (15 mL) under N<sub>2</sub> was added <i>t</i>-BuOK (1.5 g, 13.0 mmol) in small portions over 10 min. The resulting solution was stirred at room temperature for 5 min, and then 4-amino-2,5-difluorobenzonitrile (<b>39</b>, 1.0 g, 6.5 mmol) was added. The mixture was then warmed to 70 °C and stirred for 3.5 h. The mixture was cooled and diluted with EtOAc (25 mL), washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated to dryness under reduced pressure. The residue was triturated with diethyl ether/isohexane to afford the title compound (0.86 g, 80% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.15 (d, <i>J</i> = 10.4 Hz, 1H), 6.26 (d, <i>J</i> = 7.2 Hz, 1H), 4.25 (br s, 2H), 3.84 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 167 [M + H]<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-Amino-5-fluoro-2-methoxybenzoic Acid (<b>41</b>)</h3><div class="NLM_p last">A solution of 4-amino-5-fluoro-2-methoxybenzonitrile (<b>40</b>, 250 mg, 1.51 mmol) and KOH in a mixture of EtOH (5 mL) and water (5 mL) was heated at reflux for 30 h. The mixture was cooled and treated with 30% aqueous H<sub>2</sub>O<sub>2</sub> (0.25 mL). The mixture was stirred for 10 min and then heated to reflux for 18 h. After return to room temperature, water (3 mL) was added and 6 N HCl solution was added until pH 4 was obtained. The mixture was filtered and the collected solid was washed with a small amount of water and dried at 50 °C under vacuum to afford the title compound (190 mg, 68% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.8 (br s, 1H), 7.40 (d, <i>J</i> = 12.0 Hz, 1H), 6.44 (d, <i>J</i> = 8.0 Hz, 1H), 6.00 (br s, 2H), 3.75 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 186 [M + H]<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (4-Amino-5-chloro-2-methoxyphenyl)(morpholino)methanone (<b>44</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>46</b> (carried forward as crude yellow paste). LCMS, <i>m</i>/<i>z</i> = 271 [M + H]<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (4-Amino-5-fluoro-2-methoxyphenyl)(morpholino)methanone (<b>45</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>46</b> (72% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.02 (s, 2H), 6.95 (d, <i>J</i> = 10.5 Hz, 1H), 6.30 (d, <i>J</i> = 7.1 Hz, 1H), 3.76 (s, 3H), 3.72–3.64 (m, 4H), 3.58 (t, <i>J</i> = 4.9 Hz, 2H), 3.40 (t, <i>J</i> = 4.9 Hz, 2H). LCMS, <i>m</i>/<i>z</i> = 255 [M + H]<sup>+</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (4-Amino-2-fluoro-5-methoxyphenyl)(morpholino)methanone (<b>46</b>)</h3><div class="NLM_p last">A mixture of 4-amino-2-fluoro-5-methoxybenzoic acid (<b>43</b>, 4.2 g, 22.7 mmol), HATU (10.4 g, 27.2 mmol), and morpholine (5 mL, 56.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> was stirred in a cold water bath, and DIPEA (10 mL, 56.8 mmol) was added. After 10 min the mixture was allowed to warm to room temperature and stirred for 1 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and washed with saturated sodium bicarbonate solution (3 × 75 mL) and water (100 mL). The separated organic phase was passed through a hydrophobic frit, and the solvent was concentrated. The crude product was triturated with CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O and the filtered solid dried under vacuum to give the title compound (4.10 g, 71% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.80 (d, <i>J</i> = 6.0 Hz, 1H), 6.36 (d, <i>J</i> = 10.7 Hz, 1H), 4.12 (s, 2H), 3.84 (s, 3H), 3.83–3.61 (m, 6H), 3.42 (s, 2H). LCMS, <i>m</i>/<i>z</i> = 255 [M + H]<sup>+</sup>.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (4-Amino-2-chloro-5-methoxyphenyl)(morpholino)methanone (<b>50</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>46</b> (63% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (s, 1H), 7.47 (s, 1H), 3.95 (s, 3H), 3.51–3.72 (m, 6H), 3.15–3.19 (m, 2H). LCMS, <i>m</i>/<i>z</i> = 301 [M + H]<sup>+</sup>.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (5-Chloro-2-methyl-4-nitrophenyl)(morpholino)methanone (<b>51</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>46</b> (95% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76 (s, 1H), 7.36 (s, 1H), 3.83–3.76 (m, 4H), 3.66–3.58 (m, 2H), 3.28–3.20 (m, 2H), 2.37 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 285 [M + H]<sup>+</sup>.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (5-Methoxy-2-methyl-4-nitrophenyl)(morpholino)methanone (<b>52</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>46</b> (59% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (s, 1H), 6.90 (s, 1H), 3.94 (s, 3H), 3.85–3.76 (m, 4H), 3.61 (dd, <i>J</i> = 5.7, 4.0 Hz, 2H), 3.23 (dd, <i>J</i> = 5.7, 4.0 Hz, 2H), 2.30 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 281 [M + H]<sup>+</sup>.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (2-Fluoro-3-methoxy-4-nitrophenyl)(morpholino)methanone (<b>53</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>46</b> (carried forward as crude). LCMS, <i>m</i>/<i>z</i> = 285 [M + H]<sup>+</sup>.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (2,5-Dimethoxy-4-nitrophenyl)(morpholino)methanone (<b>54</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>46</b> (carried forward as crude). LCMS, <i>m</i>/<i>z</i> = 297 [M + H]<sup>+</sup>.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (4-Amino-2-chloro-5-methoxyphenyl)(morpholino)methanone (<b>55</b>)</h3><div class="NLM_p last">To a solution of (2-chloro-5-methoxy-4-nitrophenyl)(morpholino)methanone (<b>50</b>, 825 mg, 2.74 mmol) in EtOH (10 mL) were added iron dust (0.90 g, 16 mmol), NH<sub>4</sub>Cl (0.90 g, 17 mmol), and water (0.5 mL). The suspension was stirred at 90 °C under a N<sub>2</sub> atmosphere for 1 h. The reaction mixture was allowed to cool to room temperature and filtered through a pad of Celite. The filtrate was concentrated. The resulting solid residue was resuspended in EtOAc, sonicated for 1 min, and filtered. The filtrate was concentrated to give the crude title compound (743 mg), which was used without further purification. LCMS, <i>m</i>/<i>z</i> = 271 [M + H]<sup>+</sup>.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (4-Amino-5-chloro-2-methylphenyl)(morpholino)methanone (<b>56</b>)</h3><div class="NLM_p last">To (5-chloro-2-methyl-4-nitrophenyl)(morpholino)methanone (<b>51</b>, 244 mg, 0.86 mmol) in EtOH (6 mL) and water (0.6 mL) was added SnCl<sub>2</sub>·2H<sub>2</sub>O (776 mg, 3.44 mmol). The mixture was heated to 65 °C for 5 h, and then 2 M aqueous sodium hydroxide solution (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were added. The organic phase was passed through a hydrophobic frit and the solvent was removed in vacuo to give the title compound (203 mg, 93% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.07 (s, 1H), 6.60 (s, 1H), 4.10 (br s, 2H), 3.84–3.53 (br m, 6H), 3.36–3.24 (br m, 2H), 2.21 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 255 [M + H]<sup>+</sup>.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (4-Amino-5-methoxy-2-methylphenyl)(morpholino)methanone (<b>57</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>56</b> (92% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.60 (s, 1H), 6.52 (s, 1H), 3.87–3.52 (br m, 6H), 3.84 (br s, 2H), 3.82 (s, 3H), 3.36–3.23 (br m, 2H), 2.17 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 251 [M + H]<sup>+</sup>.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (4-Amino-2-fluoro-3-methoxyphenyl)(morpholino)methanone (<b>58</b>)</h3><div class="NLM_p last">To a mixture of (2-fluoro-3-methoxy-4-nitrophenyl)(morpholino)methanone (<b>53</b>, 1.2 g, 4.2 mmol) in MeOH (50 mL) was added Pd/C (10 wt %, 100 mg). The reaction mixture was stirred under H<sub>2</sub> (1 atm) at room temperature for 1 h. The insoluble material was filtered off and the filtrate was concentrated under reduced pressure to afford the crude title compound as a white solid, which was used without further purification. LCMS, <i>m</i>/<i>z</i> = 255 [M + H]<sup>+</sup>.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (4-Amino-2,5-dimethoxyphenyl)(morpholino)methanone (<b>59</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner analogous to that for <b>58</b> (carried forward as crude). LCMS, <i>m</i>/<i>z</i> = 267 [M + H]<sup>+</sup>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 3-Chloro-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)benzonitrile (<b>65</b>)</h3><div class="NLM_p last">A mixture of 2-chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>60</b>, 211 mg, 1 mmol), 4-amino-3-chlorobenzonitrile (<b>64</b>, 305 mg, 2 mmol), cesium carbonate (0.65 g, 2 mmol), Xantphos (17 mg, 0.03 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (5 mg, 0.02 mmol) in dioxane (3 mL) was sonicated in an ultrasonic bath for 1 min. The mixture was then degassed under a stream of N<sub>2</sub> for 5 min. The tube was sealed, and the mixture was heated at 100 °C for 18 h. The reaction mixture was cooled and diluted with EtOAc (15 mL). The organic layer was washed with water (2 × 20 mL), and the combined aqueous extracts were further washed with EtOAc (2 × 15 mL). The combined organics were passed through a phase separation cartridge, and the solvent was removed under reduced pressure. Purification of the residue by flash chromatography, 0–100% EtOAc/isohexane, gave the title compound as a white solid (140 mg, 45% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.85 (d, <i>J =</i> 8.8 Hz, 1H); 8.23 (d, <i>J =</i> 1.1 Hz, 1H), 7.80 (s, 1H), 7.68 (d, <i>J =</i> 1.9 Hz, 1H), 7.58–7.53 (m, 1H); 5.32 (br s, 1H), 3.11 (d, <i>J =</i> 4.7 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 328 [M + H]<sup>+</sup>.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i><sup>2</sup>-(2-Chloro-4-(2<i>H</i>-tetrazol-5-yl)phenyl)-<i>N</i><sup>4</sup>-methyl-5-(trifluoromethyl)pyrimidine-2,4-diamine (<b>66</b>)</h3><div class="NLM_p last">To a solution of 3-chloro-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)benzonitrile (<b>65</b>, 135 mg, 6.41 mmol) in DMF (2 mL) were added NaN<sub>3</sub> (80 mg, 1.24 mmol) and NH<sub>4</sub>Cl (66 mg, 1.24 mmol). The mixture was heated at 125 °C for 18 h. The mixture was cooled, filtered and the solid washed with EtOAc. The filtrate was concentrated under reduced pressure, and the crude residue was diluted with water (5 mL) and Et<sub>2</sub>O (5 mL). A precipitate formed which was filtered and washed with further portions of water and Et<sub>2</sub>O. The solid was coevaporated with CH<sub>2</sub>Cl<sub>2</sub> and MeOH and then dried in a vacuum oven to yield the title compound (130 mg, 85% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 1H), 8.26–8.19 (m, 2H), 8.14 (d, <i>J =</i> 2.0 Hz, 1H), 8.03–7.96 (m, 1H), 7.30–7.22 (m, 1H), 2.89 (t, <i>J =</i> 4.4 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 371 [M + H]<sup>+</sup>.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (2-Fluoro-5-methoxy-4-nitrophenyl)(methyl)sulfane (<b>68</b>)</h3><div class="NLM_p last">To 1,2-difluoro-4-methoxy-5-nitrobenzene (<b>67</b>, 0.72 g, 3.8 mmol) in EtOH (100 mL) was added sodium thiomethoxide (0.30 g, 4.1 mmol) in water (0.96 mL, 53 mmol), and the reaction mixture was heated to reflux for 3 h. The solvent was removed under reduced pressure and the residue was purified by flash chromatography, 0–40% EtOAc/heptane, to afford the title compound (0.75 g, 91% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.68 (d, <i>J =</i> 9.3 Hz, 1H), 6.83 (d, <i>J</i> = 6.1 Hz, 1H), 3.98 (s, 3H), 2.55 (s, 3H). LCMS, <i>m</i>/<i>z</i> = not detected.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-Fluoro-4-methoxy-2-(methylsulfonyl)-5-nitrobenzene (<b>69</b>)</h3><div class="NLM_p last">(2-Fluoro-5-methoxy-4-nitrophenyl)(methyl)sulfane (<b>68</b>, 0.75 g, 3.5 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), and <i>m</i>-CPBA (77% pure) (1.0 g, 4.5 mmol) was added portionwise. The mixture was stirred for 16 h at room temperature. Additional <i>m</i>-CPBA (77% pure) (1.5 g, 6.92 mmol) was added and the mixture stirred for another 24 h at room temperature. The solvent was removed under reduced pressure and the residue was purified by flash chromatography, 0–50% EtOAc/heptane, to afford the title compound (0.41 g, 48% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (d, <i>J =</i> 8.3 Hz, 1H), 7.68 (d, <i>J</i> = 5.2 Hz, 1H), 4.03 (s, 3H), 3.28 (s, 3H). LCMS, <i>m</i>/<i>z</i> = not detected.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 5-Fluoro-2-methoxy-4-(methylsulfonyl)aniline (<b>70</b>)</h3><div class="NLM_p last">To 1-fluoro-4-methoxy-2-(methylsulfonyl)-5-nitrobenzene (<b>69</b>, 0.41 g, 1.6 mmol) in EtOH (80 mL) was added Pd/C (10 wt %, 18 mg, 0.16 mmol), and the reaction mixture was stirred under H<sub>2</sub> (1 atm) for 12 h. The reaction mixture was filtered through Celite, and the solvents were removed under reduced pressure. The residue was purified by flash chromatography, 0–70% EtOAc/heptane, to afford the title compound (0.36 g, 99% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.19 (d, <i>J =</i> 6.2 Hz, 1H), 7.46 (d, <i>J</i> = 11.0 Hz, 1H), 4.44 (s, 3H), 3.88 (s, 3H), 3.16 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 220 [M + H]<sup>+</sup>.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (5-Amino-4-methoxypyridin-2-yl)(morpholino)methanone (<b>72</b>)</h3><div class="NLM_p last">To a microwave vial were added 6-chloro-4-methoxypyridin-3-amine (<b>71</b>, 100 mg, 0.63 mmol), molybdenum hexacarbonyl (183 mg, 0.69 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (36.5 mg, 0.03 mmol), and 4-DMAP (46.7 mg, 0.38 mmol). 1,4-Dioxane (10 mL) was then added followed by DIPEA (0.22 mL, 1.26 mmol) and morpholine (0.66 mL, 7.57 mmol). N<sub>2</sub> was then bubbled through reaction mixture for 3 min. Then the vial was capped and heated to 150 °C in a microwave for 40 min. The reaction mixture was then filtered through Celite, eluting with CH<sub>2</sub>Cl<sub>2</sub>, and the filtrate was concentrated. The crude residue was adsorbed onto silica and purified by flash chromatography, 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to give the title compound (75 mg, 50% yield) as a beige foam. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.25 (s, 1H), 5.40 (s, 1H), 3.66–3.57 (m, 2H), 1.32–1.27 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 238 [M + H]<sup>+</sup>.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2-(3,6-Dihydro-2<i>H</i>-pyran-4-yl)-4-methoxy-5-nitropyridine (<b>74</b>)</h3><div class="NLM_p last">To a microwave vial were added 2-chloro-4-methoxy-5-nitropyridine (<b>73</b>, 200 mg, 1.06 mmol), 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (312 mg, 1.48 mmol), Na<sub>2</sub>CO<sub>3</sub> (158 mg 1.48 mmol), bis(di-<i>tert</i>-butyl(4-dimethylaminophenyl)phosphine)dichloropalladium(II) (75 mg, 0.11 mmol), and KOAc (147 mg, 1.48 mmol). CH<sub>3</sub>CN (10 mL) and degassed water (2 mL) were added, and N<sub>2</sub> was bubbled through the solution for 3 min. The vial was capped and submitted to microwave heating at 140 °C for 40 min. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, filtered through Celite, eluting with CH<sub>2</sub>Cl<sub>2</sub>, and the filtrate was concentrated. The crude residue was adsorbed onto silica and purified by flash chromatography, 0–100% EtOAc/heptane, to give the title compound (197 mg, 79% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.25 (s, 1H), 5.40 (s, 1H), 3.66–3.57 (m, 2H), 1.32–1.27 (t, <i>J</i> = 7.2 Hz, 3H). LCMS, <i>m</i>/<i>z</i> = 237 [M + H]<sup>+</sup>.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Methyl 5-Methoxy-2-methyl-4-nitrobenzoate (<b>76</b>)</h3><div class="NLM_p last">To 5-methoxy-2-methyl-4-nitrobenzoic acid (<b>38</b>, 1.27 g, 6 mmol) in MeOH (15 mL) was added SOCl<sub>2</sub> (0.44 mL, 6 mmol) dropwise. The mixture was heated to reflux for 3 h and then allowed to cool. The solvent was removed, and the residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and saturated sodium bicarbonate solution (20 mL). The organic phase was passed through a hydrophobic frit, and the solvent was removed. Purification of the residue by flash chromatography, 0–100% EtOAc/isohexane, gave the title compound (1.11 g, 82% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.68 (s, 1H), 7.60 (s, 1H), 3.98 (s, 3H), 3.95 (s, 3H), 2.55 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 226 [M + H]<sup>+</sup>.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Methyl 2-(Bromomethyl)-5-methoxy-4-nitrobenzoate (<b>77</b>)</h3><div class="NLM_p last">A mixture of methyl 5-methoxy-2-methyl-4-nitrobenzoate (<b>76</b>, 1.11 g, 5 mmol) and NBS (1.07 g, 6 mmol) in MeCN (20 mL) was degassed, and then AIBN (18 mg, 0.11 mmol) was added. The mixture was heated to 70 °C for 18 h. CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and water (50 mL) were added, and the organic phase was passed through a hydrophobic frit. The solvent was removed, and purification of the residue by flash chromatography, 0–100% EtOAc/isohexane, gave the title compound (477 mg, 31% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (s, 1H), 7.66 (s, 1H), 4.88 (s, 2H), 4.02 (s, 3H), 4.00 (s, 3H). LCMS, <i>m</i>/<i>z</i> = 304 [M + H]<sup>+</sup>.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-(2-Hydroxy-2-methylpropyl)-6-methoxy-5-nitroisoindolin-1-one (<b>78</b>)</h3><div class="NLM_p last">To methyl 2-(bromomethyl)-5-methoxy-4-nitrobenzoate (<b>77</b>, 220 mg, 0.72 mmol) in MeOH (6 mL) were added Et<sub>3</sub>N (0.12 mL, 0.86 mmol) and 1-amino-2-methylpropan-2-ol (77 mg, 0.86 mmol). The mixture was heated to 70 °C for 5 h, and then EtOAc (30 mL) and 1 M HCl<sub>(aq)</sub> (30 mL) were added. The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 30 mL). The combined organic fractions were passed through a hydrophobic frit, and the solvent was removed. The residue was used directly in the next reaction without any purification. LCMS, <i>m</i>/<i>z</i> = 281 [M + H]<sup>+</sup>.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 5-Amino-2-(2-hydroxy-2-methylpropyl)-6-methoxyisoindolin-1-one (<b>79</b>)</h3><div class="NLM_p last">To crude 2-(2-hydroxy-2-methylpropyl)-6-methoxy-5-nitroisoindolin-1-one (<b>78</b>, 0.72 mmol) in a mixture of EtOH (15 mL) and water (1.5 mL) were added iron powder (134 mg, 2.4 mmol) and NH<sub>4</sub>Cl (160 mg, 3 mmol). The resulting mixture was heated at 80 °C for 18 h, then cooled to room temperature, filtered through a pad of Celite, and rinsed through with MeOH. The filtrate was evaporated, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and washed with water (3 × 50 mL). The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the title compound (138 mg, 77% yield, two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21 (s, 1H), 6.68 (s, 1H), 4.40 (br s, 2H), 4.21 (s, 2H), 3.90 (s, 3H), 3.74 (s, 1H), 3.55 (s, 2H), 1.27 (s, 6H). LCMS, <i>m</i>/<i>z</i> = 251 [M + H]<sup>+</sup>.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Molecular Modeling</h3><div class="NLM_p last">Homology models of LRRK2 were constructed using the modeling program MOE, version 2009.10 (Chemical Computing Group, Montreal),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(62)</a> and AMBER99<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(63)</a> force field. The human LRRK2 sequence was retrieved from Swiss-Prot<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(64)</a> and aligned to template structure sequences using ClustalW<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(65)</a> followed by manual fine-tuning of residues adjacent to loop regions, insertions, and deletions. The models were further refined with bound ligand using the Macromodel utility implemented in Maestro and OPLS2005 force field (Schrödinger, Inc., New York, NY).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(66)</a> Inhibitor docking studies were carried out using docking program Glide SP with one hydrogen bond constrained to the carbonyl oxygen of hinge residue Ala1950. The docking poses were evaluated based on a combination of criteria including the Glide docking score (cutoff of −6), favorable intermolecular interactions with the hinge and other parts of the ATP-binding pocket, and low strain energy of the bound ligand (<i>E</i><sub>strain</sub> < 2 kcal/mol).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74"><a href="/doi/suppl/10.1021/jm301020q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Spleen PK/PD graphs for <b>14</b>, <b>18</b>, and <b>19</b> and additional experimental procedures. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301020q/suppl_file/jm301020q_si_001.pdf">jm301020q_si_001.pdf (191.84 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm301020q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony A. Estrada</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f792848385969396d99699839f98998eb790929992d994989a"><span class="__cf_email__" data-cfemail="5d382e292f3c393c733c3329353233241d3a383338733e3230">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingrong Liu</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Baker-Glenn</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan Beresford</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Burdick</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Chambers</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan K. Chan</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huifen Chen</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao Ding</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio G. DiPasquale</span> - <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara L. Dominguez</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennafer Dotson</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Drummond</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Flagella</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Flynn</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reina Fuji</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Gill</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janet Gunzner-Toste</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seth F. Harris</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy P. Heffron</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracy Kleinheinz</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donna W. Lee</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire E. Le Pichon</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew D. Medhurst</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John G. Moffat</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susmith Mukund</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Nash</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Scearce-Levie</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zejuan Sheng</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel G. Shore</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thuy Tran</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naimisha Trivedi</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shumei Wang</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuo Zhang</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaolin Zhang</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiling Zhao</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haitao Zhu</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zachary K. Sweeney</span> - <span class="hlFld-Affiliation affiliation">†Department of Discovery Chemistry, ‡Department of Neurosciences, §Department of Biochemical
and Cellular Pharmacology, ∥Department of Drug Metabolism and Pharmacokinetics, ⊥Department of Safety
Assessment, and #Department of Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="hlFld-Affiliation affiliation">∞Department of Chemistry, ×Department of Biochemical and Cellular Pharmacology, and ○Department of
Drug Metabolism and Pharmacokinetics, BioFocus, Chesterford Research Park, Saffron Walden, CB10 1XL, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">X-ray Crystallographic Facility, University of California—Berkeley, 32 Lewis
Hall, Berkeley, California 94720, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d2526e6191-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Analytical, Bioanalytical, NMR, Pharmacokinetic, Biopharmacology, and Safety Assessment colleagues for their contributions. We thank Vivienne Allen, Linda Bao, Leo Berezhkovskiy, Po-Chang Chiang, Kang-Jye Chou, Jason Halladay, Quynh Ho, Claire Holt, Heather Kennedy, Emile Plise, Veronica Rivera, Kimberley Smith, Hilda Solanoy, and Hervé Van de Poël for their individual contributions. We also thank Dr. Zhenyu Yue and his group at the Mount Sinai School of Medicine for kindly providing the G2019S BAC transgenic mice.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> Abbreviations Used</h2><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matched molecular pair</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">LELP</td><td class="NLM_def"><p class="first last">ligand-efficiency-dependent lipophilicity</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">MDCK-MDR1</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cells-multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">BPB</td><td class="NLM_def"><p class="first last">brain protein binding</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BAC</td><td class="NLM_def"><p class="first last">bacterial artificial chromosome</p></td></tr><tr><td class="NLM_term">FVB</td><td class="NLM_def"><p class="first last">Friend virus B-type</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-2-pyrrolidone</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">methylcellulose/Tween</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 66 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_contrib-group">Lees, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span> </span><span class="NLM_article-title">Parkinson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">2055</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=2055-2066&author=A.+J.+Leesauthor=J.+Hardyauthor=T.+Revesz&title=Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D2055%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span>Erratum in  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Lancet+2009%2C+374%2C+684."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0lg3XWNBLLKHjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilks, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez de Munain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti-Masso, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=595-600&author=C.+Paisan-Ruizauthor=S.+Jainauthor=E.+W.+Evansauthor=W.+P.+Gilksauthor=J.+Simonauthor=M.+van+der+Brugauthor=A.+Lopez+de+Munainauthor=S.+Aparicioauthor=A.+M.+Gilauthor=N.+Khanauthor=J.+Johnsonauthor=J.+R.+Martinezauthor=D.+Nichollauthor=I.+M.+Carreraauthor=A.+S.+Penaauthor=R.+de+Silvaauthor=A.+Leesauthor=J.+F.+Marti-Massoauthor=J.+Perez-Turauthor=N.+W.+Woodauthor=A.+B.+Singleton&title=Cloning+of+the+gene+containing+mutations+that+cause+PARK8-linked+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DE.%2BW.%26aulast%3DGilks%26aufirst%3DW.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%2Bde%2BMunain%26aufirst%3DA.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DA.%2BM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%2BR.%26aulast%3DNicholl%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DI.%2BM.%26aulast%3DPena%26aufirst%3DA.%2BS.%26aulast%3Dde%2BSilva%26aufirst%3DR.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DMarti-Masso%26aufirst%3DJ.%2BF.%26aulast%3DPerez-Tur%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DCloning%2520of%2520the%2520gene%2520containing%2520mutations%2520that%2520cause%2520PARK8-linked%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D595%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, K. A.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s disease: protein domains and functional insights</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=286-293&author=I.+F.+Mataauthor=W.+J.+Wedemeyerauthor=M.+J.+Farrerauthor=J.+P.+Taylorauthor=K.+A.+Gallo&title=LRRK2+in+Parkinson%E2%80%99s+disease%3A+protein+domains+and+functional+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DWedemeyer%26aufirst%3DW.%2BJ.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DGallo%26aufirst%3DK.%2BA.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520protein%2520domains%2520and%2520functional%2520insights%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions</span> <span class="citation_source-journal">ASN Neuro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=e00002&author=E.+Greggioauthor=M.+R.+Cookson&title=Leucine-rich+repeat+kinase+2+mutations+and+Parkinson%E2%80%99s+disease%3A+three+questions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520mutations%2520and%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520three%2520questions%26jtitle%3DASN%2520Neuro%26date%3D2009%26volume%3D1%26spage%3De00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gandhi, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson-Delfosse, A. L.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1002%2Fjnr.21949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19025767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=1283-1295&author=P.+N.+Gandhiauthor=S.+G.+Chenauthor=A.+L.+Wilson-Delfosse&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29%3A+a+key+player+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Gandhi, Payal N.; Chen, Shu G.; Wilson-Delfosse, Amy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1283-1295</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years.  Mutations in the gene encoding leucine-rich repeat kinase-2 (LRRK2) have recently been linked to autosomal dominant, late-onset PD that is clin. indistinguishable from typical, idiopathic disease.  LRRK2 is a multidomain protein contg. several protein interaction motifs as well as dual enzymic domains of GTPase and protein kinase activities.  Disease-assocd. mutations are found throughout the multidomain structure of the protein.  LRRK2, however, is unique among the PD-causing genes, because a missense mutation, G2019S, is a frequent determinant of not only familial but also sporadic PD.  Thus, LRRK2 has emerged as a promising therapeutic target for combating PD.  In this Mini-Review, we look at the current state of knowledge regarding the domain structure, amino acid substitutions, and potential functional roles of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhitPWE7Qj1rVg90H21EOLACvtfcHk0lg-m8kUS8qYrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D&md5=81fe55081f2c1e0f665c60aaf7221951</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21949%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DP.%2BN.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DWilson-Delfosse%26aufirst%3DA.%2BL.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%253A%2520a%2520key%2520player%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D1283%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dachsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">LRRK2 and Parkinson disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1001%2Farchneurol.2010.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20457952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=542-547&author=J.+C.+Dachselauthor=M.+J.+Farrer&title=LRRK2+and+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and Parkinson disease</span></div><div class="casAuthors">Dachsel Justus C; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To review the molecular genetics and functional biology of leucine-rich repeat kinase 2 (LRRK2) in parkinsonism and to summarize the opportunities and challenges to develop interventions for Parkinson disease (PD) based on this genetic insight.  DATA SOURCES:  Publications cited are focused on LRRK2 biology between 2004 and March 2009.  STUDY SELECTION:  Literature selected was based on original contributions, seminal observations, and thoughtful reviews.  DATA EXTRACTION:  Unless stated otherwise, data was primarily abstracted from peer-reviewed literature appearing on PubMed.  DATA SYNTHESIS:  Genetic mutations that predispose PD are diagnostically useful in early or atypical presentations.  The molecular pathways identified suggest therapeutic interventions for Lrrk2 and idiopathic PD and the rationale and opportunity to develop physiologically relevant biomarkers and experimental models with which to test them.  CONCLUSIONS:  Both affected and asymptomatic LRRK2 carriers now provide the opportunity to define the natural history of PD.  This includes the frequency, penetrance, and rate of motor symptoms, nonmotor comorbidities, and their associated biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3dH7Qk4jbtZPlX7E30qdzfW6udTcc2ea6udrgu-hFkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D&md5=7f08a3bbe3fc77c7d9bac287a1ff5316</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2010.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2010.79%26sid%3Dliteratum%253Aachs%26aulast%3DDachsel%26aufirst%3DJ.%2BC.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DLRRK2%2520and%2520Parkinson%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2010%26volume%3D67%26spage%3D542%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Satake, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakabayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fng.485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19915576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1303-1307&author=W.+Satakeauthor=Y.+Nakabayashiauthor=I.+Mizutaauthor=Y.+Hirotaauthor=C.+Itoauthor=M.+Kuboauthor=T.+Kawaguchiauthor=T.+Tsunodaauthor=M.+Watanabeauthor=A.+Takedaauthor=H.+Tomiyamaauthor=K.+Nakashimaauthor=K.+Hasegawaauthor=F.+Obataauthor=T.+Yoshikawaauthor=H.+Kawakamiauthor=S.+Sakodaauthor=M.+Yamamotoauthor=N.+Hattoriauthor=M.+Murataauthor=Y.+Nakamuraauthor=T.+Toda&title=Genome-wide+association+study+identifies+common+variants+at+four+loci+as+genetic+risk+factors+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease</span></div><div class="casAuthors">Satake, Wataru; Nakabayashi, Yuko; Mizuta, Ikuko; Hirota, Yushi; Ito, Chiyomi; Kubo, Michiaki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Watanabe, Masahiko; Takeda, Atsushi; Tomiyama, Hiroyuki; Nakashima, Kenji; Hasegawa, Kazuko; Obata, Fumiya; Yoshikawa, Takeo; Kawakami, Hideshi; Sakoda, Saburo; Yamamoto, Mitsutoshi; Hattori, Nobutaka; Murata, Miho; Nakamura, Yusuke; Toda, Tatsushi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1303-1307</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To identify susceptibility variants for Parkinson's disease (PD), we performed a genome-wide assocn. study (GWAS) and two replication studies in a total of 2,011 cases and 18,381 controls from Japan.  We identified a new susceptibility locus on 1q32 (P = 1.52 × 10-12) and designated this as PARK16, and we also identified BST1 on 4p15 as a second new risk locus (P = 3.94 × 10-9).  We also detected strong assocns. at SNCA on 4q22 (P = 7.35 × 10-17) and LRRK2 on 12q12 (P = 2.72 × 10-8), both of which are implicated in autosomal dominant forms of parkinsonism.  By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences.  Our results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiCdi72L_e27Vg90H21EOLACvtfcHk0lh8P_IP9HQ6Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O&md5=46e665390ca8166d83a4688d4f581cf5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng.485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.485%26sid%3Dliteratum%253Aachs%26aulast%3DSatake%26aufirst%3DW.%26aulast%3DNakabayashi%26aufirst%3DY.%26aulast%3DMizuta%26aufirst%3DI.%26aulast%3DHirota%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DC.%26aulast%3DKubo%26aufirst%3DM.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DTomiyama%26aufirst%3DH.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DObata%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DSakoda%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DToda%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520identifies%2520common%2520variants%2520at%2520four%2520loci%2520as%2520genetic%2520risk%2520factors%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1303%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Simón-Sánchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bras, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalls, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Illig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okun, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racette, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonozi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwinn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatzkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuschl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riess, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study reveals genetic risk underlying Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fng.487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19915575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1308-1312&author=J.+Sim%C3%B3n-S%C3%A1nchezauthor=C.+Schulteauthor=J.+M.+Brasauthor=M.+Sharmaauthor=J.+R.+Gibbsauthor=D.+Bergauthor=C.+Paisan-Ruizauthor=P.+Lichtnerauthor=S.+W.+Scholzauthor=D.+G.+Hernandezauthor=R.+Kr%C3%BCgerauthor=M.+Federoffauthor=C.+Kleinauthor=A.+Goateauthor=J.+Perlmutterauthor=M.+Boninauthor=M.+A.+Nallsauthor=T.+Illigauthor=C.+Giegerauthor=H.+Houldenauthor=M.+Steffensauthor=M.+S.+Okunauthor=B.+A.+Racetteauthor=M.+R.+Cooksonauthor=K.+D.+Footeauthor=H.+H.+Fernandezauthor=B.+J.+Traynorauthor=S.+Schreiberauthor=S.+Arepalliauthor=R.+Zonoziauthor=K.+Gwinnauthor=M.+van+der+Brugauthor=G.+Lopezauthor=S.+J.+Chanockauthor=A.+Schatzkinauthor=Y.+Parkauthor=A.+Hollenbeckauthor=J.+Gaoauthor=X.+Huangauthor=N.+W.+Woodauthor=D.+Lorenzauthor=G.+Deuschlauthor=H.+Chenauthor=O.+Riessauthor=J.+A.+Hardyauthor=A.+B.+Singletonauthor=T.+Gasser&title=Genome-wide+association+study+reveals+genetic+risk+underlying+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study reveals genetic risk underlying Parkinson's disease</span></div><div class="casAuthors">Simon-Sanchez, Javier; Schulte, Claudia; Bras, Jose M.; Sharma, Manu; Gibbs, J. Raphael; Berg, Daniela; Paisan-Ruiz, Coro; Lichtner, Peter; Scholz, Sonja W.; Hernandez, Dena G.; Krueger, Rejko; Federoff, Monica; Klein, Christine; Goate, Alison; Perlmutter, Joel; Bonin, Michael; Nalls, Michael A.; Illig, Thomas; Gieger, Christian; Houlden, Henry; Steffens, Michael; Okun, Michael S.; Racette, Brad A.; Cookson, Mark R.; Foote, Kelly D.; Fernandez, Hubert H.; Traynor, Bryan J.; Schreiber, Stefan; Arepalli, Sampath; Zonozi, Ryan; Gwinn, Katrina; van der Brug, Marcel; Lopez, Grisel; Chanock, Stephen J.; Schatzkin, Arthur; Park, Yikyung; Hollenbeck, Albert; Gao, Jianjun; Huang, Xuemei; Wood, Nick W.; Lorenz, Delia; Deuschl, Guenther; Chen, Honglei; Riess, Olaf; Hardy, John A.; Singleton, Andrew B.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1308-1312</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We performed a genome-wide assocn. study (GWAS) in 1713 individuals of European ancestry with Parkinson's disease (PD) and 3978 controls.  After replication in 3361 cases and 4573 controls, we obsd. two strong assocn. signals, one in the gene encoding α-synuclein (SNCA; rs2736990, OR = 1.23, P = 2.24 × 10-16) and another at the MAPT locus (rs393152, OR = 0.77, P = 1.95 × 10-16).  We exchanged data with colleagues performing a GWAS in Japanese PD cases.  Assocn. to PD at SNCA was replicated in the Japanese GWAS, confirming this as a major risk locus across populations.  We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 × 10-8) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 × 10-5).  These data demonstrate an unequivocal role for common genetic variants in the etiol. of typical PD and suggest population-specific genetic heterogeneity in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PHkVNrI1D7Vg90H21EOLACvtfcHk0lim0x-lP8eQwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP&md5=7dae0abacbde642a41eb9d4899b8980d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fng.487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.487%26sid%3Dliteratum%253Aachs%26aulast%3DSim%25C3%25B3n-S%25C3%25A1nchez%26aufirst%3DJ.%26aulast%3DSchulte%26aufirst%3DC.%26aulast%3DBras%26aufirst%3DJ.%2BM.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DGibbs%26aufirst%3DJ.%2BR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DScholz%26aufirst%3DS.%2BW.%26aulast%3DHernandez%26aufirst%3DD.%2BG.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DFederoff%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DPerlmutter%26aufirst%3DJ.%26aulast%3DBonin%26aufirst%3DM.%26aulast%3DNalls%26aufirst%3DM.%2BA.%26aulast%3DIllig%26aufirst%3DT.%26aulast%3DGieger%26aufirst%3DC.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DSteffens%26aufirst%3DM.%26aulast%3DOkun%26aufirst%3DM.%2BS.%26aulast%3DRacette%26aufirst%3DB.%2BA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26aulast%3DFoote%26aufirst%3DK.%2BD.%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DTraynor%26aufirst%3DB.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DArepalli%26aufirst%3DS.%26aulast%3DZonozi%26aufirst%3DR.%26aulast%3DGwinn%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DG.%26aulast%3DChanock%26aufirst%3DS.%2BJ.%26aulast%3DSchatzkin%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DHollenbeck%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DLorenz%26aufirst%3DD.%26aulast%3DDeuschl%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRiess%26aufirst%3DO.%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520reveals%2520genetic%2520risk%2520underlying%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1308%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+leucine-rich+repeat+kinase+2+augment+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520leucine-rich%2520repeat%2520kinase%25202%2520augment%2520kinase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaganovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1016%2Fj.nbd.2006.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=16750377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=329-341&author=E.+Greggioauthor=S.+Jainauthor=A.+Kingsburyauthor=R.+Bandopadhyayauthor=P.+Lewisauthor=A.+Kaganovichauthor=M.+P.+van+der+Brugauthor=A.+Beilinaauthor=J.+Blackintonauthor=K.+J.+Thomasauthor=R.+Ahmadauthor=D.+W.+Millerauthor=S.+Kesavapanyauthor=A.+Singletonauthor=A.+Leesauthor=R.+J.+Harveyauthor=K.+Harveyauthor=M.+R.+Cookson&title=Kinase+activity+is+required+for+the+toxic+effects+of+mutant+LRRK2%2Fdardarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span></div><div class="casAuthors">Greggio, Elisa; Jain, Shushant; Kingsbury, Ann; Bandopadhyay, Rina; Lewis, Patrick; Kaganovich, Alice; van der Brug, Marcel P.; Beilina, Alexandra; Blackinton, Jeff; Thomas, Kelly Jean; Ahmad, Rili; Miller, David W.; Kesavapany, Sashi; Singleton, Andrew; Lees, Andrew; Harvey, Robert J.; Harvey, Kirsten; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-341</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).  Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain.  However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations.  In this study, we noted two cellular phenotypes assocd. with mutant dardarin.  First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies.  Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.  Manipulating activity by replacing the kinase domain with a kinase-dead' version blocks inclusion body formation and strongly delays cell death.  This predicts that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD.  We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Hag6uVnmkLVg90H21EOLACvtfcHk0lhndRl63SBsEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D&md5=52b400fe2f04c2cdeae2a2aa0be67ece</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKingsbury%26aufirst%3DA.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DKaganovich%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DBlackinton%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DK.%2BJ.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BW.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DKinase%2520activity%2520is%2520required%2520for%2520the%2520toxic%2520effects%2520of%2520mutant%2520LRRK2%252Fdardarin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D23%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnrn2935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=21088684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=791-797&author=M.+R.+Cookson&title=The+role+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</span></div><div class="casAuthors">Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">791-797</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component.  Here, I discuss how mutations in a large complex gene - leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau.  These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ6sTeax7vLVg90H21EOLACvtfcHk0li010DotKgG0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO&md5=1600eaee5fea809aa325e2d7a7963b35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrn2935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2935%26sid%3Dliteratum%253Aachs%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DThe%2520role%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D791%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rudenko, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson’s disease?</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1186%2F1741-7015-10-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=22361010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=20-27&author=I.+N.+Rudenkoauthor=R.+Chiaauthor=M.+R.+Cookson&title=Is+inhibition+of+kinase+activity+the+only+therapeutic+strategy+for+LRRK2-associated+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?</span></div><div class="casAuthors">Rudenko, Iakov N.; Chia, Ruth; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20</span>CODEN:
                <span class="NLM_cas:coden">BMMECZ</span>;
        ISSN:<span class="NLM_cas:issn">1741-7015</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of familial Parkinson's disease (PD).  Variation around the LRRK2 locus also contributes to the risk of sporadic PD.  The LRRK2 protein contains a central catalytic region, and pathogenic mutations cluster in the Ras of complex protein C terminus of Ras of complex protein (mutations N1437H, R1441G/C and Y1699C) and kinase (G2019S and I2020T) domains.  Much attention has been focused on the kinase domain, because kinase-dead versions of mutant LRRK2 are less toxic than kinase-active versions of the same proteins.  Furthermore, kinase inhibitors may be able to mimic this effect in mouse models, although the currently tested inhibitors are not completely specific.  In this review, we discuss the recent progress in the development of specific LRRK2 kinase inhibitors.  We also discuss non-kinase-based therapeutic strategies for LRRK2-assocd. PD as it is possible that different approaches may be needed for different mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArNzblopm1bVg90H21EOLACvtfcHk0li010DotKgG0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D&md5=e1de091de6b38b8a1138327f7292ae48</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-10-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-10-20%26sid%3Dliteratum%253Aachs%26aulast%3DRudenko%26aufirst%3DI.%2BN.%26aulast%3DChia%26aufirst%3DR.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DIs%2520inhibition%2520of%2520kinase%2520activity%2520the%2520only%2520therapeutic%2520strategy%2520for%2520LRRK2-associated%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DBMC%2520Med.%26date%3D2012%26volume%3D10%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamichi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in <i>Caenorhabditis elegans</i> and <i>Drosophila</i> Parkinson’s disease models</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1093%2Fhmg%2Fddr312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=21768216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=3933-3942&author=Z.+Liuauthor=S.+Hamamichiauthor=B.+D.+Leeauthor=D.+Yangauthor=A.+Rayauthor=G.+A.+Caldwellauthor=K.+A.+Caldwellauthor=T.+M.+Dawsonauthor=W.+W.+Smithauthor=V.+L.+Dawson&title=Inhibitors+of+LRRK2+kinase+attenuate+neurodegeneration+and+Parkinson-like+phenotypes+in+Caenorhabditis+elegans+and+Drosophila+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models</span></div><div class="casAuthors">Liu, Zhao-Hui; Hamamichi, Shusei; Lee, Byoung-Dae; Yang, De-Jun; Ray, Arpita; Caldwell, Guy A.; Caldwell, Kim A.; Dawson, Ted M.; Smith, Wanli W.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3933-3942</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) have been identified as a genetic cause of familial Parkinson's disease (PD) and have also been found in the more common sporadic form of PD, thus positioning LRRK2 as important in the pathogenesis of PD.  Biochem. studies of the disease-causing mutants of LRRK2 implicates an enhancement of kinase activity as the basis of neuronal toxicity and thus possibly the pathogenesis of PD due to LRRK2 mutations.  Previously, a chem. library screen identified inhibitors of LRRK2 kinase activity.  Here, two of these inhibitors, GW5074 and sorafenib, are shown to protect against G2019S LRRK2-induced neurodegeneration in vivo in Caenorhabditis elegans and in Drosophila.  These findings indicate that increased kinase activity of LRRK2 is neurotoxic and that inhibition of LRRK2 activity can have a disease-modifying effect.  This suggests that inhibition of LRRK2 holds promise as a treatment for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUI1BJ-I2FnrVg90H21EOLACvtfcHk0livoViq2k7Vcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL&md5=53f130209a8364ac8c8c1f553ab4cd63</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr312%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHamamichi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DCaldwell%26aufirst%3DK.%2BA.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DInhibitors%2520of%2520LRRK2%2520kinase%2520attenuate%2520neurodegeneration%2520and%2520Parkinson-like%2520phenotypes%2520in%2520Caenorhabditis%2520elegans%2520and%2520Drosophila%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D3933%26epage%3D3942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanKampen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire-Zeiss, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnm.2199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20729864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=998-1000&author=B.+D.+Leeauthor=J.-H.+Shinauthor=J.+VanKampenauthor=L.+Petrucelliauthor=A.+B.+Westauthor=H.+S.+Koauthor=Y.-I.+Leeauthor=K.+A.+Maguire-Zeissauthor=W.+J.+Bowersauthor=H.+J.+Federoffauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Inhibitors+of+leucine-rich+repeat+kinase-2+protect+against+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease</span></div><div class="casAuthors">Lee, Byoung Dae; Shin, Joo-Ho; Van Kampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1000</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease.  Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration.  These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78Hm84uiebVg90H21EOLACvtfcHk0livoViq2k7Vcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE&md5=d6c5df67511a2f154b21a523af408f65</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnm.2199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2199%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DShin%26aufirst%3DJ.-H.%26aulast%3DVanKampen%26aufirst%3DJ.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DKo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DY.-I.%26aulast%3DMaguire-Zeiss%26aufirst%3DK.%2BA.%26aulast%3DBowers%26aufirst%3DW.%2BJ.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DInhibitors%2520of%2520leucine-rich%2520repeat%2520kinase-2%2520protect%2520against%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D998%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><div class="note"><p class="first last">For a recent review on LRRK2 small molecule kinase inhibitors, see the following: </p></div><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göring, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amombo, G. M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for LRRK2 and their application to Parkinson’s disease models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200117j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=151-160&author=T.+Kramerauthor=F.+Lo+Monteauthor=S.+G%C3%B6ringauthor=G.+M.+O.+Amomboauthor=B.+Schmidt&title=Small+molecule+kinase+inhibitors+for+LRRK2+and+their+application+to+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models</span></div><div class="casAuthors">Kramer, Thomas; Lo Monte, Fabio; Goering, Stefan; Okala Amombo, Ghislaine Marlyse; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder.  Several single gene mutations have been linked to this disease.  Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) indicate LRRK2 as promising therapeutic target for the treatment of PD.  LRRK2 mutations were obsd. in sporadic as well as familial PD patients and have been investigated intensively.  LRRK2 is a large and complex protein, with multiple enzymic and protein-interaction domains, each of which is effected by mutations.  The most common mutation in PD patients is G2019S.  Several LRRK2 inhibitors have been reported already, although the crystal structure of LRRK2 has not yet been detd.  This review provides a summary of known LRRK2 inhibitors and will discuss recent in vitro and in vivo results of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUiu7gx3NxLVg90H21EOLACvtfcHk0ljA8sv8lE_VPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D&md5=bda078bde5e0b515ca9d6f183d8b06f8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn200117j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200117j%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26aulast%3DG%25C3%25B6ring%26aufirst%3DS.%26aulast%3DAmombo%26aufirst%3DG.%2BM.%2BO.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520LRRK2%2520and%2520their%2520application%2520to%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=365-373&author=B.+D.+Leeauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+as+a+potential+therapeutic+target+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+selective+inhibitor+of+the+Parkinson%E2%80%99s+disease+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0ljA8sv8lE_VPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren., Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span> </span><span class="NLM_article-title">Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson’s disease-related toxicity in human neurons</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb2002413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1021-1028&author=N.+Ramsdenauthor=J.+Perrinauthor=Z.+Ren.author=B.+D.+Leeauthor=N.+Zinnauthor=V.+L.+Dawsonauthor=D.+Tamauthor=M.+Bovaauthor=M.+Langauthor=G.+Drewesauthor=M.+Bantscheffauthor=F.+Bardauthor=T.+M.+Dawsonauthor=C.+Hopf&title=Chemoproteomics-based+design+of+potent+LRRK2-selective+lead+compounds+that+attenuate+Parkinson%E2%80%99s+disease-related+toxicity+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcb2002413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb2002413%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRen.%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DBova%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHopf%26aufirst%3DC.%26atitle%3DChemoproteomics-based%2520design%2520of%2520potent%2520LRRK2-selective%2520lead%2520compounds%2520that%2520attenuate%2520Parkinson%25E2%2580%2599s%2520disease-related%2520toxicity%2520in%2520human%2520neurons%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1021%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Nichols, P. L.; Eatherton, A. J.; Bamborough, P.; Jandu, K. S.; Philps, O. J.; Andreotti, D.</span><span> </span><span class="NLM_article-title">Novel Compounds</span>. WO 2011/038572 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+L.+Nichols&author=A.+J.+Eatherton&author=P.+Bamborough&author=K.+S.+Jandu&author=O.+J.+Philps&author=D.+Andreotti&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzoni, C.</span><span> </span><span class="NLM_article-title">LRRK2 and human disease: a complicated question or a question of complexes?</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">pe2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1126%2Fscisignal.2002680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=22253261" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=pe2&author=P.+A.+Lewisauthor=C.+Manzoni&title=LRRK2+and+human+disease%3A+a+complicated+question+or+a+question+of+complexes%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002680%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DManzoni%26aufirst%3DC.%26atitle%3DLRRK2%2520and%2520human%2520disease%253A%2520a%2520complicated%2520question%2520or%2520a%2520question%2520of%2520complexes%253F%26jtitle%3DSci.%2520Signaling%26date%3D2012%26volume%3D5%26spage%3Dpe2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.3109%2F01677063.2011.627072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=22077787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=140-151&author=R.+E.+Droletauthor=J.+M.+Sandersauthor=J.+T.+Kern&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+cellular+biology%3A+a+review+of+recent+advances+in+identifying+physiological+substrates+and+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions</span></div><div class="casAuthors">Drolet, Robert E.; Sanders, John M.; Kern, Jonathan T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">140-151</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common forms of inheritable Parkinson's disease and likely play a role in sporadic disease as well.  LRRK2 is a large multidomain protein contg. two key groups, a Ras-like GTP binding domain and a serine, threonine kinase domain.  Mutations in the LRRK2 gene that assoc. with Parkinson's disease reside primarily within the two functional domains of the protein, suggesting that LRRK2 function is crit. to the pathogenesis of the disease.  The most common LRRK2 mutation increases kinase activity, making LRRK2 kinase inhibition an attractive target for small mol. drug development.  However, the physiol. function of LRRK2 kinase as well as its endogenous protein substrates remains poorly understood and has hindered drug development efforts.  Recent advances in LRRK2 biol. have revealed several potential cellular roles, interacting proteins, and putative physiol. substrates.  Together, a picture emerges of a complex multifunctional protein that exists in multiple cellular compartments.  Through unclear mechanisms, LRRK2 kinase regulates cytoskeleton architecture through control of protein translation, phosphorylation of cytoskeletal proteins, and response to cellular stressors.  This article will briefly cover some interesting recent studies in LRRK2 cellular biol. and highlight emerging cellular models of LRRK2 kinase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIaZnsxyLANrVg90H21EOLACvtfcHk0lhWbJ-YsPb3Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL&md5=b4b40ac3ccfa45091410f59e1401587c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627072%26sid%3Dliteratum%253Aachs%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520cellular%2520biology%253A%2520a%2520review%2520of%2520recent%2520advances%2520in%2520identifying%2520physiological%2520substrates%2520and%2520cellular%2520functions%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D140%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a potent LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+potent+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520potent%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Sheng, Z.; Zhang, S.; Bustos, D.; Kleinheinz, T.; Le Pichon, C. E.; Dominguez, S. L.; Solanoy, H. O.; Drummond, J.; Zhang, X.; Ding, X.; Cai, F.; Song, Q.; Li, X.; Yue, Z.; van der Brug, M. P.; Burdick, D. J.; Gunzner-Toste, J.; Chen, H.; Liu, X.; Estrada, A. A.; Sweeney, Z. K.; Scearce-Levie, K.; Moffat, J. G.; Kirkpatrick, D. S.; Zhu, H.</span><span> </span><span class="NLM_article-title">Ser1292 autophosphorylation is a biomarker of LRRK2 kinase activity and mediates cellular effects of PD mutations</span>.  <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Z.+Sheng&author=S.+Zhang&author=D.+Bustos&author=T.+Kleinheinz&author=C.+E.+Le+Pichon&author=S.+L.+Dominguez&author=H.+O.+Solanoy&author=J.+Drummond&author=X.+Zhang&author=X.+Ding&author=F.+Cai&author=Q.+Song&author=X.+Li&author=Z.+Yue&author=M.+P.+van+der+Brug&author=D.+J.+Burdick&author=J.+Gunzner-Toste&author=H.+Chen&author=X.+Liu&author=A.+A.+Estrada&author=Z.+K.+Sweeney&author=K.+Scearce-Levie&author=J.+G.+Moffat&author=D.+S.+Kirkpatrick&author=H.+Zhu&title=Ser1292+autophosphorylation+is+a+biomarker+of+LRRK2+kinase+activity+and+mediates+cellular+effects+of+PD+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26atitle%3DSer1292%2520autophosphorylation%2520is%2520a%2520biomarker%2520of%2520LRRK2%2520kinase%2520activity%2520and%2520mediates%2520cellular%2520effects%2520of%2520PD%2520mutations%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5545</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5536-5545&author=H.+Chenauthor=B.+K.+Chanauthor=J.+Drummondauthor=A.+A.+Estradaauthor=J.+Gunzner-Tosteauthor=X.+Liuauthor=Y.+Liuauthor=J.+G.+Moffatauthor=D.+Shoreauthor=Z.+K.+Sweeneyauthor=T.+Tranauthor=S.+Wangauthor=G.+Zhaoauthor=H.+Zhuauthor=D.+J.+Burdick&title=Discovery+of+selective+LRRK2+inhibitors+guided+by+computational+analysis+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span></div><div class="casAuthors">Chen, Huifen; Chan, Bryan K.; Drummond, Jason; Estrada, Anthony A.; Gunzner-Toste, Janet; Liu, Xingrong; Liu, Yichin; Moffat, John; Shore, Daniel; Sweeney, Zachary K.; Tran, Thuy; Wang, Shumei; Zhao, Guiling; Zhu, Haitao; Burdick, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5536-5545</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson's disease (PD).  Potent and selective small mols. capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD.  In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homol. model was developed that provided robust guidance in the hit-to-lead optimization of small mol. LRRK2 inhibitors.  Through a combination of mol. modeling, sequence anal., and matched mol. pair (MMP) activity cliff anal., a potent and selective lead inhibitor was discovered.  The selectivity of this compd. could be understood using the LRRK2 homol. model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YrcBmeoRILVg90H21EOLACvtfcHk0lhWbJ-YsPb3Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D&md5=fe4d3a709a35f94e3c092b73bdb09936</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300452p%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DShore%26aufirst%3DD.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520LRRK2%2520inhibitors%2520guided%2520by%2520computational%2520analysis%2520and%2520molecular%2520modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5536%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="ref125_1"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avshalumov, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, Z.</span><span> </span><span class="NLM_article-title">Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson’s disease mutation G2019S</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/ref125_1&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1523%2FJNEUROSCI.5604-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/ref125_1&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20130188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/ref125_1&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2jurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=1788-1797&author=X.+Liauthor=J.+C.+Patelauthor=J.+Wangauthor=M.+V.+Avshalumovauthor=C.+Nicholsonauthor=J.+D.+Buxbaumauthor=G.+A.+Elderauthor=M.+E.+Riceauthor=Z.+Yue&title=Enhanced+striatal+dopamine+transmission+and+motor+performance+with+LRRK2+overexpression+in+mice+is+eliminated+by+familial+Parkinson%E2%80%99s+disease+mutation+G2019S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref125_1R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S</span></div><div class="casAuthors">Li, Xianting; Patel, Jyoti C.; Wang, Jing; Avshalumov, Marat V.; Nicholson, Charles; Buxbaum, Joseph D.; Elder, Gregory A.; Rice, Margaret E.; Yue, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1788-1797</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">PARK8/LRRK2 (leucine-rich repeat kinase 2) was recently identified as a causative gene for autosomal dominant Parkinson's disease (PD), with LRRK2 mutation G2019S linked to the most frequent familial form of PD.  Emerging in vitro evidence indicates that aberrant enzymic activity of LRRK2 protein carrying this mutation can cause neurotoxicity.  However, the physiol. and pathophysiol. functions of LRRK2 in vivo remain elusive.  Here we characterize two bacterial artificial chromosome (BAC) transgenic mouse strains overexpressing LRRK2 wild-type (Wt) or mutant G2019S.  Transgenic LRRK2-Wt mice had elevated striatal dopamine (DA) release with unaltered DA uptake or tissue content.  Consistent with this result, LRRK2-Wt mice were hyperactive and showed enhanced performance in motor function tests.  These results suggest a role for LRRK2 in striatal DA transmission and the consequent motor function.  In contrast, LRRK2-G2019S mice showed an age-dependent decrease in striatal DA content, as well as decreased striatal DA release and uptake.  Despite increased brain kinase activity, LRRK2-G2019S overexpression was not assocd. with loss of DAergic neurons in substantia nigra or degeneration of nigrostriatal terminals at 12 mo.  Our results thus reveal a pivotal role for LRRK2 in regulating striatal DA transmission and consequent control of motor function.  The PD-assocd. mutation G2019S may exert pathogenic effects by impairing these functions of LRRK2.  Our LRRK2 BAC transgenic mice, therefore, could provide a useful model for understanding early PD pathol. events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqebY5-NeADCLVg90H21EOLACvtfcHk0ljH4rOrs4FYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2jurY%253D&md5=3c547266dea53eb88779e765dfcf1e7d</span></div><a href="/servlet/linkout?suffix=ref125_1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5604-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5604-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAvshalumov%26aufirst%3DM.%2BV.%26aulast%3DNicholson%26aufirst%3DC.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26aulast%3DElder%26aufirst%3DG.%2BA.%26aulast%3DRice%26aufirst%3DM.%2BE.%26aulast%3DYue%26aufirst%3DZ.%26atitle%3DEnhanced%2520striatal%2520dopamine%2520transmission%2520and%2520motor%2520performance%2520with%2520LRRK2%2520overexpression%2520in%2520mice%2520is%2520eliminated%2520by%2520familial%2520Parkinson%25E2%2580%2599s%2520disease%2520mutation%2520G2019S%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D1788%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3001138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1138-1145&author=X.+Huauthor=Y.+Huauthor=M.+Vogtauthor=D.+Stumpfeauthor=J.+Bajorath&title=MMP-Cliffs%3A+systematic+identification+of+activity+cliffs+on+the+basis+of+matched+molecular+pairs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs</span></div><div class="casAuthors">Hu, Xiaoying; Hu, Ye; Vogt, Martin; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1145</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity cliffs are generally defined as pairs of structurally similar compds. having large differences in potency.  The anal. of activity cliffs is of general interest because structure-activity relationship (SAR) determinants can often be deduced from them.  Crit. questions for the study of activity cliffs include how similar compds. should be to qualify as cliff partners, how similarity should be assessed, and how large potency differences between participating compds. should be.  Thus far, activity cliffs have mostly been defined on the basis of calcd. Tanimoto similarity values using structural descriptors, esp. 2D fingerprints.  As any theor. assessment of mol. similarity, this approach has its limitations.  For example, calcd. Tanimoto similarities might often be difficult to reconcile and interpret from a chem. perspective, a point of critique frequently raised in medicinal chem.  Herein, we have explored activity cliffs by considering well-defined substructure replacements instead of calcd. similarity values.  For this purpose, the matched mol. pair (MMP) formalism has been applied.  MMPs were systematically derived from public domain compds., and activity cliffs were extd. from them, termed MMP-cliffs.  The frequency of cliff formation was detd. for compds. active against different targets, MMP-cliffs were analyzed in detail, and re-evaluated on the basis of Tanimoto similarity.  In many instances, chem. intuitive activity cliffs were only detected on the basis of MMPs, but not Tanimoto similarity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCYSOxNqPjGbVg90H21EOLACvtfcHk0lgNeBj_dHKhHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D&md5=958a76d85d0a06424b43eb1b694cf3ca</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fci3001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3001138%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DVogt%26aufirst%3DM.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DMMP-Cliffs%253A%2520systematic%2520identification%2520of%2520activity%2520cliffs%2520on%2520the%2520basis%2520of%2520matched%2520molecular%2520pairs%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1138%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">The power of MMPA and a teaching lesson in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1815</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300163y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1815-1816&author=K.+Muller&title=The+power+of+MMPA+and+a+teaching+lesson+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300163y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300163y%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DThe%2520power%2520of%2520MMPA%2520and%2520a%2520teaching%2520lesson%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1815%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Exploring activity cliffs in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2932</span><span class="NLM_x">–</span> <span class="NLM_lpage">2942</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201706b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2932-2942&author=D.+Stumpfeauthor=J.+Bajorath&title=Exploring+activity+cliffs+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Activity Cliffs in Medicinal Chemistry</span></div><div class="casAuthors">Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2932-2942</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, structure-activity relationships (SARs) have increasingly been studied through mining of large compd. data sets, leading to a renaissance of the activity landscape concept.  In general terms, an activity landscape is defined as any graphical representation that integrates similarity and potency relationships between compds. sharing a specific activity.  From activity landscape representations of different design, both global and local SAR features present in compd. data sets can be extd.  Modeling and rationalizing activity landscapes require the application of computational methods.  As such, the activity landscape concept is of comparable relevance for chemoinformatics (having a strong focus on data mining and representation) and medicinal chem. (given its immediate relevance for SAR anal.).  Herein, we describe in detail the multifaceted nature of activity cliffs, discuss underlying scientific concepts, and explain how their individual or systematic anal. might (or might not) provide useful information for medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1wydp65qQLVg90H21EOLACvtfcHk0lgNeBj_dHKhHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D&md5=ceddd1de5798b585d6381ac18ba67fc9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm201706b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201706b%26sid%3Dliteratum%253Aachs%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DExploring%2520activity%2520cliffs%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2932%26epage%3D2942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0lh3Mes4dbA24A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Chemical transformations that yield compounds with distinct activity profiles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=523-527&author=Y.+Huauthor=J.+Bajorath&title=Chemical+transformations+that+yield+compounds+with+distinct+activity+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fml2000609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000609%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DChemical%2520transformations%2520that%2520yield%2520compounds%2520with%2520distinct%2520activity%2520profiles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D523%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span> </span><span class="NLM_article-title">Targeted kinase selectivity from kinase profiling data</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300012r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=383-386&author=F.+Millettiauthor=J.+C.+Hermann&title=Targeted+kinase+selectivity+from+kinase+profiling+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fml300012r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300012r%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26atitle%3DTargeted%2520kinase%2520selectivity%2520from%2520kinase%2520profiling%2520data%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D383%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32a1"><span>Erratum in Proc. Natl. Acad. Sci. U.S.A.<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span>. </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Proc.+Natl.+Acad.+Sci.+U.S.A.+2007%2C+104%2C+2025.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase+activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase%2520activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Baker-Glenn, C.; Burdick, D. J.; Chambers, M.; Chan, B. K.; Chen, H.; Estrada, A.; Gunzner, J. L.; Shore, D.; Sweeney, Z. K.; Wang, S.; Zhao, G.</span><span> </span><span class="NLM_article-title">Aminopyrimidine derivatives as LRRK2 modulators and their preparation and use for the treatment of Parkinson’s disease</span>. WO2011151360A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Baker-Glenn&author=D.+J.+Burdick&author=M.+Chambers&author=B.+K.+Chan&author=H.+Chen&author=A.+Estrada&author=J.+L.+Gunzner&author=D.+Shore&author=Z.+K.+Sweeney&author=S.+Wang&author=G.+Zhao&title=Aminopyrimidine+derivatives+as+LRRK2+modulators+and+their+preparation+and+use+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaker-Glenn%26aufirst%3DC.%26atitle%3DAminopyrimidine%2520derivatives%2520as%2520LRRK2%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Brain penetrant LRRK2 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300123a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=658-662&author=H.+G.+Choiauthor=J.+Zhangauthor=X.+Dengauthor=J.+M.+Hatcherauthor=M.+P.+Patricelliauthor=Z.+Zhaoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Brain+penetrant+LRRK2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fml300123a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300123a%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DBrain%2520penetrant%2520LRRK2%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D658%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond the rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+the+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljvDXRKQyMOww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520the%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgcT5guq5r3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Keserű, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C5%B1author=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C5%25B1%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="note"><p class="first last">For impact of lipophilic efficiency parameters on compound quality, see the following: </p></div><div class="NLM_citation" id="cit39a"><span><span class="NLM_contrib-group">Tarcsay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyíri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keserű, G. M.</span><span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Ny%C3%ADriauthor=G.+M.+Keser%C5%B1&title=Impact+of+lipophilic+efficiency+on+compound+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0lgcT5guq5r3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNy%25C3%25ADri%26aufirst%3DK.%26aulast%3DKeser%25C5%25B1%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><div class="note"><p class="first last">For impact on CNS drugs and candidates, see the following: </p></div><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0li-aL_TNjWetQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liederer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Use of cassette dosing approach to assess brain penetration in drug discovery</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=963-969&author=X.+Liuauthor=X.+Dingauthor=G.+Deshmukhauthor=B.+M.+Liedererauthor=C.+E.+C.+A.+Hop&title=Use+of+cassette+dosing+approach+to+assess+brain+penetration+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DUse%2520of%2520cassette%2520dosing%2520approach%2520to%2520assess%2520brain%2520penetration%2520in%2520drug%2520discovery%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D963%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hennig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Leon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Cornejo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, L.</span><span> </span><span class="NLM_article-title">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1016%2Fj.jfluchem.2009.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2009&pages=453-460&author=L.+Hennigauthor=K.+Ayala-Leonauthor=J.+Angulo-Cornejoauthor=R.+Richterauthor=L.+Beyer&title=Fluorine+hydrogen+short+contacts+and+hydrogen+bonds+in+substituted+benzamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span></div><div class="casAuthors">Hennig, Lothar; Ayala-Leon, Ketty; Angulo-Cornejo, Jorge; Richter, Rainer; Beyer, Lothar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ten Fluorine substituted benzamides were synthesized and studied by spectroscopic methods (NMR, IR, MS) and x-ray structure anal.  The configuration of these compds. strongly depends on solvent, temp. and substitution pattern.  Unexpectedly, some of these compds. form weak intramol. hydrogen bonds/short N-H···F-C contacts in CDCl3 soln. and in the solid state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO1miRde9jnbVg90H21EOLACvtfcHk0lgBcR8Yb2qNJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D&md5=2abb3e0d14e81fe2adda68b51bd6b6b8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2009.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2009.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DAyala-Leon%26aufirst%3DK.%26aulast%3DAngulo-Cornejo%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DL.%26atitle%3DFluorine%2520hydrogen%2520short%2520contacts%2520and%2520hydrogen%2520bonds%2520in%2520substituted%2520benzamides%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2009%26volume%3D130%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Fritz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, T.</span><span> </span><span class="NLM_article-title">Weitreichende kopplung zwischen protonen und fluor in 2-fluorbenzamiden</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">836</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1974&pages=836-839&author=H.+Fritzauthor=T.+Winkler&title=Weitreichende+kopplung+zwischen+protonen+und+fluor+in+2-fluorbenzamiden"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DH.%26aulast%3DWinkler%26aufirst%3DT.%26atitle%3DWeitreichende%2520kopplung%2520zwischen%2520protonen%2520und%2520fluor%2520in%25202-fluorbenzamiden%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1974%26volume%3D57%26spage%3D836%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of a compound</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+a+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520a%2520compound%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgBcR8Yb2qNJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0liAbEnI12UJ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfronga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J.</span><span> </span><span class="NLM_article-title">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1124%2Fdmd.105.008201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=16760229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1443-1447&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrongaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+R.+Nelsonauthor=M.+A.+Szewcauthor=J.+Van+Deusen&title=Evaluation+of+cerebrospinal+fluid+concentration+and+plasma+free+concentration+as+a+surrogate+measurement+for+brain+free+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the use of cerebrospinal fluid (CSF) drug concn. and plasma unbound concn. (Cu,plasma) to predict brain unbound concn. (Cu,brain).  The concn.-time profiles in CSF, plasma, and brain of seven model compds. were detd. after s.c. administration in rats.  The Cu,brain was estd. from the product of total brain concns. and unbound fractions, which were detd. using brain tissue slice and brain homogenate methods.  For theobromine, theophylline, caffeine, fluoxetine, and propranolol, which represent rapid brain penetration compds. with a simple diffusion mechanism, the ratios of the area under the curve of Cu,brain/CCSF and Cu,brain/Cu,plasma were 0.27 to 1.5 and 0.29 to 2.1, resp., using the brain slice method, and were 0.27 to 2.9 and 0.36 to 3.9, resp., using the brain homogenate method.  A P-glycoprotein substrate, CP-141938 (methoxy-3-[(2-phenyl-piperidinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.57 and 0.066, using the brain slice method, and 1.1 and 0.13, using the brain homogenate method, resp.  The slow brain-penetrating compd., N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine, had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.94 and 0.12 using the brain slice method and 0.15 and 0.018 using the brain homogenate method, resp.  Therefore, for quick brain penetration with simple diffusion mechanism compds., CCSF and Cu,plasma represent Cu,brain equally well; for efflux substrates or slow brain penetration compds., CCSF appears to be equiv. to or more accurate than Cu,plasma to represent Cu,brain.  Thus, we hypothesize that CCSF is equiv. to or better than Cu,plasma to predict Cu,brain.  This hypothesis is supported by the literature data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43dRkq9lx7Vg90H21EOLACvtfcHk0liAbEnI12UJ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D&md5=cef079e1a667dbddf9d5a2f7d01889e8</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.008201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.008201%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfronga%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520cerebrospinal%2520fluid%2520concentration%2520and%2520plasma%2520free%2520concentration%2520as%2520a%2520surrogate%2520measurement%2520for%2520brain%2520free%2520concentration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1443%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+an+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0litvwutHJyhOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520an%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit48"><span>Invitrogen Lanthascreen Eu kinase binding assay kit for TTK.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Invitrogen+Lanthascreen+Eu+kinase+binding+assay+kit+for+TTK."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelluma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manak, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deveraux, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+P.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+Mps1+cell+cycle+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0litvwutHJyhOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520Mps1%2520cell%2520cycle%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Olaharski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzaludo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span> </span><span class="NLM_article-title">Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000446&author=A.+J.+Olaharskiauthor=N.+Gonzaludoauthor=H.+Bitterauthor=D.+Goldsteinauthor=S.+Kirchnerauthor=H.+Uppalauthor=K.+Kolaja&title=Identification+of+a+kinase+profile+that+predicts+chromosome+damage+induced+by+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlaharski%26aufirst%3DA.%2BJ.%26aulast%3DGonzaludo%26aufirst%3DN.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DUppal%26aufirst%3DH.%26aulast%3DKolaja%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520kinase%2520profile%2520that%2520predicts%2520chromosome%2520damage%2520induced%2520by%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3De1000446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">A chemical tool box defines mitotic and interphase roles for Mps1 kinase</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=21-24&author=W.+Lanauthor=D.+W.+Cleveland&title=A+chemical+tool+box+defines+mitotic+and+interphase+roles+for+Mps1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DW.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DA%2520chemical%2520tool%2520box%2520defines%2520mitotic%2520and%2520interphase%2520roles%2520for%2520Mps1%2520kinase%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D21%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wilberg, K. B.</span><span> </span><span class="NLM_article-title">The deuterium isotope effect</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1955&pages=713&author=K.+B.+Wilberg&title=The+deuterium+isotope+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilberg%26aufirst%3DK.%2BB.%26atitle%3DThe%2520deuterium%2520isotope%2520effect%26jtitle%3DChem.%2520Rev.%26date%3D1955%26volume%3D55%26spage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule–kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.-M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule%E2%80%93kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.-M.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule%25E2%2580%2593kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Porter, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revell, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span> </span><span class="NLM_article-title">Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fsj.bjp.0702751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=10498829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=13-20&author=R.+H.+Porterauthor=K.+R.+Benwellauthor=H.+Lambauthor=C.+S.+Malcolmauthor=N.+H.+Allenauthor=D.+F.+Revellauthor=D.+R.+Adamsauthor=M.+J.+Sheardown&title=Functional+characterization+of+agonists+at+recombinant+human+5-HT2A%2C+5-HT2B+and+5-HT2C+receptors+in+CHO-K1+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells</span></div><div class="casAuthors">Porter, R. H. P.; Benwell, K. R.; Lamb, H.; Malcolm, C. S.; Allen, N. H.; Revell, D. F.; Adams, D. R.; Sheardown, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The goal of this study was to characterize the agonist pharmacol. of human 5-HT2A, 5-HT2B and 5-HT2C (VSV) receptors expressed in CHO-K1 (Chinese hamster ovary) cells.  We used a fluorometric imaging plate reader (FLIPR) which allows rapid detection of rises in intracellular calcium levels upon the addn. of agonists.  Stimulation of all three receptors by 5-HT caused a robust concn. dependent increase in intracellular calcium levels.  No such effect was obsd. from non-transfected control CHO-K1 cells.  The rank order of potency of agonists at the different receptor subtypes varied.  Tryptamines, BW-723C86, d-norfenfluramine, Ro 60-0175 and LSD exhibited the following rank order of potency; 5-HT2B>5-HT2C>5-HT2A.  Piperazines such as m-chlorophenylpiperazine (mCPP), ORG-12962, MK-212 and also ORG-37684 exhibited a rank order of potency of 5-HT2C>5-HT2B>5-HT2A.  The phenylisopropylamines DOI and DOB had a rank order of 5-HT2A>5-HT2B>5-HT2C.  Many agonists tested had partial agonist actions when compared to 5-HT, and a wide range of relative efficacies were exhibited, which was cell line dependent.  For example, mCPP had a relative efficacy of 65% at 5-HT2C receptors but <25% at either 5-HT2A or 5-HT2B receptors.  Interpretation of literature values of functional assays using different cell lines, different receptor expression levels and different receptor isoforms, is complex.  Species differences and the previous use of antagonist radioligands to characterize agonist potency in binding assays emphasizes the importance of studying agonists in the same expt. using the same assay conditions and parental cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgNDFqRrlEtbVg90H21EOLACvtfcHk0lgxLq2FUwlSjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D&md5=ff33f4122999f10960865e75161179ca</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702751%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DBenwell%26aufirst%3DK.%2BR.%26aulast%3DLamb%26aufirst%3DH.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DAllen%26aufirst%3DN.%2BH.%26aulast%3DRevell%26aufirst%3DD.%2BF.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26atitle%3DFunctional%2520characterization%2520of%2520agonists%2520at%2520recombinant%2520human%25205-HT2A%252C%25205-HT2B%2520and%25205-HT2C%2520receptors%2520in%2520CHO-K1%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Zhou, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-P.</span><span> </span><span class="NLM_article-title">Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.3109%2F03602530903286476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19961320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFehsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=268-354&author=S.-F.+Zhouauthor=B.+Wangauthor=L.-P.+Yangauthor=J.-P.+Liu&title=Structure%2C+function%2C+regulation+and+polymorphism+and+the+clinical+significance+of+human+cytochrome+P450+1A2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2</span></div><div class="casAuthors">Zhou, Shu-Feng; Wang, Bo; Yang, Li-Ping; Liu, Jun-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-354</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Human CYP1A2 is one of the major CYPs in human liver and metabolizes a no. of clin. drugs (e.g., clozapine, tacrine, tizanidine, and theophylline; n > 110), a no. of procarcinogens (e.g., benzo[a]pyrene and arom. amines), and several important endogenous compds. (e.g., steroids).  CYP1A2 is subject to reversible and/or irreversible inhibition by a no. of drugs, natural substances, and other compds.  The CYP1A gene cluster has been mapped on to chromosome 15q24.1, with close link between CYP1A1 and 1A2 sharing a common 5'-flanking region.  The human CYP1A2 gene spans almost 7.8 kb comprising seven exons and six introns and codes a 515-residue protein with a mol. mass of 58,294 Da.  The recently resolved CYP1A2 structure has a relatively compact, planar active site cavity that is highly adapted for the size and shape of its substrates.  The architecture of the active site of 1A2 is characterized by multiple residues on helixes F and I that constitutes two parallel substrate binding platforms on either side of the cavity.  A large interindividual variability in the expression and activity of CYP1A2 has been obsd., which is largely caused by genetic, epigenetic and environmental factors (e.g., smoking).  CYP1A2 is primarily regulated by the arom. hydrocarbon receptor (AhR) and CYP1A2 is induced through AhR-mediated transactivation following ligand binding and nuclear translocation.  Induction or inhibition of CYP1A2 may provide partial explanation for some clin. drug interactions.  To date, more than 15 variant alleles and a series of subvariants of the CYP1A2 gene have been identified and some of them have been assocd. with altered drug clearance and response and disease susceptibility.  Further studies are warranted to explore the clin. and toxicol. significance of altered CYP1A2 expression and activity caused by genetic, epigenetic, and environmental factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwfCc84BYyO7Vg90H21EOLACvtfcHk0lgxLq2FUwlSjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFehsL0%253D&md5=808977d5168454cc990a5a5daa167cc0</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3109%2F03602530903286476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602530903286476%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.-F.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DL.-P.%26aulast%3DLiu%26aufirst%3DJ.-P.%26atitle%3DStructure%252C%2520function%252C%2520regulation%2520and%2520polymorphism%2520and%2520the%2520clinical%2520significance%2520of%2520human%2520cytochrome%2520P450%25201A2%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2010%26volume%3D42%26spage%3D268%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Zhou, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span> </span><span class="NLM_article-title">Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=481-494&author=S.-F.+Zhouauthor=L.-P.+Yangauthor=Z.-W.+Zhouauthor=Y.-H.+Liuauthor=E.+Chan&title=Insights+into+the+substrate+specificity%2C+inhibitors%2C+regulation%2C+and+polymorphisms+and+the+clinical+impact+of+human+cytochrome+P450+1A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.-F.%26aulast%3DYang%26aufirst%3DL.-P.%26aulast%3DZhou%26aufirst%3DZ.-W.%26aulast%3DLiu%26aufirst%3DY.-H.%26aulast%3DChan%26aufirst%3DE.%26atitle%3DInsights%2520into%2520the%2520substrate%2520specificity%252C%2520inhibitors%252C%2520regulation%252C%2520and%2520polymorphisms%2520and%2520the%2520clinical%2520impact%2520of%2520human%2520cytochrome%2520P450%25201A2%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D481%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="note"><p class="first last">Cellular assay is triple mutant LRRK2 (R1441G/Y1699C/G2019S), and BAC transgenic mice are G2019S mutant LRRK2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Akabane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramura, T.</span><span> </span><span class="NLM_article-title">A comparison of pharmacokinetics between humans and monkeys</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=308-316&author=T.+Akabaneauthor=K.+Tabataauthor=K.+Kadonoauthor=S.+Sakudaauthor=S.+Terashitaauthor=T.+Teramura&title=A+comparison+of+pharmacokinetics+between+humans+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkabane%26aufirst%3DT.%26aulast%3DTabata%26aufirst%3DK.%26aulast%3DKadono%26aufirst%3DK.%26aulast%3DSakuda%26aufirst%3DS.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTeramura%26aufirst%3DT.%26atitle%3DA%2520comparison%2520of%2520pharmacokinetics%2520between%2520humans%2520and%2520monkeys%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D308%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Roller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laspina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1080%2F00498250802546861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19219746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=33-45&author=S.+Rollerauthor=D.+Cuiauthor=C.+Laspinaauthor=C.+Miller-Steinauthor=J.+Roweauthor=B+Wongauthor=T.+Prueksaritanont&title=Preclinical+pharmacokinetics+of+MK-0974%2C+an+orally+active+calcitonin-gene+related+peptide+%28CGRP%29-receptor+antagonist%2C+mechanism+of+dose+dependency+and+species+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span></div><div class="casAuthors">Roller, S.; Cui, D.; Laspina, C.; Miller-Stein, C.; Rowe, J.; Wong, B.; Prueksaritanont, T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The underlying mechanism for low oral bioavailability of MK-0974, a potent calcitonin-gene related peptide (CGRP)-receptor antagonist, in monkeys and for species-dependent non-linear pharmacokinetics in monkeys and rats were investigated.  In monkeys, MK-0974 displayed moderate clearance (14-20 mL min-1 kg-1), while oral bioavailability was 6%.  The pharmacokinetics of MK-0974 remained linear across 0.5-10 mg kg-1 i.v. dose in monkeys, but the oral area under the blood plasma concn.-time curve (AUC) increase (5-30 mg kg-1) was 15-fold over dose-proportional.  Based on a comparison of AUC following hepatic portal vein administration and cephalic vein infusion, MK-0974 exhibited a low-to-moderate hepatic extn. ratio (36%) in monkeys.  Following oral dose of [14C]MK-0974 to monkeys, the hepatic portal AUC ratio of MK-0974 vs. total radioactivity was 0.32, and the total radioactivity recovered in bile and urine was 45-83%.  MK-0974 undergoes significant oxidative metab. (cytochrome P 450 (CYP) 3A) in monkey intestinal microsomes.  In contrast, oral AUC of MK-0974 in rats was near dose-proportional (15-100 mg kg-1).  Following oral administration of [14C]MK-0974 to rats, the hepatic portal AUC ratio of MK-0974 to total radioactivity (0.67) was higher than in monkeys.  Addnl., the metabolic rate of MK-0974 was slower in rat than in monkey intestinal microsomes.  Collectively, intestinal 1st-pass metab. played a significant role in the low oral bioavailability in monkeys and contributed to the species-dependent non-linear oral pharmacokinetics in rats and monkeys of MK-0974.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSGwTRkl7ECrVg90H21EOLACvtfcHk0lj71BTX48bjKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D&md5=4b3039fc4abdf2cfca46a7e0f1fceb53</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1080%2F00498250802546861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250802546861%26sid%3Dliteratum%253Aachs%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DLaspina%26aufirst%3DC.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DRowe%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DB%26aulast%3DPrueksaritanont%26aufirst%3DT.%26atitle%3DPreclinical%2520pharmacokinetics%2520of%2520MK-0974%252C%2520an%2520orally%2520active%2520calcitonin-gene%2520related%2520peptide%2520%2528CGRP%2529-receptor%2520antagonist%252C%2520mechanism%2520of%2520dose%2520dependency%2520and%2520species%2520differences%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26spage%3D33%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit61"><span> <span class="citation_source-book">MOE</span>, version <span class="NLM_edition">2009.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal, Quebec, Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE%2C+version+2009.10%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C+Quebec%2C+Canada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMOE%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0lj71BTX48bjKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26spage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, E.</span><span> </span><span class="NLM_article-title">Swiss-Prot: juggling between evolution and stability</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1093%2Fbib%2F5.1.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=15153305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=39-55&author=A.+Bairochauthor=B.+Boeckmannauthor=S.+Ferroauthor=E.+Gasteiger&title=Swiss-Prot%3A+juggling+between+evolution+and+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Swiss-Prot: juggling between evolution and stability</span></div><div class="casAuthors">Bairoch, Amos; Boeckmann, Brigitte; Ferro, Serenella; Gasteiger, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-55</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">Some of the aspects of Swiss-Prot that make it unique are described and the developments that are necessary for the database to continue to play its role as a focal point of protein knowledge are discussed.  Advices pertinent to the development of high-quality knowledge resources on one aspect or the other of the life sciences are provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEgdtQ3E4iD7Vg90H21EOLACvtfcHk0lgasiywA52urA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D&md5=20bac4d8d69b26959f71a271299fd233</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Fbib%2F5.1.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252F5.1.39%26sid%3Dliteratum%253Aachs%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DBoeckmann%26aufirst%3DB.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DGasteiger%26aufirst%3DE.%26atitle%3DSwiss-Prot%253A%2520juggling%2520between%2520evolution%2520and%2520stability%26jtitle%3DBriefings%2520Bioinf.%26date%3D2004%26volume%3D5%26spage%3D39%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position+specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position%2520specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit65"><span> <span class="citation_source-book">Maestro Suites</span>, version <span class="NLM_edition">2009</span>; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro+Suites%2C+version+2009%3B+Schr%C3%B6dinger%2C+Inc.%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%2520Suites%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref125':['ref125_1'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32a1'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':[],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 85 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Weichao Li, Yiqing Zhou, Guanghui Tang, Nai-Kei Wong, Mengquan Yang, Dan Tan, <span class="NLM_string-name hlFld-ContribAuthor">Youli Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoproteomics Reveals the Antiproliferative Potential of Parkinson’s Disease Kinase Inhibitor LRRK2-IN-1 by Targeting PCNA Protein. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (8)
                                     , 3252-3259. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00325" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00325%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DChemoproteomics%252BReveals%252Bthe%252BAntiproliferative%252BPotential%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%252BKinase%252BInhibitor%252BLRRK2-IN-1%252Bby%252BTargeting%252BPCNA%252BProtein%26aulast%3DLi%26aufirst%3DWeichao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26032018%26date%3D11072018%26date%3D10062018%26date%3D24072018%26date%3D11072018%26volume%3D15%26issue%3D8%26spage%3D3252%26epage%3D3259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2166-2210. <a href="https://doi.org/10.1021/acs.jmedchem.7b00315" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00315%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNatural-Products-Inspired%252BUse%252Bof%252Bthe%252Bgem-Dimethyl%252BGroup%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D27022017%26date%3D08092017%26date%3D29082017%26volume%3D61%26issue%3D6%26spage%3D2166%26epage%3D2210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Williamson</span>, <span class="hlFld-ContribAuthor ">Garrick P.  Smith</span>, <span class="hlFld-ContribAuthor ">Pamela  Acheson-Dossang</span>, <span class="hlFld-ContribAuthor ">Simon T.  Bedford</span>, <span class="hlFld-ContribAuthor ">Victoria  Chell</span>, <span class="hlFld-ContribAuthor ">I-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Justus C. A.  Daechsel</span>, <span class="hlFld-ContribAuthor ">Zoe  Daniels</span>, <span class="hlFld-ContribAuthor ">Laurent  David</span>, <span class="hlFld-ContribAuthor ">Pawel  Dokurno</span>, <span class="hlFld-ContribAuthor ">Morten  Hentzer</span>, <span class="hlFld-ContribAuthor ">Martin C.  Herzig</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Samantha  Newland</span>, <span class="hlFld-ContribAuthor ">Stuart C.  Ray</span>, <span class="hlFld-ContribAuthor ">Terry  Shaw</span>, <span class="hlFld-ContribAuthor ">Allan E.  Surgenor</span>, <span class="hlFld-ContribAuthor ">Lindsey  Terry</span>, <span class="hlFld-ContribAuthor ">Kenneth  Thirstrup</span>, <span class="hlFld-ContribAuthor ">Yikang  Wang</span>, and <span class="hlFld-ContribAuthor ">Kenneth V.  Christensen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8945-8962. <a href="https://doi.org/10.1021/acs.jmedchem.7b01186" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01186%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%252BUsing%252Ba%252BCrystallographic%252BSurrogate%252BDerived%252Bfrom%252BCheckpoint%252BKinase%252B1%252B%252528CHK1%252529%26aulast%3DWilliamson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15082017%26date%3D27102017%26date%3D09112017%26date%3D12102017%26volume%3D60%26issue%3D21%26spage%3D8945%26epage%3D8962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Snahel  Patel</span>, <span class="hlFld-ContribAuthor ">William J.  Meilandt</span>, <span class="hlFld-ContribAuthor ">Rebecca I.  Erickson</span>, <span class="hlFld-ContribAuthor ">Jinhua  Chen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Reina N.  Fuji</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Amy  Gustafson</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Jose  Imperio</span>, <span class="hlFld-ContribAuthor ">Wendy  Liu</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Changyou  Ma</span>, <span class="hlFld-ContribAuthor ">Jianping  Yin</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Lewcock</span>, and <span class="hlFld-ContribAuthor ">Michael  Siu</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 8083-8102. <a href="https://doi.org/10.1021/acs.jmedchem.7b00843" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00843%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BInhibitors%252Bof%252BDual%252BLeucine%252BZipper%252BKinase%252B%252528DLK%25252C%252BMAP3K12%252529%252Bwith%252BActivity%252Bin%252Ba%252BModel%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPatel%26aufirst%3DSnahel%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12062017%26date%3D20092017%26date%3D12102017%26volume%3D60%26issue%3D19%26spage%3D8083%26epage%3D8102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span> and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6733-6746. <a href="https://doi.org/10.1021/acs.jmedchem.5b00261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252BBiology%252Bof%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D14052015%26date%3D10092015%26date%3D27042015%26volume%3D58%26issue%3D17%26spage%3D6733%26epage%3D6746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Hatcher</span>, <span class="hlFld-ContribAuthor ">Jinwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Genta  Ito</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , 584-589. <a href="https://doi.org/10.1021/acsmedchemlett.5b00064" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00064%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPyrrolopyrimidine%252B%252528JH-II-127%252529%25252C%252Ba%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain%252BPenetrant%252BLRRK2%252BInhibitor%26aulast%3DHatcher%26aufirst%3DJohn%2BM.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05022015%26date%3D07042015%26date%3D13042015%26date%3D14052015%26date%3D07042015%26volume%3D6%26issue%3D5%26spage%3D584%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernd K.  Gilsbach</span>, <span class="hlFld-ContribAuthor ">Ana C.  Messias</span>, <span class="hlFld-ContribAuthor ">Genta  Ito</span>, <span class="hlFld-ContribAuthor ">Michael  Sattler</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, <span class="hlFld-ContribAuthor ">Alfred  Wittinghofer</span>, and <span class="hlFld-ContribAuthor ">Arjan  Kortholt</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Characterization of LRRK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (9)
                                     , 3751-3756. <a href="https://doi.org/10.1021/jm5018779" title="DOI URL">https://doi.org/10.1021/jm5018779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5018779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5018779%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BCharacterization%252Bof%252BLRRK2%252BInhibitors%26aulast%3DGilsbach%26aufirst%3DBernd%2BK.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D04122014%26date%3D01052015%26date%3D14052015%26date%3D21042015%26volume%3D58%26issue%3D9%26spage%3D3751%26epage%3D3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Yunhui  Lang</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Grace  Ng</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Louise  Edwards</span>, <span class="hlFld-ContribAuthor ">Bryan  Forrest</span>, <span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Nickolay Y.  Chirgadze</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Dan Chi-Chia  Lin</span>, <span class="hlFld-ContribAuthor ">Yi  Che</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Brian  Madeira</span>, <span class="hlFld-ContribAuthor ">Graham C.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Mark R.  Bray</span>, and <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (8)
                                     , 3366-3392. <a href="https://doi.org/10.1021/jm501740a" title="DOI URL">https://doi.org/10.1021/jm501740a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501740a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501740a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BOrally%252BBioavailable%252BTyrosine%252BThreonine%252BKinase%252B%252528TTK%252529%252BInhibitors%25253A%252B3-%2525284-%252528heterocyclyl%252529phenyl%252529-1H-indazole-5-carboxamides%252Bas%252BAnticancer%252BAgents%26aulast%3DLiu%26aufirst%3DYong%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D10112014%26date%3D03042015%26date%3D23042015%26date%3D12032015%26volume%3D58%26issue%3D8%26spage%3D3366%26epage%3D3392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Hayward</span>, <span class="hlFld-ContribAuthor ">Karen J.  Coffman</span>, <span class="hlFld-ContribAuthor ">Jayasankar  Jasti</span>, <span class="hlFld-ContribAuthor ">Ravi G.  Kurumbail</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, <span class="hlFld-ContribAuthor ">G. Stephen  Noell</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Elie  Needle</span>, <span class="hlFld-ContribAuthor ">Zdenek  Berger</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Christopher  Houle</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>, and <span class="hlFld-ContribAuthor ">Paul  Galatsis</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 419-432. <a href="https://doi.org/10.1021/jm5014055" title="DOI URL">https://doi.org/10.1021/jm5014055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5014055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5014055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BPreclinical%252BProfiling%252Bof%252B3-%25255B4-%252528Morpholin-4-yl%252529-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-5-yl%25255Dbenzonitrile%252B%252528PF-06447475%252529%25252C%252Ba%252BHighly%252BPotent%25252C%252BSelective%25252C%252BBrain%252BPenetrant%25252C%252Band%252Bin%252BVivo%252BActive%252BLRRK2%252BKinase%252BInhibitor%26aulast%3DHenderson%26aufirst%3DJaclyn%2BL.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D12092014%26date%3D17112014%26date%3D08012015%26date%3D29102014%26volume%3D58%26issue%3D1%26spage%3D419%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inês M.  Rocha</span>, <span class="hlFld-ContribAuthor ">Tiago L. P.  Galvão</span>, <span class="hlFld-ContribAuthor ">Maria D. M. C.  Ribeiro da Silva</span>, and <span class="hlFld-ContribAuthor ">Manuel A. V.  Ribeiro da Silva</span>  . </span><span class="cited-content_cbyCitation_article-title">Thermodynamic Study of Chlorobenzonitrile Isomers: A Survey on the Polymorphism, Pseudosymmetry, and the Chloro···Cyano Interaction. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry A</span><span> <strong>2014,</strong> <em>118 </em>
                                    (8)
                                     , 1502-1510. <a href="https://doi.org/10.1021/jp410187q" title="DOI URL">https://doi.org/10.1021/jp410187q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp410187q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp410187q%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520A%26atitle%3DThermodynamic%252BStudy%252Bof%252BChlorobenzonitrile%252BIsomers%25253A%252BA%252BSurvey%252Bon%252Bthe%252BPolymorphism%25252C%252BPseudosymmetry%25252C%252Band%252Bthe%252BChloro%2525C2%2525B7%2525C2%2525B7%2525C2%2525B7Cyano%252BInteraction%26aulast%3DRocha%26aufirst%3DIn%25C3%25AAs%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D2014%26date%3D14102013%26date%3D31012014%26date%3D11022014%26date%3D27022014%26date%3D31012014%26volume%3D118%26issue%3D8%26spage%3D1502%26epage%3D1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Charles  Baker-Glenn</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Mark  Chambers</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Sara L.  Dominguez</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Michael  Flagella</span>, <span class="hlFld-ContribAuthor ">Reina  Fuji</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Jason  Halladay</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Donna W.  Lee</span>, <span class="hlFld-ContribAuthor ">Claire E. Le  Pichon</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Kevin  Nash</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Zejuan  Sheng</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Susan  Wong</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 921-936. <a href="https://doi.org/10.1021/jm401654j" title="DOI URL">https://doi.org/10.1021/jm401654j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401654j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401654j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain-Penetrant%252BAminopyrazole%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BSmall%252BMolecule%252BInhibitors%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D25102013%26date%3D15012014%26date%3D13022014%26date%3D19122013%26volume%3D57%26issue%3D3%26spage%3D921%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Naud</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Amir  Faisal</span>, <span class="hlFld-ContribAuthor ">Peter  Sheldrake</span>, <span class="hlFld-ContribAuthor ">Vassilios  Bavetsias</span>, <span class="hlFld-ContribAuthor ">Butrus  Atrash</span>, <span class="hlFld-ContribAuthor ">Kwai-Ming J.  Cheung</span>, <span class="hlFld-ContribAuthor ">Manjuan  Liu</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Jessica  Schmitt</span>, <span class="hlFld-ContribAuthor ">Amy  Wood</span>, <span class="hlFld-ContribAuthor ">Vanessa  Choi</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Grace  Mak</span>, <span class="hlFld-ContribAuthor ">Mark  Gurden</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis  de Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Alan  Henley</span>, <span class="hlFld-ContribAuthor ">Ross  Baker</span>, <span class="hlFld-ContribAuthor ">Craig  McAndrew</span>, <span class="hlFld-ContribAuthor ">Berry  Matijssen</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Spiros  Linardopoulos</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, and <span class="hlFld-ContribAuthor ">Julian  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (24)
                                     , 10045-10065. <a href="https://doi.org/10.1021/jm401395s" title="DOI URL">https://doi.org/10.1021/jm401395s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401395s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BOrally%252BBioavailable%252B1H-Pyrrolo%25255B3%25252C2-c%25255Dpyridine%252BInhibitors%252Bof%252BMitotic%252BKinase%252BMonopolar%252BSpindle%252B1%252B%252528MPS1%252529%26aulast%3DNaud%26aufirst%3DS%25C3%25A9bastien%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D10092013%26date%3D02122013%26date%3D27122013%26date%3D20112013%26volume%3D56%26issue%3D24%26spage%3D10045%26epage%3D10065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yangbo  Feng</span>, <span class="hlFld-ContribAuthor ">Jeremy W.  Chambers</span>, <span class="hlFld-ContribAuthor ">Sarah  Iqbal</span>, <span class="hlFld-ContribAuthor ">Marcel  Koenig</span>, <span class="hlFld-ContribAuthor ">HaJeung  Park</span>, <span class="hlFld-ContribAuthor ">Lisa  Cherry</span>, <span class="hlFld-ContribAuthor ">Pamela  Hernandez</span>, <span class="hlFld-ContribAuthor ">Mariana  Figuera-Losada</span>, and <span class="hlFld-ContribAuthor ">Philip V.  LoGrasso</span>  . </span><span class="cited-content_cbyCitation_article-title">A Small Molecule Bidentate-Binding Dual Inhibitor Probe of the LRRK2 and JNK Kinases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , 1747-1754. <a href="https://doi.org/10.1021/cb3006165" title="DOI URL">https://doi.org/10.1021/cb3006165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb3006165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb3006165%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DA%252BSmall%252BMolecule%252BBidentate-Binding%252BDual%252BInhibitor%252BProbe%252Bof%252Bthe%252BLRRK2%252Band%252BJNK%252BKinases%26aulast%3DFeng%26aufirst%3DYangbo%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D14112012%26date%3D28052013%26date%3D10062013%26date%3D16082013%26volume%3D8%26issue%3D8%26spage%3D1747%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip  Cohen</span> and <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>  . </span><span class="cited-content_cbyCitation_article-title">Kinase Drug Discovery – What’s Next in the Field?. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (1)
                                     , 96-104. <a href="https://doi.org/10.1021/cb300610s" title="DOI URL">https://doi.org/10.1021/cb300610s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb300610s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb300610s%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DKinase%252BDrug%252BDiscovery%252B%2525E2%252580%252593%252BWhat%2525E2%252580%252599s%252BNext%252Bin%252Bthe%252BField%25253F%26aulast%3DCohen%26aufirst%3DPhilip%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09112012%26date%3D19122012%26date%3D31122012%26date%3D18012013%26volume%3D8%26issue%3D1%26spage%3D96%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">John  Atherall</span>, <span class="hlFld-ContribAuthor ">Charles  Baker-Glenn</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Mark  Chambers</span>, <span class="hlFld-ContribAuthor ">Sara L.  Dominguez</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Claire E.  Le Pichon</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Kevin  Nash</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Zejuan  Sheng</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Hervé  Van de Poël</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     , 85-90. <a href="https://doi.org/10.1021/ml3003007" title="DOI URL">https://doi.org/10.1021/ml3003007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml3003007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml3003007%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BHighly%252BSelective%25252C%252BBrain-Penetrant%252BAminopyrazole%252BLRRK2%252BInhibitor%26aulast%3DChan%26aufirst%3DBryan%2BK.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D24092012%26date%3D23112012%26date%3D29112012%26date%3D10012013%26date%3D23112012%26volume%3D4%26issue%3D1%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jarkko  Rautio</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of LRRK2 Kinase Activity To Probe the Treatment Option in Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9414-9415. <a href="https://doi.org/10.1021/jm301460x" title="DOI URL">https://doi.org/10.1021/jm301460x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301460x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301460x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252BLRRK2%252BKinase%252BActivity%252BTo%252BProbe%252Bthe%252BTreatment%252BOption%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DRautio%26aufirst%3DJarkko%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09102012%26date%3D18102012%26date%3D26112012%26volume%3D55%26issue%3D22%26spage%3D9414%26epage%3D9415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Azeggagh</span>, <span class="hlFld-ContribAuthor ">Daniel C.  Berwick</span>. </span><span class="cited-content_cbyCitation_article-title">The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1111/bph.15575" title="DOI URL">https://doi.org/10.1111/bph.15575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15575%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252Bdevelopment%252Bof%252Binhibitors%252Bof%252Bleucine%2525E2%252580%252590rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252BParkinson%252527s%252Bdisease%25253A%252Bthe%252Bcurrent%252Bstate%252Bof%252Bplay%26aulast%3DAzeggagh%26aufirst%3DSonia%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markella  Konstantinidou</span>, <span class="hlFld-ContribAuthor ">Asmaa  Oun</span>, <span class="hlFld-ContribAuthor ">Pragya  Pathak</span>, <span class="hlFld-ContribAuthor ">Bidong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zefeng  Wang</span>, <span class="hlFld-ContribAuthor ">Frans  ter Brake</span>, <span class="hlFld-ContribAuthor ">Amalia M.  Dolga</span>, <span class="hlFld-ContribAuthor ">Arjan  Kortholt</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 959-965. <a href="https://doi.org/10.1002/cmdc.202000872" title="DOI URL">https://doi.org/10.1002/cmdc.202000872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000872%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252Btale%252Bof%252Bproteolysis%252Btargeting%252Bchimeras%252B%252528PROTACs%252529%252Bfor%252BLeucine%2525E2%252580%252590Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%26aulast%3DKonstantinidou%26aufirst%3DMarkella%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D6%26spage%3D959%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xylena  Reed</span>, <span class="hlFld-ContribAuthor ">Artur  Schumacher-Schuh</span>, <span class="hlFld-ContribAuthor ">Jing  Hu</span>, <span class="hlFld-ContribAuthor ">Sara  Bandres-Ciga</span>. </span><span class="cited-content_cbyCitation_article-title">Advancing Personalized Medicine in Common Forms of Parkinson’s Disease through Genetics: Current Therapeutics and the Future of Individualized Management. </span><span class="cited-content_cbyCitation_journal-name">Journal of Personalized Medicine</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 169. <a href="https://doi.org/10.3390/jpm11030169" title="DOI URL">https://doi.org/10.3390/jpm11030169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jpm11030169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjpm11030169%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Personalized%2520Medicine%26atitle%3DAdvancing%252BPersonalized%252BMedicine%252Bin%252BCommon%252BForms%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%252Bthrough%252BGenetics%25253A%252BCurrent%252BTherapeutics%252Band%252Bthe%252BFuture%252Bof%252BIndividualized%252BManagement%26aulast%3DReed%26aufirst%3DXylena%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqian  Gao</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Fen  Yang</span>, <span class="hlFld-ContribAuthor ">Liuxing  Xie</span>, <span class="hlFld-ContribAuthor ">Jun  Shen</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Brimble</span>, <span class="hlFld-ContribAuthor ">Qicai  Xiao</span>, <span class="hlFld-ContribAuthor ">Shao Q.  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (2)
                                     , 1219-1250. <a href="https://doi.org/10.1039/D0CS00115E" title="DOI URL">https://doi.org/10.1039/D0CS00115E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00115E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00115E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DFluorescent%252Bprobes%252Bfor%252Bbioimaging%252Bof%252Bpotential%252Bbiomarkers%252Bin%252BParkinson%252527s%252Bdisease%26aulast%3DGao%26aufirst%3DLiqian%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D2%26spage%3D1219%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noeen  Malik</span>, <span class="hlFld-ContribAuthor ">Rick  Kornelsen</span>, <span class="hlFld-ContribAuthor ">Siobhan  McCormick</span>, <span class="hlFld-ContribAuthor ">Nadine  Colpo</span>, <span class="hlFld-ContribAuthor ">Helen  Merkens</span>, <span class="hlFld-ContribAuthor ">Shreya  Bendre</span>, <span class="hlFld-ContribAuthor ">Francois  Benard</span>, <span class="hlFld-ContribAuthor ">Vesna  Sossi</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Paul  Schaffer</span>. </span><span class="cited-content_cbyCitation_article-title">Development and biological evaluation of[18F]FMN3PA & [18F]FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113005. <a href="https://doi.org/10.1016/j.ejmech.2020.113005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bbiological%252Bevaluation%252Bof%25255B18F%25255DFMN3PA%252B%252526%252B%25255B18F%25255DFMN3PU%252Bfor%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Bin%2525C2%2525A0vivo%252BPET%252Bimaging%26aulast%3DMalik%26aufirst%3DNoeen%26date%3D2021%26volume%3D211%26spage%3D113005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhou  Deng</span>, <span class="hlFld-ContribAuthor ">Guyue  Chen</span>, <span class="hlFld-ContribAuthor ">Shuang  Liu</span>, <span class="hlFld-ContribAuthor ">Yunzhan  Li</span>, <span class="hlFld-ContribAuthor ">Jiaji  Zhong</span>, <span class="hlFld-ContribAuthor ">Baoding  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Huiying  Huang</span>, <span class="hlFld-ContribAuthor ">Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Qingyan  Xu</span>, <span class="hlFld-ContribAuthor ">Xianming  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of methyl 3-((2-((1-(dimethylglycyl)-5-methoxyindolin-6-yl)amino)-5-(trifluoro-methyl) pyrimidin-4-yl)amino)thiophene-2-carboxylate as a potent and selective polo-like kinase 1 (PLK1) inhibitor for combating hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112697. <a href="https://doi.org/10.1016/j.ejmech.2020.112697" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112697%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bmethyl%252B3-%252528%2525282-%252528%2525281-%252528dimethylglycyl%252529-5-methoxyindolin-6-yl%252529amino%252529-5-%252528trifluoro-methyl%252529%252Bpyrimidin-4-yl%252529amino%252529thiophene-2-carboxylate%252Bas%252Ba%252Bpotent%252Band%252Bselective%252Bpolo-like%252Bkinase%252B1%252B%252528PLK1%252529%252Binhibitor%252Bfor%252Bcombating%252Bhepatocellular%252Bcarcinoma%26aulast%3DDeng%26aufirst%3DZhou%26date%3D2020%26volume%3D206%26spage%3D112697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniele  Colombo</span>, <span class="hlFld-ContribAuthor ">Paraskevi  Pnevmatikou</span>, <span class="hlFld-ContribAuthor ">Elsa  Melloni</span>, <span class="hlFld-ContribAuthor ">Charlotte  Keywood</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approaches. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2020,</strong> <em>20 </em>
                                    (10)
                                     , 1047-1064. <a href="https://doi.org/10.1080/14737175.2020.1800454" title="DOI URL">https://doi.org/10.1080/14737175.2020.1800454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2020.1800454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2020.1800454%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DTherapeutic%252Binnovation%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%25253A%252Ba%252B2020%252Bupdate%252Bon%252Bdisease-modifying%252Bapproaches%26aulast%3DColombo%26aufirst%3DDaniele%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D10%26spage%3D1047%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wakana  Mori</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Yasushi  Hattori</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Masayuki  Fujinaga</span>, <span class="hlFld-ContribAuthor ">Masayuki  Hanyu</span>, <span class="hlFld-ContribAuthor ">Nobuki  Nengaki</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and evaluation of 4-(6-[
              18
              F]Fluoro-4-(5-isopropoxy-1
              H
              -indazol-3-yl)pyridin-2-yl)morpholine as a novel radiotracer candidate targeting leucine-rich repeat kinase 2. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 676-684. <a href="https://doi.org/10.1039/C9MD00590K" title="DOI URL">https://doi.org/10.1039/C9MD00590K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00590K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00590K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRadiosynthesis%252Band%252Bevaluation%252Bof%252B4-%2525286-%25255B%252B18%252BF%25255DFluoro-4-%2525285-isopropoxy-1%252BH%252B-indazol-3-yl%252529pyridin-2-yl%252529morpholine%252Bas%252Ba%252Bnovel%252Bradiotracer%252Bcandidate%252Btargeting%252Bleucine-rich%252Brepeat%252Bkinase%252B2%26aulast%3DMori%26aufirst%3DWakana%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D6%26spage%3D676%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Toffoli</span>, <span class="hlFld-ContribAuthor ">S.R.L.  Vieira</span>, <span class="hlFld-ContribAuthor ">A.H.V.  Schapira</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic causes of PD: A pathway to disease modification. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>170 </em>, 108022. <a href="https://doi.org/10.1016/j.neuropharm.2020.108022" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108022%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DGenetic%252Bcauses%252Bof%252BPD%25253A%252BA%252Bpathway%252Bto%252Bdisease%252Bmodification%26aulast%3DToffoli%26aufirst%3DM.%26date%3D2020%26volume%3D170%26spage%3D108022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco A. S.  Baptista</span>, <span class="hlFld-ContribAuthor ">Kalpana  Merchant</span>, <span class="hlFld-ContribAuthor ">Ted  Barrett</span>, <span class="hlFld-ContribAuthor ">Sakshi  Bhargava</span>, <span class="hlFld-ContribAuthor ">Dianne K.  Bryce</span>, <span class="hlFld-ContribAuthor ">J. Michael  Ellis</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fell</span>, <span class="hlFld-ContribAuthor ">Brian K.  Fiske</span>, <span class="hlFld-ContribAuthor ">Reina N.  Fuji</span>, <span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Anastasia G.  Henry</span>, <span class="hlFld-ContribAuthor ">Sue  Hill</span>, <span class="hlFld-ContribAuthor ">Warren  Hirst</span>, <span class="hlFld-ContribAuthor ">Christopher  Houle</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Matthew L.  Maddess</span>, <span class="hlFld-ContribAuthor ">Carrie  Markgraf</span>, <span class="hlFld-ContribAuthor ">Hong  Mei</span>, <span class="hlFld-ContribAuthor ">William A.  Meier</span>, <span class="hlFld-ContribAuthor ">Elie  Needle</span>, <span class="hlFld-ContribAuthor ">Stephen  Ploch</span>, <span class="hlFld-ContribAuthor ">Christopher  Royer</span>, <span class="hlFld-ContribAuthor ">Karin  Rudolph</span>, <span class="hlFld-ContribAuthor ">Alok K.  Sharma</span>, <span class="hlFld-ContribAuthor ">Antonia  Stepan</span>, <span class="hlFld-ContribAuthor ">Stefan  Steyn</span>, <span class="hlFld-ContribAuthor ">Craig  Trost</span>, <span class="hlFld-ContribAuthor ">Zhizhang  Yin</span>, <span class="hlFld-ContribAuthor ">Hongshi  Yu</span>, <span class="hlFld-ContribAuthor ">Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Todd B.  Sherer</span>. </span><span class="cited-content_cbyCitation_article-title">LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2020,</strong> <em>12 </em>
                                    (540)
                                     , eaav0820. <a href="https://doi.org/10.1126/scitranslmed.aav0820" title="DOI URL">https://doi.org/10.1126/scitranslmed.aav0820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aav0820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aav0820%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DLRRK2%252Binhibitors%252Binduce%252Breversible%252Bchanges%252Bin%252Bnonhuman%252Bprimate%252Blungs%252Bwithout%252Bmeasurable%252Bpulmonary%252Bdeficits%26aulast%3DBaptista%26aufirst%3DMarco%2BA.%2BS.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D540%26spage%3Deaav0820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Feng  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 275-286. <a href="https://doi.org/10.1080/13543776.2020.1729354" title="DOI URL">https://doi.org/10.1080/13543776.2020.1729354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1729354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1729354%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-present%252529%26aulast%3DDing%26aufirst%3DXiao%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Tuo  Shao</span>, <span class="hlFld-ContribAuthor ">Wei  Gao</span>, <span class="hlFld-ContribAuthor ">Hualong  Fu</span>, <span class="hlFld-ContribAuthor ">Thomas Lee  Collier</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Qingzhen  Yu</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Zhang</span>, <span class="hlFld-ContribAuthor ">April T.  Davenport</span>, <span class="hlFld-ContribAuthor ">James B.  Daunais</span>, <span class="hlFld-ContribAuthor ">Hsiao‐Ying  Wey</span>, <span class="hlFld-ContribAuthor ">Yihan  Shao</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Wen‐Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Steven  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Preliminary Evaluation of [
              11
              C]GNE‐1023 as a Potent PET Probe for Imaging Leucine‐Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (17)
                                     , 1580-1585. <a href="https://doi.org/10.1002/cmdc.201900321" title="DOI URL">https://doi.org/10.1002/cmdc.201900321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900321%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BPreliminary%252BEvaluation%252Bof%252B%25255B%252B11%252BC%25255DGNE%2525E2%252580%2525901023%252Bas%252Ba%252BPotent%252BPET%252BProbe%252Bfor%252BImaging%252BLeucine%2525E2%252580%252590Rich%252BRepeat%252BKinase%2525E2%252580%2525852%252B%252528LRRK2%252529%252Bin%252BParkinson%252527s%252BDisease%26aulast%3DChen%26aufirst%3DZhen%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D17%26spage%3D1580%26epage%3D1585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Domingos</span>, <span class="hlFld-ContribAuthor ">Teresa  Duarte</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Rita C  Guedes</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (15)
                                     , 1953-1977. <a href="https://doi.org/10.4155/fmc-2018-0484" title="DOI URL">https://doi.org/10.4155/fmc-2018-0484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0484%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%252527s%252Bdisease%26aulast%3DDomingos%26aufirst%3DSofia%26date%3D2019%26volume%3D11%26issue%3D15%26spage%3D1953%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Zhao</span>, <span class="hlFld-ContribAuthor ">Nicolas  Dzamko</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in LRRK2-Targeted Therapy for Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2019,</strong> <em>79 </em>
                                    (10)
                                     , 1037-1051. <a href="https://doi.org/10.1007/s40265-019-01139-4" title="DOI URL">https://doi.org/10.1007/s40265-019-01139-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-019-01139-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-019-01139-4%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DRecent%252BDevelopments%252Bin%252BLRRK2-Targeted%252BTherapy%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DZhao%26aufirst%3DYe%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D10%26spage%3D1037%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel G.M.  Shore</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">Edward G.  McIver</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 674-680. <a href="https://doi.org/10.1016/j.bmcl.2018.10.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Bazaindazole%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%252Bpossessing%252Ba%252Bkey%252Bintramolecular%252Bhydrogen%252Bbond%252B%2525E2%252580%252593%252BPart%252B2%26aulast%3DShore%26aufirst%3DDaniel%2BG.M.%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D674%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanne  Osborne</span>, <span class="hlFld-ContribAuthor ">Kristian  Birchall</span>, <span class="hlFld-ContribAuthor ">Denise J.  Tsagris</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Ela  Smiljanic-Hurley</span>, <span class="hlFld-ContribAuthor ">Debra L.  Taylor</span>, <span class="hlFld-ContribAuthor ">Alison  Levy</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, <span class="hlFld-ContribAuthor ">Edward G.  McIver</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) – Part 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 668-673. <a href="https://doi.org/10.1016/j.bmcl.2018.11.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Bselective%252B5-azaindazole%252Binhibitors%252Bof%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252B%2525E2%252580%252593%252BPart%252B1%26aulast%3DOsborne%26aufirst%3DJoanne%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D668%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miho  Araki</span>, <span class="hlFld-ContribAuthor ">Genta  Ito</span>, <span class="hlFld-ContribAuthor ">Taisuke  Tomita</span>. </span><span class="cited-content_cbyCitation_article-title">Physiological and pathological functions of LRRK2: implications from substrate proteins. </span><span class="cited-content_cbyCitation_journal-name">Neuronal Signaling</span><span> <strong>2018,</strong> <em>2 </em>
                                    (4)
                                     <a href="https://doi.org/10.1042/NS20180005" title="DOI URL">https://doi.org/10.1042/NS20180005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/NS20180005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FNS20180005%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuronal%2520Signaling%26atitle%3DPhysiological%252Band%252Bpathological%252Bfunctions%252Bof%252BLRRK2%25253A%252Bimplications%252Bfrom%252Bsubstrate%252Bproteins%26aulast%3DAraki%26aufirst%3DMiho%26date%3D2018%26date%3D2018%26volume%3D2%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Cao</span>, <span class="hlFld-ContribAuthor ">Yan  Zhuang</span>, <span class="hlFld-ContribAuthor ">Juyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhuwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuai  Yuan</span>, <span class="hlFld-ContribAuthor ">Peng  Zhang</span>, <span class="hlFld-ContribAuthor ">Haiying  Li</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Haitao  Shen</span>, <span class="hlFld-ContribAuthor ">Zhong  Wang</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 aggravates secondary brain injury induced by intracerebral hemorrhage in rats by regulating the P38 MAPK/Drosha pathway. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2018,</strong> <em>119 </em>, 53-64. <a href="https://doi.org/10.1016/j.nbd.2018.07.024" title="DOI URL">https://doi.org/10.1016/j.nbd.2018.07.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2018.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2018.07.024%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Baggravates%252Bsecondary%252Bbrain%252Binjury%252Binduced%252Bby%252Bintracerebral%252Bhemorrhage%252Bin%252Brats%252Bby%252Bregulating%252Bthe%252BP38%252BMAPK%25252FDrosha%252Bpathway%26aulast%3DCao%26aufirst%3DJie%26date%3D2018%26volume%3D119%26spage%3D53%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathan J.  Lanning</span>, <span class="hlFld-ContribAuthor ">Calvin  VanOpstall</span>, <span class="hlFld-ContribAuthor ">Megan L.  Goodall</span>, <span class="hlFld-ContribAuthor ">Jeffrey P.  MacKeigan</span>, <span class="hlFld-ContribAuthor ">Brendan D.  Looyenga</span>. </span><span class="cited-content_cbyCitation_article-title">LRRK2 deficiency impairs
              trans
              -Golgi to lysosome trafficking and endocytic cargo degradation in human renal proximal tubule epithelial cells. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Renal Physiology</span><span> <strong>2018,</strong> <em>315 </em>
                                    (5)
                                     , F1465-F1477. <a href="https://doi.org/10.1152/ajprenal.00009.2018" title="DOI URL">https://doi.org/10.1152/ajprenal.00009.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajprenal.00009.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajprenal.00009.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Renal%2520Physiology%26atitle%3DLRRK2%252Bdeficiency%252Bimpairs%252Btrans%252B-Golgi%252Bto%252Blysosome%252Btrafficking%252Band%252Bendocytic%252Bcargo%252Bdegradation%252Bin%252Bhuman%252Brenal%252Bproximal%252Btubule%252Bepithelial%252Bcells%26aulast%3DLanning%26aufirst%3DNathan%2BJ.%26date%3D2018%26volume%3D315%26issue%3D5%26spage%3DF1465%26epage%3DF1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Shi</span>, <span class="hlFld-ContribAuthor ">Mary  Mader</span>. </span><span class="cited-content_cbyCitation_article-title">Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 1981-1991. <a href="https://doi.org/10.1016/j.bmcl.2018.05.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain%252Bpenetrant%252Bkinase%252Binhibitors%25253A%252BLearning%252Bfrom%252Bkinase%252Bneuroscience%252Bdiscovery%26aulast%3DShi%26aufirst%3DYuan%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-Aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 237-283. <a href="https://doi.org/10.1002/9781118686263.ch7" title="DOI URL">https://doi.org/10.1002/9781118686263.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch7%26sid%3Dliteratum%253Aachs%26atitle%3D2-Aminopyrimidines%26date%3D2018%26date%3D2018%26spage%3D237%26epage%3D283%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhua  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Jiali  Pu</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-Rich Repeat Kinase 2 in Parkinson’s Disease: Updated from Pathogenesis to Potential Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">European Neurology</span><span> <strong>2018,</strong> <em>79 </em>
                                    (5-6)
                                     , 256-265. <a href="https://doi.org/10.1159/000488938" title="DOI URL">https://doi.org/10.1159/000488938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1159/000488938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1159%2F000488938%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Neurology%26atitle%3DLeucine-Rich%252BRepeat%252BKinase%252B2%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%25253A%252BUpdated%252Bfrom%252BPathogenesis%252Bto%252BPotential%252BTherapeutic%252BTarget%26aulast%3DChen%26aufirst%3DJinhua%26date%3D2018%26date%3D2018%26volume%3D79%26issue%3D5-6%26spage%3D256%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noeen  Malik</span>, <span class="hlFld-ContribAuthor ">Andrew N  Gifford</span>, <span class="hlFld-ContribAuthor ">Johan  Sandell</span>, <span class="hlFld-ContribAuthor ">Daniel  Tuchman</span>, <span class="hlFld-ContribAuthor ">Yu-Shin  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and In Vitro and In Vivo Evaluation of [3H]LRRK2-IN-1 as a Novel Radioligand for LRRK2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2017,</strong> <em>19 </em>
                                    (6)
                                     , 837-845. <a href="https://doi.org/10.1007/s11307-017-1070-1" title="DOI URL">https://doi.org/10.1007/s11307-017-1070-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-017-1070-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-017-1070-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DSynthesis%252Band%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEvaluation%252Bof%252B%25255B3H%25255DLRRK2-IN-1%252Bas%252Ba%252BNovel%252BRadioligand%252Bfor%252BLRRK2%26aulast%3DMalik%26aufirst%3DNoeen%26date%3D2017%26date%3D2017%26volume%3D19%26issue%3D6%26spage%3D837%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Egon  Deyaert</span>, <span class="hlFld-ContribAuthor ">Lina  Wauters</span>, <span class="hlFld-ContribAuthor ">Giambattista  Guaitoli</span>, <span class="hlFld-ContribAuthor ">Albert  Konijnenberg</span>, <span class="hlFld-ContribAuthor ">Margaux  Leemans</span>, <span class="hlFld-ContribAuthor ">Susanne  Terheyden</span>, <span class="hlFld-ContribAuthor ">Arsen  Petrovic</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Gallardo</span>, <span class="hlFld-ContribAuthor ">Laura M.  Nederveen-Schippers</span>, <span class="hlFld-ContribAuthor ">Panagiotis S.  Athanasopoulos</span>, <span class="hlFld-ContribAuthor ">Henderikus  Pots</span>, <span class="hlFld-ContribAuthor ">Peter J. M.  Van Haastert</span>, <span class="hlFld-ContribAuthor ">Frank  Sobott</span>, <span class="hlFld-ContribAuthor ">Christian Johannes  Gloeckner</span>, <span class="hlFld-ContribAuthor ">Rouslan  Efremov</span>, <span class="hlFld-ContribAuthor ">Arjan  Kortholt</span>, <span class="hlFld-ContribAuthor ">Wim  Versées</span>. </span><span class="cited-content_cbyCitation_article-title">A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-01103-4" title="DOI URL">https://doi.org/10.1038/s41467-017-01103-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-01103-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-01103-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DA%252Bhomologue%252Bof%252Bthe%252BParkinson%2525E2%252580%252599s%252Bdisease-associated%252Bprotein%252BLRRK2%252Bundergoes%252Ba%252Bmonomer-dimer%252Btransition%252Bduring%252BGTP%252Bturnover%26aulast%3DDeyaert%26aufirst%3DEgon%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Xuedong  Dai</span>, <span class="hlFld-ContribAuthor ">Kai  Long</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Daniele  Andreotti</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Eatherton</span>, <span class="hlFld-ContribAuthor ">Colin  Edge</span>, <span class="hlFld-ContribAuthor ">Karamjit S.  Jandu</span>, <span class="hlFld-ContribAuthor ">Paula L.  Nichols</span>, <span class="hlFld-ContribAuthor ">Oliver J.  Philps</span>, <span class="hlFld-ContribAuthor ">Luigi Piero  Stasi</span>, <span class="hlFld-ContribAuthor ">Zehong  Wan</span>, <span class="hlFld-ContribAuthor ">Jia-Ning  Xiang</span>, <span class="hlFld-ContribAuthor ">Kelly  Dong</span>, <span class="hlFld-ContribAuthor ">Pamela  Dossang</span>, <span class="hlFld-ContribAuthor ">Ming-Hsun  Ho</span>, <span class="hlFld-ContribAuthor ">Yi  Li</span>, <span class="hlFld-ContribAuthor ">Lucy  Mensah</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Guan</span>, <span class="hlFld-ContribAuthor ">Alastair D.  Reith</span>, <span class="hlFld-ContribAuthor ">Feng  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (17)
                                     , 4034-4038. <a href="https://doi.org/10.1016/j.bmcl.2017.07.052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B5-substituent-N-arylbenzamide%252Bderivatives%252Bas%252Bpotent%25252C%252Bselective%252Band%252Borally%252Bbioavailable%252BLRRK2%252Binhibitors%26aulast%3DDing%26aufirst%3DXiao%26date%3D2017%26volume%3D27%26issue%3D17%26spage%3D4034%26epage%3D4038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garrick P.  Smith</span>, <span class="hlFld-ContribAuthor ">Lassina  Badolo</span>, <span class="hlFld-ContribAuthor ">Victoria  Chell</span>, <span class="hlFld-ContribAuthor ">I-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Kenneth Vielsted  Christensen</span>, <span class="hlFld-ContribAuthor ">Laurent  David</span>, <span class="hlFld-ContribAuthor ">Justus Alfred  Daechsel</span>, <span class="hlFld-ContribAuthor ">Morten  Hentzer</span>, <span class="hlFld-ContribAuthor ">Martin Christian  Herzig</span>, <span class="hlFld-ContribAuthor ">Gitte Kobberøe  Mikkelsen</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Watson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4500-4505. <a href="https://doi.org/10.1016/j.bmcl.2017.07.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdesign%252Band%252BSAR%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252B2-aminopyridine%252Bbased%252BLRRK2%252Binhibitors%26aulast%3DSmith%26aufirst%3DGarrick%2BP.%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4500%26epage%3D4505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marian  Blanca Ramírez</span>, <span class="hlFld-ContribAuthor ">Antonio Jesús Lara  Ordóñez</span>, <span class="hlFld-ContribAuthor ">Elena  Fdez</span>, <span class="hlFld-ContribAuthor ">Jesús  Madero-Pérez</span>, <span class="hlFld-ContribAuthor ">Adriano  Gonnelli</span>, <span class="hlFld-ContribAuthor ">Matthieu  Drouyer</span>, <span class="hlFld-ContribAuthor ">Marie-Christine  Chartier-Harlin</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Taymans</span>, <span class="hlFld-ContribAuthor ">Luigi  Bubacco</span>, <span class="hlFld-ContribAuthor ">Elisa  Greggio</span>, <span class="hlFld-ContribAuthor ">Sabine  Hilfiker</span>. </span><span class="cited-content_cbyCitation_article-title">GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2. </span><span class="cited-content_cbyCitation_journal-name">Human Molecular Genetics</span><span> <strong>2017,</strong> <em>26 </em>
                                    (14)
                                     , 2747-2767. <a href="https://doi.org/10.1093/hmg/ddx161" title="DOI URL">https://doi.org/10.1093/hmg/ddx161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/hmg/ddx161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fhmg%2Fddx161%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Molecular%2520Genetics%26atitle%3DGTP%252Bbinding%252Bregulates%252Bcellular%252Blocalization%252Bof%252BParkinson%252527s%252Bdisease-associated%252BLRRK2%26aulast%3DBlanca%2BRam%25C3%25ADrez%26aufirst%3DMarian%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D14%26spage%3D2747%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharon L.  Chan</span>, <span class="hlFld-ContribAuthor ">Eng-King  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting LRRK2 in Parkinson’s disease: an update on recent developments. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2017,</strong> <em>21 </em>
                                    (6)
                                     , 601-610. <a href="https://doi.org/10.1080/14728222.2017.1323881" title="DOI URL">https://doi.org/10.1080/14728222.2017.1323881</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2017.1323881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2017.1323881%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252BLRRK2%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%25253A%252Ban%252Bupdate%252Bon%252Brecent%252Bdevelopments%26aulast%3DChan%26aufirst%3DSharon%2BL.%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D6%26spage%3D601%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Liu</span>, <span class="hlFld-ContribAuthor ">Andrew B.  West</span>. </span><span class="cited-content_cbyCitation_article-title">The dual enzyme LRRK2 hydrolyzes GTP in both its GTPase and kinase domains in vitro. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2017,</strong> <em>1865 </em>
                                    (3)
                                     , 274-280. <a href="https://doi.org/10.1016/j.bbapap.2016.12.001" title="DOI URL">https://doi.org/10.1016/j.bbapap.2016.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2016.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2016.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DThe%252Bdual%252Benzyme%252BLRRK2%252Bhydrolyzes%252BGTP%252Bin%252Bboth%252Bits%252BGTPase%252Band%252Bkinase%252Bdomains%252Bin%252Bvitro%26aulast%3DLiu%26aufirst%3DZhiyong%26date%3D2017%26volume%3D1865%26issue%3D3%26spage%3D274%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1351-1355. <a href="https://doi.org/10.1016/j.bmcl.2017.02.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B%25255B11C%25255DHG-10-102-01%252Bas%252Ba%252Bnew%252Bpotential%252BPET%252Bagent%252Bfor%252Bimaging%252Bof%252BLRRK2%252Benzyme%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DWang%26aufirst%3DMin%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1351%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Qin</span>, <span class="hlFld-ContribAuthor ">Lian-Teng  Zhi</span>, <span class="hlFld-ContribAuthor ">Xian-Ting  Li</span>, <span class="hlFld-ContribAuthor ">Zhen-Yu  Yue</span>, <span class="hlFld-ContribAuthor ">Guo-Zhong  Li</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2017,</strong> <em>23 </em>
                                    (2)
                                     , 162-173. <a href="https://doi.org/10.1111/cns.12660" title="DOI URL">https://doi.org/10.1111/cns.12660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.12660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.12660%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DEffects%252Bof%252BLRRK2%252BInhibitors%252Bon%252BNigrostriatal%252BDopaminergic%252BNeurotransmission%26aulast%3DQin%26aufirst%3DQi%26date%3D2017%26date%3D2016%26volume%3D23%26issue%3D2%26spage%3D162%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Hatcher</span>, <span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of LRRK2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 241-264. <a href="https://doi.org/10.1007/978-3-319-49969-7_13" title="DOI URL">https://doi.org/10.1007/978-3-319-49969-7_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-49969-7_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-49969-7_13%26sid%3Dliteratum%253Aachs%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BLRRK2%26aulast%3DHatcher%26aufirst%3DJohn%2BM.%26date%3D2017%26date%3D2017%26spage%3D241%26epage%3D264%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%26aulast%3DRideout%26aufirst%3DHardy%2BJ.%26date%3D2017%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.V.  Christensen</span>, <span class="hlFld-ContribAuthor ">G.P.  Smith</span>, <span class="hlFld-ContribAuthor ">D.S.  Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 37-80. <a href="https://doi.org/10.1016/bs.pmch.2016.11.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2016.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2016.11.002%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BLRRK2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%252527s%252BDisease%26aulast%3DChristensen%26aufirst%3DK.V.%26date%3D2017%26spage%3D37%26epage%3D80%26pub%3DElsevier%26date%3D2017%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Beier</span>, <span class="hlFld-ContribAuthor ">Mikhail  Zibinsky</span>, <span class="hlFld-ContribAuthor ">G. K. Surya  Prakash</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic Additions of Perfluoroalkyl Groups. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-492. <a href="https://doi.org/10.1002/0471264180.or091.01" title="DOI URL">https://doi.org/10.1002/0471264180.or091.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or091.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or091.01%26sid%3Dliteratum%253Aachs%26atitle%3DNucleophilic%252BAdditions%252Bof%252BPerfluoroalkyl%252BGroups%26aulast%3DBeier%26aufirst%3DPetr%26date%3D2016%26date%3D2016%26spage%3D1%26epage%3D492%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas J.  Greshock</span>, <span class="hlFld-ContribAuthor ">John M.  Sanders</span>, <span class="hlFld-ContribAuthor ">Robert E.  Drolet</span>, <span class="hlFld-ContribAuthor ">Hemaka A.  Rajapakse</span>, <span class="hlFld-ContribAuthor ">Ronald K.  Chang</span>, <span class="hlFld-ContribAuthor ">Boyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Vanessa L.  Rada</span>, <span class="hlFld-ContribAuthor ">Heather E.  Tiscia</span>, <span class="hlFld-ContribAuthor ">Hua  Su</span>, <span class="hlFld-ContribAuthor ">Ming-Tain  Lai</span>, <span class="hlFld-ContribAuthor ">Sylvie M.  Sur</span>, <span class="hlFld-ContribAuthor ">Rosa I.  Sanchez</span>, <span class="hlFld-ContribAuthor ">Mark T.  Bilodeau</span>, <span class="hlFld-ContribAuthor ">John J.  Renger</span>, <span class="hlFld-ContribAuthor ">Jonathan T.  Kern</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>. </span><span class="cited-content_cbyCitation_article-title">Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2631-2635. <a href="https://doi.org/10.1016/j.bmcl.2016.04.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%25252C%252Bselective%252Band%252Borally%252Bbioavailable%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%26aulast%3DGreshock%26aufirst%3DThomas%2BJ.%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2631%26epage%3D2635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongjia  Zhang</span>, <span class="hlFld-ContribAuthor ">Rongsheng  Tong</span>, <span class="hlFld-ContribAuthor ">Lan  Bai</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging targets and new small molecule therapies in Parkinson’s disease treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (7)
                                     , 1419-1430. <a href="https://doi.org/10.1016/j.bmc.2016.02.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Btargets%252Band%252Bnew%252Bsmall%252Bmolecule%252Btherapies%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%252Btreatment%26aulast%3DZhang%26aufirst%3DHongjia%26date%3D2016%26volume%3D24%26issue%3D7%26spage%3D1419%26epage%3D1430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Tassini</span>, <span class="hlFld-ContribAuthor ">Daniele  Castagnolo</span>, <span class="hlFld-ContribAuthor ">Nicolò  Scalacci</span>, <span class="hlFld-ContribAuthor ">Miroslava  Kissova</span>, <span class="hlFld-ContribAuthor ">Jorge I.  Armijos-Rivera</span>, <span class="hlFld-ContribAuthor ">Federica  Giagnorio</span>, <span class="hlFld-ContribAuthor ">Giovanni  Maga</span>, <span class="hlFld-ContribAuthor ">Gabriele  Costantino</span>, <span class="hlFld-ContribAuthor ">Emmanuele  Crespan</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>. </span><span class="cited-content_cbyCitation_article-title">A multicomponent pharmacophore fragment-decoration approach to identify selective LRRK2-targeting probes. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 484-494. <a href="https://doi.org/10.1039/C5MD00462D" title="DOI URL">https://doi.org/10.1039/C5MD00462D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00462D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00462D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DA%252Bmulticomponent%252Bpharmacophore%252Bfragment-decoration%252Bapproach%252Bto%252Bidentify%252Bselective%252BLRRK2-targeting%252Bprobes%26aulast%3DTassini%26aufirst%3DSabrina%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D484%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M.  Garbaccio</span>, <span class="hlFld-ContribAuthor ">Emma R.  Parmee</span>. </span><span class="cited-content_cbyCitation_article-title">The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2016,</strong> <em>23 </em>
                                    (1)
                                     , 10-17. <a href="https://doi.org/10.1016/j.chembiol.2015.11.011" title="DOI URL">https://doi.org/10.1016/j.chembiol.2015.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2015.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2015.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DThe%252BImpact%252Bof%252BChemical%252BProbes%252Bin%252BDrug%252BDiscovery%25253A%252BA%252BPharmaceutical%252BIndustry%252BPerspective%26aulast%3DGarbaccio%26aufirst%3DRobert%25C2%25A0M.%26date%3D2016%26volume%3D23%26issue%3D1%26spage%3D10%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allen F  Brooks</span>, <span class="hlFld-ContribAuthor ">Lindsey R  Drake</span>, <span class="hlFld-ContribAuthor ">Megan N  Stewart</span>, <span class="hlFld-ContribAuthor ">Brian P  Cary</span>, <span class="hlFld-ContribAuthor ">Isaac M  Jackson</span>, <span class="hlFld-ContribAuthor ">Dale  Mallette</span>, <span class="hlFld-ContribAuthor ">Andrew V  Mossine</span>, <span class="hlFld-ContribAuthor ">Peter JH  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-18 patents (2009–2015). Part 1: novel radiotracers. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2016,</strong> <em>5 </em>
                                    (1)
                                     , 17-47. <a href="https://doi.org/10.4155/ppa.15.36" title="DOI URL">https://doi.org/10.4155/ppa.15.36</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.15.36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.15.36%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DFluorine-18%252Bpatents%252B%2525282009%2525E2%252580%2525932015%252529.%252BPart%252B1%25253A%252Bnovel%252Bradiotracers%26aulast%3DBrooks%26aufirst%3DAllen%2BF%26date%3D2016%26volume%3D5%26issue%3D1%26spage%3D17%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew J.  Fell</span>, <span class="hlFld-ContribAuthor ">Christian  Mirescu</span>, <span class="hlFld-ContribAuthor ">Kallol  Basu</span>, <span class="hlFld-ContribAuthor ">Boonlert  Cheewatrakoolpong</span>, <span class="hlFld-ContribAuthor ">Duane E.  DeMong</span>, <span class="hlFld-ContribAuthor ">J. Michael  Ellis</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Yinghui  Lin</span>, <span class="hlFld-ContribAuthor ">Carrie G.  Markgraf</span>, <span class="hlFld-ContribAuthor ">Hong  Mei</span>, <span class="hlFld-ContribAuthor ">Michael  Miller</span>, <span class="hlFld-ContribAuthor ">Frederique M.  Poulet</span>, <span class="hlFld-ContribAuthor ">Jack D.  Scott</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Smith</span>, <span class="hlFld-ContribAuthor ">Zhizhang  Yin</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">John A.  Morrow</span>. </span><span class="cited-content_cbyCitation_article-title">MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2015,</strong> <em>355 </em>
                                    (3)
                                     , 397-409. <a href="https://doi.org/10.1124/jpet.115.227587" title="DOI URL">https://doi.org/10.1124/jpet.115.227587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.115.227587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.115.227587%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DMLi-2%25252C%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BCentrally%252BActive%252BCompound%252Bfor%252BExploring%252Bthe%252BTherapeutic%252BPotential%252Band%252BSafety%252Bof%252BLRRK2%252BKinase%252BInhibition%26aulast%3DFell%26aufirst%3DMatthew%2BJ.%26date%3D2015%26date%3D2015%26volume%3D355%26issue%3D3%26spage%3D397%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takumi  Kagawa</span>, <span class="hlFld-ContribAuthor ">Daiki  Shigehiro</span>, <span class="hlFld-ContribAuthor ">Kosuke  Kawada</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoroethoxy group as a leaving group for regioselective sequential substitution reactions of 5-trifluoromethylpyrimidine derivative with heteroatom nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2015,</strong> <em>179 </em>, 150-158. <a href="https://doi.org/10.1016/j.jfluchem.2015.07.016" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2015.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2015.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2015.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DTrifluoroethoxy%252Bgroup%252Bas%252Ba%252Bleaving%252Bgroup%252Bfor%252Bregioselective%252Bsequential%252Bsubstitution%252Breactions%252Bof%252B5-trifluoromethylpyrimidine%252Bderivative%252Bwith%252Bheteroatom%252Bnucleophiles%26aulast%3DKagawa%26aufirst%3DTakumi%26date%3D2015%26volume%3D179%26spage%3D150%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian A.  Lang</span>, <span class="hlFld-ContribAuthor ">Soumya S.  Ray</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Ambuj K.  Singh</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Cuny</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of LRRK2 inhibitors using sequential in silico joint pharmacophore space (JPS) and ensemble docking. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (13)
                                     , 2713-2719. <a href="https://doi.org/10.1016/j.bmcl.2015.04.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.04.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.04.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BLRRK2%252Binhibitors%252Busing%252Bsequential%252Bin%252Bsilico%252Bjoint%252Bpharmacophore%252Bspace%252B%252528JPS%252529%252Band%252Bensemble%252Bdocking%26aulast%3DLang%26aufirst%3DChristian%2BA.%26date%3D2015%26volume%3D25%26issue%3D13%26spage%3D2713%26epage%3D2719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwen A.  Feng</span>, <span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Jeff M.  Blaney</span>, <span class="hlFld-ContribAuthor ">Erin K.  Bradley</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Man-Ling  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Johnny  Wu</span>, <span class="hlFld-ContribAuthor ">Alberto  Gobbi</span>. </span><span class="cited-content_cbyCitation_article-title">An integrated suite of modeling tools that empower scientists in structure- and property-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2015,</strong> <em>29 </em>
                                    (6)
                                     , 511-523. <a href="https://doi.org/10.1007/s10822-015-9845-4" title="DOI URL">https://doi.org/10.1007/s10822-015-9845-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-015-9845-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-015-9845-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DAn%252Bintegrated%252Bsuite%252Bof%252Bmodeling%252Btools%252Bthat%252Bempower%252Bscientists%252Bin%252Bstructure-%252Band%252Bproperty-based%252Bdrug%252Bdesign%26aulast%3DFeng%26aufirst%3DJianwen%2BA.%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D6%26spage%3D511%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, <span class="hlFld-ContribAuthor ">Madeline E.  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Athena F.  Phoa</span>, <span class="hlFld-ContribAuthor ">Benjamin  Heng</span>, <span class="hlFld-ContribAuthor ">Nicolas  Dzamko</span>, <span class="hlFld-ContribAuthor ">Ew-Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Munikumar Reddy  Doddareddy</span>, <span class="hlFld-ContribAuthor ">Gilles J.  Guillemin</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 29-34. <a href="https://doi.org/10.1016/j.ejmech.2015.03.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimisation%252Bof%252BLRRK2%252Binhibitors%252Band%252Bassessment%252Bof%252Bfunctional%252Befficacy%252Bin%252Bcell-based%252Bmodels%252Bof%252Bneuroinflammation%26aulast%3DMunoz%26aufirst%3DLenka%26date%3D2015%26volume%3D95%26spage%3D29%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elpida  Tsika</span>, <span class="hlFld-ContribAuthor ">An Phu Tran  Nguyen</span>, <span class="hlFld-ContribAuthor ">Julien  Dusonchet</span>, <span class="hlFld-ContribAuthor ">Philippe  Colin</span>, <span class="hlFld-ContribAuthor ">Bernard L.  Schneider</span>, <span class="hlFld-ContribAuthor ">Darren J.  Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2015,</strong> <em>77 </em>, 49-61. <a href="https://doi.org/10.1016/j.nbd.2015.02.019" title="DOI URL">https://doi.org/10.1016/j.nbd.2015.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2015.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2015.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DAdenoviral-mediated%252Bexpression%252Bof%252BG2019S%252BLRRK2%252Binduces%252Bstriatal%252Bpathology%252Bin%252Ba%252Bkinase-dependent%252Bmanner%252Bin%252Ba%252Brat%252Bmodel%252Bof%252BParkinson%252527s%252Bdisease%26aulast%3DTsika%26aufirst%3DElpida%26date%3D2015%26volume%3D77%26spage%3D49%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reina N.  Fuji</span>, <span class="hlFld-ContribAuthor ">Michael  Flagella</span>, <span class="hlFld-ContribAuthor ">Miriam  Baca</span>, <span class="hlFld-ContribAuthor ">Marco A.  S. Baptista</span>, <span class="hlFld-ContribAuthor ">Jens  Brodbeck</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Brian K.  Fiske</span>, <span class="hlFld-ContribAuthor ">Lee  Honigberg</span>, <span class="hlFld-ContribAuthor ">Adrian M.  Jubb</span>, <span class="hlFld-ContribAuthor ">Paula  Katavolos</span>, <span class="hlFld-ContribAuthor ">Donna W.  Lee</span>, <span class="hlFld-ContribAuthor ">Sock-Cheng  Lewin-Koh</span>, <span class="hlFld-ContribAuthor ">Tori  Lin</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Shannon  Liu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Jennifer  O’Mahony</span>, <span class="hlFld-ContribAuthor ">Mike  Reichelt</span>, <span class="hlFld-ContribAuthor ">Merone  Roose-Girma</span>, <span class="hlFld-ContribAuthor ">Zejuan  Sheng</span>, <span class="hlFld-ContribAuthor ">Todd  Sherer</span>, <span class="hlFld-ContribAuthor ">Ashley  Smith</span>, <span class="hlFld-ContribAuthor ">Margaret  Solon</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Tarrant</span>, <span class="hlFld-ContribAuthor ">Alison  Urkowitz</span>, <span class="hlFld-ContribAuthor ">Søren  Warming</span>, <span class="hlFld-ContribAuthor ">Murat  Yaylaoglu</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of selective LRRK2 kinase inhibition on nonhuman primate lung. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2015,</strong> <em>7 </em>
                                    (273)
                                     , 273ra15-273ra15. <a href="https://doi.org/10.1126/scitranslmed.aaa3634" title="DOI URL">https://doi.org/10.1126/scitranslmed.aaa3634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aaa3634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aaa3634%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DEffect%252Bof%252Bselective%252BLRRK2%252Bkinase%252Binhibition%252Bon%252Bnonhuman%252Bprimate%252Blung%26aulast%3DFuji%26aufirst%3DReina%2BN.%26date%3D2015%26date%3D2015%26volume%3D7%26issue%3D273%26spage%3D273ra15%26epage%3D273ra15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Raquel  Esteves</span>, <span class="hlFld-ContribAuthor ">Russell H.  Swerdlow</span>, <span class="hlFld-ContribAuthor ">Sandra M.  Cardoso</span>. </span><span class="cited-content_cbyCitation_article-title">LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurology</span><span> <strong>2014,</strong> <em>261 </em>, 206-216. <a href="https://doi.org/10.1016/j.expneurol.2014.05.025" title="DOI URL">https://doi.org/10.1016/j.expneurol.2014.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.expneurol.2014.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.expneurol.2014.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurology%26atitle%3DLRRK2%25252C%252Ba%252Bpuzzling%252Bprotein%25253A%252BInsights%252Binto%252BParkinson%252527s%252Bdisease%252Bpathogenesis%26aulast%3DEsteves%26aufirst%3DA.%2BRaquel%26date%3D2014%26volume%3D261%26spage%3D206%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Longo</span>, <span class="hlFld-ContribAuthor ">Isabella  Russo</span>, <span class="hlFld-ContribAuthor ">Derya R.  Shimshek</span>, <span class="hlFld-ContribAuthor ">Elisa  Greggio</span>, <span class="hlFld-ContribAuthor ">Michele  Morari</span>. </span><span class="cited-content_cbyCitation_article-title">Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Disease</span><span> <strong>2014,</strong> <em>71 </em>, 62-73. <a href="https://doi.org/10.1016/j.nbd.2014.07.013" title="DOI URL">https://doi.org/10.1016/j.nbd.2014.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nbd.2014.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nbd.2014.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Disease%26atitle%3DGenetic%252Band%252Bpharmacological%252Bevidence%252Bthat%252BG2019S%252BLRRK2%252Bconfers%252Ba%252Bhyperkinetic%252Bphenotype%25252C%252Bresistant%252Bto%252Bmotor%252Bdecline%252Bassociated%252Bwith%252Baging%26aulast%3DLongo%26aufirst%3DFrancesco%26date%3D2014%26volume%3D71%26spage%3D62%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iakov N.  Rudenko</span>, <span class="hlFld-ContribAuthor ">Mark R.  Cookson</span>. </span><span class="cited-content_cbyCitation_article-title">Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications. </span><span class="cited-content_cbyCitation_journal-name">Neurotherapeutics</span><span> <strong>2014,</strong> <em>11 </em>
                                    (4)
                                     , 738-750. <a href="https://doi.org/10.1007/s13311-014-0284-z" title="DOI URL">https://doi.org/10.1007/s13311-014-0284-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13311-014-0284-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13311-014-0284-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotherapeutics%26atitle%3DHeterogeneity%252Bof%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252BMutations%25253A%252BGenetics%25252C%252BMechanisms%252Band%252BTherapeutic%252BImplications%26aulast%3DRudenko%26aufirst%3DIakov%2BN.%26date%3D2014%26date%3D2014%26volume%3D11%26issue%3D4%26spage%3D738%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Grace  Ng</span>, <span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar B.  Patel</span>, <span class="hlFld-ContribAuthor ">Louise G.  Edwards</span>, <span class="hlFld-ContribAuthor ">Yunhui  Lang</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Don E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Genie  Leung</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Guodong  Mao</span>, <span class="hlFld-ContribAuthor ">Xunyi  Luo</span>, <span class="hlFld-ContribAuthor ">Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Erin  Green</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Dan Chi-Chia  Lin</span>, <span class="hlFld-ContribAuthor ">Marees  Harris-Brandts</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Vincent  Nadeem</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Guohua J.  Pan</span>, <span class="hlFld-ContribAuthor ">Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Nickolay Y.  Chirgadze</span>, <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 4968-4997. <a href="https://doi.org/10.1016/j.bmc.2014.06.027" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.06.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.06.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.06.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Binhibitors%252Bof%252Bthe%252Bmitotic%252Bkinase%252BTTK%252Bbased%252Bon%252BN-%2525283-%2525283-sulfamoylphenyl%252529-1H-indazol-5-yl%252529-acetamides%252Band%252Bcarboxamides%26aulast%3DLaufer%26aufirst%3DRadoslaw%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D4968%26epage%3D4997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Seungil  Han</span>, <span class="hlFld-ContribAuthor ">Ravi G.  Kurumbail</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, <span class="hlFld-ContribAuthor ">G. Stephen  Noell</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Elie  Needle</span>, <span class="hlFld-ContribAuthor ">Zdenek  Berger</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Christopher  Houle</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (17)
                                     , 4132-4140. <a href="https://doi.org/10.1016/j.bmcl.2014.07.052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DKinase%252Bdomain%252Binhibition%252Bof%252Bleucine%252Brich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Busing%252Ba%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-b%25255Dpyridazine%252Bscaffold%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2014%26volume%3D24%26issue%3D17%26spage%3D4132%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sagar S.  Bhayye</span>, <span class="hlFld-ContribAuthor ">Kunal  Roy</span>, <span class="hlFld-ContribAuthor ">Achintya  Saha</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring structural requirement, pharmacophore modeling, and de novo design of LRRK2 inhibitors using homology modeling approach. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (8)
                                     , 3705-3713. <a href="https://doi.org/10.1007/s00044-014-0955-7" title="DOI URL">https://doi.org/10.1007/s00044-014-0955-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-0955-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-0955-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DExploring%252Bstructural%252Brequirement%25252C%252Bpharmacophore%252Bmodeling%25252C%252Band%252Bde%252Bnovo%252Bdesign%252Bof%252BLRRK2%252Binhibitors%252Busing%252Bhomology%252Bmodeling%252Bapproach%26aulast%3DBhayye%26aufirst%3DSagar%2BS.%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D8%26spage%3D3705%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong In  Yun</span>, <span class="hlFld-ContribAuthor ">Eun Hye  Yang</span>, <span class="hlFld-ContribAuthor ">Muhammad  Latif</span>, <span class="hlFld-ContribAuthor ">Hyeon Ji  Lee</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Chang-Soo  Yun</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Chong Ock  Lee</span>, <span class="hlFld-ContribAuthor ">Chong Hak  Chae</span>, <span class="hlFld-ContribAuthor ">Sung Yun  Cho</span>, <span class="hlFld-ContribAuthor ">Hee Jung  Jung</span>, <span class="hlFld-ContribAuthor ">Pilho  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>, <span class="hlFld-ContribAuthor ">Hyoung Rae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2014,</strong> <em>37 </em>
                                    (7)
                                     , 873-881. <a href="https://doi.org/10.1007/s12272-013-0247-7" title="DOI URL">https://doi.org/10.1007/s12272-013-0247-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-013-0247-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-013-0247-7%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DNovel%252B2%25252C4-dianilino-5-fluoropyrimidine%252Bderivatives%252Bpossessing%252BALK%252Binhibitory%252Bactivities%26aulast%3DYun%26aufirst%3DJeong%2BIn%26date%3D2014%26date%3D2013%26volume%3D37%26issue%3D7%26spage%3D873%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raghava R  Kethiri</span>, <span class="hlFld-ContribAuthor ">Rajagopal  Bakthavatchalam</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (7)
                                     , 745-757. <a href="https://doi.org/10.1517/13543776.2014.907275" title="DOI URL">https://doi.org/10.1517/13543776.2014.907275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.907275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.907275%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Brecent%252Bpatents%252B%2525282011%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DKethiri%26aufirst%3DRaghava%2BR%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D7%26spage%3D745%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">April  Reynolds</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Doggett</span>, <span class="hlFld-ContribAuthor ">Steve M.  Riddle</span>, <span class="hlFld-ContribAuthor ">Connie S.  Lebakken</span>, <span class="hlFld-ContribAuthor ">R. Jeremy  Nichols</span>. </span><span class="cited-content_cbyCitation_article-title">LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2014,</strong> <em>7 </em><a href="https://doi.org/10.3389/fnmol.2014.00054" title="DOI URL">https://doi.org/10.3389/fnmol.2014.00054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2014.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2014.00054%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DLRRK2%252Bkinase%252Bactivity%252Band%252Bbiology%252Bare%252Bnot%252Buniformly%252Bpredicted%252Bby%252Bits%252Bautophosphorylation%252Band%252Bcellular%252Bphosphorylation%252Bsite%252Bstatus%26aulast%3DReynolds%26aufirst%3DApril%26date%3D2014%26date%3D2014%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory C.  Luerman</span>, <span class="hlFld-ContribAuthor ">Chuong  Nguyen</span>, <span class="hlFld-ContribAuthor ">Harry  Samaroo</span>, <span class="hlFld-ContribAuthor ">Paula  Loos</span>, <span class="hlFld-ContribAuthor ">Hualin  Xi</span>, <span class="hlFld-ContribAuthor ">Andres  Hurtado-Lorenzo</span>, <span class="hlFld-ContribAuthor ">Elie  Needle</span>, <span class="hlFld-ContribAuthor ">G.  Stephen Noell</span>, <span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">John  Dunlop</span>, <span class="hlFld-ContribAuthor ">Kieran F.  Geoghegan</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2014,</strong> <em>128 </em>
                                    (4)
                                     , 561-576. <a href="https://doi.org/10.1111/jnc.12483" title="DOI URL">https://doi.org/10.1111/jnc.12483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.12483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.12483%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DPhosphoproteomic%252Bevaluation%252Bof%252Bpharmacological%252Binhibition%252Bof%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252Breveals%252Bsignificant%252Boff-target%252Beffects%252Bof%252BLRRK-2-IN-1%26aulast%3DLuerman%26aufirst%3DGregory%2BC.%26date%3D2014%26date%3D2013%26volume%3D128%26issue%3D4%26spage%3D561%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 111-148. <a href="https://doi.org/10.1007/7355_2014_69" title="DOI URL">https://doi.org/10.1007/7355_2014_69</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_69%26sid%3Dliteratum%253Aachs%26atitle%3DLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2014%26date%3D2014%26spage%3D111%26epage%3D148%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNovel%252BTherapeutic%252BApproaches%252Bto%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DHopkins%26aufirst%3DCorey%2BR.%26date%3D2016%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Jaclyn  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Development of LRRK2 Kinase Inhibitors for Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 43-58. <a href="https://doi.org/10.1016/B978-0-12-800167-7.00004-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-800167-7.00004-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800167-7.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800167-7.00004-3%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BLRRK2%252BKinase%252BInhibitors%252Bfor%252BParkinson%252527s%252BDisease%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2014%26spage%3D43%26epage%3D58%26pub%3DElsevier%26date%3D2014%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Aziz</span>, <span class="hlFld-ContribAuthor ">Roland W.  Bürli</span>, <span class="hlFld-ContribAuthor ">David F.  Fischer</span>, <span class="hlFld-ContribAuthor ">Julie  Frearson</span>, <span class="hlFld-ContribAuthor ">Michael D.  Wall</span>. </span><span class="cited-content_cbyCitation_article-title">Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 199-290. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50004-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50004-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50004-0%26sid%3Dliteratum%253Aachs%26atitle%3DTowards%252BSmall%252BMolecules%252Bas%252BTherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BOther%252BNeurodegenerative%252BDisorders%26aulast%3DAziz%26aufirst%3DOmar%26date%3D2014%26spage%3D199%26epage%3D290%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">William  Cho</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>. </span><span class="cited-content_cbyCitation_article-title">From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 227-254. <a href="https://doi.org/10.1002/9783527677252.ch10" title="DOI URL">https://doi.org/10.1002/9783527677252.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527677252.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527677252.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BHuman%252BGenetics%252Bto%252BDrug%252BCandidates%25253A%252BAn%252BIndustrial%252BPerspective%252Bon%252BLRRK2%252BInhibition%252Bas%252Ba%252BTreatment%252Bfor%252BParkinson%252527s%252BDisease%26aulast%3DZhu%26aufirst%3DHaitao%26date%3D2013%26date%3D2013%26spage%3D227%26epage%3D254%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bto%252BPersonalized%252BMedicine%26aulast%3DLackey%26aufirst%3DKaren%26date%3D2013%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dana  Ferraris</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Yang</span>, <span class="hlFld-ContribAuthor ">Derek  Welsbie</span>. </span><span class="cited-content_cbyCitation_article-title">Dual leucine zipper kinase as a therapeutic target for neurodegenerative conditions. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (16)
                                     , 1923-1934. <a href="https://doi.org/10.4155/fmc.13.150" title="DOI URL">https://doi.org/10.4155/fmc.13.150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.150%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDual%252Bleucine%252Bzipper%252Bkinase%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Bneurodegenerative%252Bconditions%26aulast%3DFerraris%26aufirst%3DDana%26date%3D2013%26volume%3D5%26issue%3D16%26spage%3D1923%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel T.  Richter</span>, <span class="hlFld-ContribAuthor ">John C.  Kath</span>, <span class="hlFld-ContribAuthor ">Michael J.  Luzzio</span>, <span class="hlFld-ContribAuthor ">Nandell  Keene</span>, <span class="hlFld-ContribAuthor ">Martin A.  Berliner</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Wessel</span>. </span><span class="cited-content_cbyCitation_article-title">Selective addition of amines to 5-trifluoromethyl-2,4-dichloropyrimidine induced by Lewis acids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (35)
                                     , 4610-4612. <a href="https://doi.org/10.1016/j.tetlet.2013.06.025" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSelective%252Baddition%252Bof%252Bamines%252Bto%252B5-trifluoromethyl-2%25252C4-dichloropyrimidine%252Binduced%252Bby%252BLewis%252Bacids%26aulast%3DRichter%26aufirst%3DDaniel%2BT.%26date%3D2013%26volume%3D54%26issue%3D35%26spage%3D4610%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madeline E.  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Munikumar Reddy  Doddareddy</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">The development of CNS-active LRRK2 inhibitors using property-directed optimisation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (13)
                                     , 3690-3696. <a href="https://doi.org/10.1016/j.bmcl.2013.04.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdevelopment%252Bof%252BCNS-active%252BLRRK2%252Binhibitors%252Busing%252Bproperty-directed%252Boptimisation%26aulast%3DKavanagh%26aufirst%3DMadeline%2BE.%26date%3D2013%26volume%3D23%26issue%3D13%26spage%3D3690%26epage%3D3696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Troxler</span>, <span class="hlFld-ContribAuthor ">Paulette  Greenidge</span>, <span class="hlFld-ContribAuthor ">Kaspar  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Sandrine  Desrayaud</span>, <span class="hlFld-ContribAuthor ">Peter  Drückes</span>, <span class="hlFld-ContribAuthor ">Tatjana  Schweizer</span>, <span class="hlFld-ContribAuthor ">Daniela  Stauffer</span>, <span class="hlFld-ContribAuthor ">Giorgio  Rovelli</span>, <span class="hlFld-ContribAuthor ">Derya R.  Shimshek</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (14)
                                     , 4085-4090. <a href="https://doi.org/10.1016/j.bmcl.2013.05.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bindolinone-based%25252C%252Bpotent%25252C%252Bselective%252Band%252Bbrain%252Bpenetrant%252Binhibitors%252Bof%252BLRRK2%26aulast%3DTroxler%26aufirst%3DThomas%26date%3D2013%26volume%3D23%26issue%3D14%26spage%3D4085%26epage%3D4090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Dzamko</span>, <span class="hlFld-ContribAuthor ">Glenda M  Halliday</span>. </span><span class="cited-content_cbyCitation_article-title">Unlocking the secrets of LRRK2 function with selective kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Neurology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (3)
                                     , 347-357. <a href="https://doi.org/10.2217/fnl.13.9" title="DOI URL">https://doi.org/10.2217/fnl.13.9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fnl.13.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffnl.13.9%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Neurology%26atitle%3DUnlocking%252Bthe%252Bsecrets%252Bof%252BLRRK2%252Bfunction%252Bwith%252Bselective%252Bkinase%252Binhibitors%26aulast%3DDzamko%26aufirst%3DNicolas%26date%3D2013%26volume%3D8%26issue%3D3%26spage%3D347%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel Jon  Burdick</span>. </span><span class="cited-content_cbyCitation_article-title">Response to Deng
              et al.
              's LRRK2 patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (2)
                                     , 279-279. <a href="https://doi.org/10.1517/13543776.2013.757594" title="DOI URL">https://doi.org/10.1517/13543776.2013.757594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.757594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.757594%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DResponse%252Bto%252BDeng%252Bet%252Bal.%252B%252527s%252BLRRK2%252Bpatent%252Breview%26aulast%3DBurdick%26aufirst%3DDaniel%2BJon%26date%3D2013%26date%3D2012%26volume%3D23%26issue%3D2%26spage%3D279%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Docking model of <b>1</b> (cyan) in LRRK2 (green with L1949 in yellow). The side chain of Y931 of JAK2 is also shown (magenta). Intermolecular hydrogen bond interactions are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Small molecule X-ray crystal structure of <b>7</b> with suggested intramolecular hydrogen bonds in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Key residue differences between LRRK2 homology model (green) and TTK X-ray structure (magenta) with <b>7</b> (cyan) docked in TTK. Hydrogen bond interactions between the TTK hinge residue Gly605 and <b>7</b> are shown as yellow dashed lines. The red arrow shows the measured distance between C-5′ of <b>7</b> and the side chain carboxyl oxygen of Asp608.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Vortex charts illustrating (A) binned cLogD (pH 7.4) values for aminopyrimidines colored by in vitro human hepatocyte stability measured from cryopreserved hepatocytes and (B) binned TPSA values for aminopyrimidines colored by MDCK-MDR1 efflux ratios (ER), Vortex, version 2012.02.13219.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. KinomeScan selectivity tree for <b>18</b> at 0.1 μM (100-fold over LRRK2 <i>K</i><sub>i</sub>). Of 451 profiled kinases, only LRRK2, TTK, and ALK demonstrated <35% inhibition of % control (>65% probe displacement).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo G2019S LRRK2 transgenic mouse PK/PD results measuring brain pSer1292 autophosphorylation. The closed circles represent the observed data, and the lines represent the predicted data from a direct inhibition model. Percent inhibition is normalized to pSer1292 levels observed in mice dosed with vehicle alone (<i>n</i> = 3). Plotted data are shown for mice treated with (A) <b>18</b> [15 mg/kg, po, at 1, 3, and 6 h (<i>n</i> = 4/dose); 50 mg/kg, po, at 1, 3, 6, and 12 h (<i>n</i> = 4/dose) and 24 h (<i>n</i> = 1); 10 mg/kg, ip, at 1 and 2.5 h (<i>n</i> = 3/dose); 50 mg/kg, ip, at 1 and 6 h (<i>n</i> = 3/dose)]; (B) <b>19</b> [10 and 50 mg/kg, ip, at 1 and 6 h (<i>n</i> = 3/dose)]; (C) <b>14</b> [10 and 50 mg/kg, ip, at 1 and 6 h (<i>n</i> = 3/dose)].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 2,4-Diaminopyrimidine Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, KF, TMSCF<sub>3</sub>, DMF, Δ, 69%; (b) <i>c</i>-PrNH<sub>2</sub>, THF, 34%.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Aminopyrimidine-4-methoxy Analogues <b>2</b> and <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,5-dichloro-4-methoxypyrimidine, Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, microwave, 15%; (b) 5-bromo-2-chloro-4-methoxypyrimidine, TFA, <i>n</i>-BuOH, microwave, 35%; (c) morpholine, HBTU, DIPEA, DMF, 56%.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Tetrasubstituted Phenyl Intermediates for the Synthesis of <b>13</b>, <b>14</b>, and <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) acetone, conc HCl, H<sub>2</sub>O, NaNO<sub>2</sub>, then CuCN, NaCN; (b) AcOH, conc H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, Δ; (c) <i>t</i>-BuOK, MeOH, THF, 80%; (d) KOH, EtOH, H<sub>2</sub>O, 68%.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Aminopyrimidine Phenyl Tetra- and Pentasubstituted Morpholinoamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Reagents and conditions: (a) morpholine, HATU or HBTU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>; (b) TFA, <i>n</i>-BuOH, Δ; (c) Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd(OAc)<sub>2</sub>, dioxane, microwave; (d) PTSA, dioxane, Δ; (e) TFA, <i>n</i>-BuOH, microwave; (f) Pd/C, MeOH, H<sub>2</sub> or SnCl<sub>2</sub>·2H<sub>2</sub>O, EtOH, H<sub>2</sub>O, Δ or Fe dust, EtOH, NH<sub>4</sub>Cl, H<sub>2</sub>O, Δ; (g) <i>n</i>-BuOH, microwave; (h) 2-chloro-<i>N</i>-alkyl-5-(trifluoromethyl)pyrimidin-4-amine, PTSA, dioxane, Δ.</p><p class="last"><span class="fn-label">Scheme b</span>Morpholine-<i>d</i><sub>8</sub> analogue.</p></p></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Aminopyrimidineamide Isosteres <b>20</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>60</b>, Cs<sub>2</sub>CO<sub>3</sub>, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, Δ, 45%; (b) NaN<sub>3</sub>, NH<sub>4</sub>Cl, DMF, Δ, 85%; (c) MeI, K<sub>2</sub>CO<sub>3</sub>, acetone, Δ, 70%; (d) MeSNa, EtOH, Δ, 91%; (e) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 48%; (f) Pd/C, EtOH, H<sub>2</sub>, 99%; (g) <b>60</b>, TFA, 2-methoxyethanol, Δ, 19%.</p></p></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/medium/jm-2012-01020q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyridine Analogues and Morpholinoamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301020q/production/images/large/jm-2012-01020q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301020q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mo(CO)<sub>6</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 4-DMAP, DIPEA, morpholine, dioxane, microwave, 50%; (b) <b>28</b>, BrettPhos, BrettPhos precatalyst, NaO-<i>t</i>-Bu, <i>t</i>-BuOH, Δ, 35%; (c) 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Na<sub>2</sub>CO<sub>3</sub>, KOAc, Pd(amphos)Cl<sub>2</sub>, CH<sub>3</sub>CN, degassed H<sub>2</sub>O, microwave, 79%; (d) Pd/C, EtOH, H<sub>2</sub>; (e) <b>60</b>, BrettPhos, BrettPhos precatalyst, NaO-<i>t</i>-Bu, <i>t</i>-BuOH, Δ, 52%, two steps; (f) <b>28</b>, PTSA, dioxane, Δ; (g) 1-amino-2-methylpropan-2-ol, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 95%, two steps; (h) SOCl<sub>2</sub>, MeOH, Δ, 82%; (i) NBS, CH<sub>3</sub>CN, AIBN, Δ, 31%; (j) 1-amino-2-methylpropan-2-ol, Et<sub>3</sub>N, MeOH, Δ; (k) Fe dust, EtOH, NH<sub>4</sub>Cl, H<sub>2</sub>O, Δ, 77%, two steps; (l) PTSA, dioxane, Δ, 33%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 66 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_contrib-group">Lees, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span> </span><span class="NLM_article-title">Parkinson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">2055</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=2055-2066&author=A.+J.+Leesauthor=J.+Hardyauthor=T.+Revesz&title=Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D2055%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span>Erratum in  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Lancet+2009%2C+374%2C+684."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0lhZ07wGJih3TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilks, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez de Munain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti-Masso, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=595-600&author=C.+Paisan-Ruizauthor=S.+Jainauthor=E.+W.+Evansauthor=W.+P.+Gilksauthor=J.+Simonauthor=M.+van+der+Brugauthor=A.+Lopez+de+Munainauthor=S.+Aparicioauthor=A.+M.+Gilauthor=N.+Khanauthor=J.+Johnsonauthor=J.+R.+Martinezauthor=D.+Nichollauthor=I.+M.+Carreraauthor=A.+S.+Penaauthor=R.+de+Silvaauthor=A.+Leesauthor=J.+F.+Marti-Massoauthor=J.+Perez-Turauthor=N.+W.+Woodauthor=A.+B.+Singleton&title=Cloning+of+the+gene+containing+mutations+that+cause+PARK8-linked+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DE.%2BW.%26aulast%3DGilks%26aufirst%3DW.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%2Bde%2BMunain%26aufirst%3DA.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DA.%2BM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%2BR.%26aulast%3DNicholl%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DI.%2BM.%26aulast%3DPena%26aufirst%3DA.%2BS.%26aulast%3Dde%2BSilva%26aufirst%3DR.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DMarti-Masso%26aufirst%3DJ.%2BF.%26aulast%3DPerez-Tur%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DCloning%2520of%2520the%2520gene%2520containing%2520mutations%2520that%2520cause%2520PARK8-linked%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D595%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, K. A.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s disease: protein domains and functional insights</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=286-293&author=I.+F.+Mataauthor=W.+J.+Wedemeyerauthor=M.+J.+Farrerauthor=J.+P.+Taylorauthor=K.+A.+Gallo&title=LRRK2+in+Parkinson%E2%80%99s+disease%3A+protein+domains+and+functional+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DWedemeyer%26aufirst%3DW.%2BJ.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DGallo%26aufirst%3DK.%2BA.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520protein%2520domains%2520and%2520functional%2520insights%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions</span> <span class="citation_source-journal">ASN Neuro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=e00002&author=E.+Greggioauthor=M.+R.+Cookson&title=Leucine-rich+repeat+kinase+2+mutations+and+Parkinson%E2%80%99s+disease%3A+three+questions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520mutations%2520and%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520three%2520questions%26jtitle%3DASN%2520Neuro%26date%3D2009%26volume%3D1%26spage%3De00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gandhi, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson-Delfosse, A. L.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1002%2Fjnr.21949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19025767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=1283-1295&author=P.+N.+Gandhiauthor=S.+G.+Chenauthor=A.+L.+Wilson-Delfosse&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29%3A+a+key+player+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Gandhi, Payal N.; Chen, Shu G.; Wilson-Delfosse, Amy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1283-1295</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years.  Mutations in the gene encoding leucine-rich repeat kinase-2 (LRRK2) have recently been linked to autosomal dominant, late-onset PD that is clin. indistinguishable from typical, idiopathic disease.  LRRK2 is a multidomain protein contg. several protein interaction motifs as well as dual enzymic domains of GTPase and protein kinase activities.  Disease-assocd. mutations are found throughout the multidomain structure of the protein.  LRRK2, however, is unique among the PD-causing genes, because a missense mutation, G2019S, is a frequent determinant of not only familial but also sporadic PD.  Thus, LRRK2 has emerged as a promising therapeutic target for combating PD.  In this Mini-Review, we look at the current state of knowledge regarding the domain structure, amino acid substitutions, and potential functional roles of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhitPWE7Qj1rVg90H21EOLACvtfcHk0lhsLzx15LAvGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D&md5=81fe55081f2c1e0f665c60aaf7221951</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21949%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DP.%2BN.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DWilson-Delfosse%26aufirst%3DA.%2BL.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%253A%2520a%2520key%2520player%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D1283%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dachsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">LRRK2 and Parkinson disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1001%2Farchneurol.2010.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20457952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=542-547&author=J.+C.+Dachselauthor=M.+J.+Farrer&title=LRRK2+and+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and Parkinson disease</span></div><div class="casAuthors">Dachsel Justus C; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To review the molecular genetics and functional biology of leucine-rich repeat kinase 2 (LRRK2) in parkinsonism and to summarize the opportunities and challenges to develop interventions for Parkinson disease (PD) based on this genetic insight.  DATA SOURCES:  Publications cited are focused on LRRK2 biology between 2004 and March 2009.  STUDY SELECTION:  Literature selected was based on original contributions, seminal observations, and thoughtful reviews.  DATA EXTRACTION:  Unless stated otherwise, data was primarily abstracted from peer-reviewed literature appearing on PubMed.  DATA SYNTHESIS:  Genetic mutations that predispose PD are diagnostically useful in early or atypical presentations.  The molecular pathways identified suggest therapeutic interventions for Lrrk2 and idiopathic PD and the rationale and opportunity to develop physiologically relevant biomarkers and experimental models with which to test them.  CONCLUSIONS:  Both affected and asymptomatic LRRK2 carriers now provide the opportunity to define the natural history of PD.  This includes the frequency, penetrance, and rate of motor symptoms, nonmotor comorbidities, and their associated biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3dH7Qk4jbtZPlX7E30qdzfW6udTcc2eY6CXzGJYy7Bbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D&md5=7f08a3bbe3fc77c7d9bac287a1ff5316</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2010.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2010.79%26sid%3Dliteratum%253Aachs%26aulast%3DDachsel%26aufirst%3DJ.%2BC.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DLRRK2%2520and%2520Parkinson%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2010%26volume%3D67%26spage%3D542%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Satake, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakabayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fng.485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19915576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1303-1307&author=W.+Satakeauthor=Y.+Nakabayashiauthor=I.+Mizutaauthor=Y.+Hirotaauthor=C.+Itoauthor=M.+Kuboauthor=T.+Kawaguchiauthor=T.+Tsunodaauthor=M.+Watanabeauthor=A.+Takedaauthor=H.+Tomiyamaauthor=K.+Nakashimaauthor=K.+Hasegawaauthor=F.+Obataauthor=T.+Yoshikawaauthor=H.+Kawakamiauthor=S.+Sakodaauthor=M.+Yamamotoauthor=N.+Hattoriauthor=M.+Murataauthor=Y.+Nakamuraauthor=T.+Toda&title=Genome-wide+association+study+identifies+common+variants+at+four+loci+as+genetic+risk+factors+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease</span></div><div class="casAuthors">Satake, Wataru; Nakabayashi, Yuko; Mizuta, Ikuko; Hirota, Yushi; Ito, Chiyomi; Kubo, Michiaki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Watanabe, Masahiko; Takeda, Atsushi; Tomiyama, Hiroyuki; Nakashima, Kenji; Hasegawa, Kazuko; Obata, Fumiya; Yoshikawa, Takeo; Kawakami, Hideshi; Sakoda, Saburo; Yamamoto, Mitsutoshi; Hattori, Nobutaka; Murata, Miho; Nakamura, Yusuke; Toda, Tatsushi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1303-1307</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To identify susceptibility variants for Parkinson's disease (PD), we performed a genome-wide assocn. study (GWAS) and two replication studies in a total of 2,011 cases and 18,381 controls from Japan.  We identified a new susceptibility locus on 1q32 (P = 1.52 × 10-12) and designated this as PARK16, and we also identified BST1 on 4p15 as a second new risk locus (P = 3.94 × 10-9).  We also detected strong assocns. at SNCA on 4q22 (P = 7.35 × 10-17) and LRRK2 on 12q12 (P = 2.72 × 10-8), both of which are implicated in autosomal dominant forms of parkinsonism.  By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences.  Our results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiCdi72L_e27Vg90H21EOLACvtfcHk0lheiHTmPXmnFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O&md5=46e665390ca8166d83a4688d4f581cf5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fng.485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.485%26sid%3Dliteratum%253Aachs%26aulast%3DSatake%26aufirst%3DW.%26aulast%3DNakabayashi%26aufirst%3DY.%26aulast%3DMizuta%26aufirst%3DI.%26aulast%3DHirota%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DC.%26aulast%3DKubo%26aufirst%3DM.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DTomiyama%26aufirst%3DH.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DObata%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DSakoda%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DToda%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520identifies%2520common%2520variants%2520at%2520four%2520loci%2520as%2520genetic%2520risk%2520factors%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1303%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Simón-Sánchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bras, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalls, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Illig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okun, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racette, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonozi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwinn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatzkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuschl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riess, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study reveals genetic risk underlying Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fng.487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19915575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1308-1312&author=J.+Sim%C3%B3n-S%C3%A1nchezauthor=C.+Schulteauthor=J.+M.+Brasauthor=M.+Sharmaauthor=J.+R.+Gibbsauthor=D.+Bergauthor=C.+Paisan-Ruizauthor=P.+Lichtnerauthor=S.+W.+Scholzauthor=D.+G.+Hernandezauthor=R.+Kr%C3%BCgerauthor=M.+Federoffauthor=C.+Kleinauthor=A.+Goateauthor=J.+Perlmutterauthor=M.+Boninauthor=M.+A.+Nallsauthor=T.+Illigauthor=C.+Giegerauthor=H.+Houldenauthor=M.+Steffensauthor=M.+S.+Okunauthor=B.+A.+Racetteauthor=M.+R.+Cooksonauthor=K.+D.+Footeauthor=H.+H.+Fernandezauthor=B.+J.+Traynorauthor=S.+Schreiberauthor=S.+Arepalliauthor=R.+Zonoziauthor=K.+Gwinnauthor=M.+van+der+Brugauthor=G.+Lopezauthor=S.+J.+Chanockauthor=A.+Schatzkinauthor=Y.+Parkauthor=A.+Hollenbeckauthor=J.+Gaoauthor=X.+Huangauthor=N.+W.+Woodauthor=D.+Lorenzauthor=G.+Deuschlauthor=H.+Chenauthor=O.+Riessauthor=J.+A.+Hardyauthor=A.+B.+Singletonauthor=T.+Gasser&title=Genome-wide+association+study+reveals+genetic+risk+underlying+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study reveals genetic risk underlying Parkinson's disease</span></div><div class="casAuthors">Simon-Sanchez, Javier; Schulte, Claudia; Bras, Jose M.; Sharma, Manu; Gibbs, J. Raphael; Berg, Daniela; Paisan-Ruiz, Coro; Lichtner, Peter; Scholz, Sonja W.; Hernandez, Dena G.; Krueger, Rejko; Federoff, Monica; Klein, Christine; Goate, Alison; Perlmutter, Joel; Bonin, Michael; Nalls, Michael A.; Illig, Thomas; Gieger, Christian; Houlden, Henry; Steffens, Michael; Okun, Michael S.; Racette, Brad A.; Cookson, Mark R.; Foote, Kelly D.; Fernandez, Hubert H.; Traynor, Bryan J.; Schreiber, Stefan; Arepalli, Sampath; Zonozi, Ryan; Gwinn, Katrina; van der Brug, Marcel; Lopez, Grisel; Chanock, Stephen J.; Schatzkin, Arthur; Park, Yikyung; Hollenbeck, Albert; Gao, Jianjun; Huang, Xuemei; Wood, Nick W.; Lorenz, Delia; Deuschl, Guenther; Chen, Honglei; Riess, Olaf; Hardy, John A.; Singleton, Andrew B.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1308-1312</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We performed a genome-wide assocn. study (GWAS) in 1713 individuals of European ancestry with Parkinson's disease (PD) and 3978 controls.  After replication in 3361 cases and 4573 controls, we obsd. two strong assocn. signals, one in the gene encoding α-synuclein (SNCA; rs2736990, OR = 1.23, P = 2.24 × 10-16) and another at the MAPT locus (rs393152, OR = 0.77, P = 1.95 × 10-16).  We exchanged data with colleagues performing a GWAS in Japanese PD cases.  Assocn. to PD at SNCA was replicated in the Japanese GWAS, confirming this as a major risk locus across populations.  We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 × 10-8) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 × 10-5).  These data demonstrate an unequivocal role for common genetic variants in the etiol. of typical PD and suggest population-specific genetic heterogeneity in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PHkVNrI1D7Vg90H21EOLACvtfcHk0lixl2iAJx5Oow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP&md5=7dae0abacbde642a41eb9d4899b8980d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fng.487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.487%26sid%3Dliteratum%253Aachs%26aulast%3DSim%25C3%25B3n-S%25C3%25A1nchez%26aufirst%3DJ.%26aulast%3DSchulte%26aufirst%3DC.%26aulast%3DBras%26aufirst%3DJ.%2BM.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DGibbs%26aufirst%3DJ.%2BR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DScholz%26aufirst%3DS.%2BW.%26aulast%3DHernandez%26aufirst%3DD.%2BG.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DFederoff%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DPerlmutter%26aufirst%3DJ.%26aulast%3DBonin%26aufirst%3DM.%26aulast%3DNalls%26aufirst%3DM.%2BA.%26aulast%3DIllig%26aufirst%3DT.%26aulast%3DGieger%26aufirst%3DC.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DSteffens%26aufirst%3DM.%26aulast%3DOkun%26aufirst%3DM.%2BS.%26aulast%3DRacette%26aufirst%3DB.%2BA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26aulast%3DFoote%26aufirst%3DK.%2BD.%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DTraynor%26aufirst%3DB.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DArepalli%26aufirst%3DS.%26aulast%3DZonozi%26aufirst%3DR.%26aulast%3DGwinn%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DG.%26aulast%3DChanock%26aufirst%3DS.%2BJ.%26aulast%3DSchatzkin%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DHollenbeck%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DLorenz%26aufirst%3DD.%26aulast%3DDeuschl%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRiess%26aufirst%3DO.%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520reveals%2520genetic%2520risk%2520underlying%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1308%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+leucine-rich+repeat+kinase+2+augment+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520leucine-rich%2520repeat%2520kinase%25202%2520augment%2520kinase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaganovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1016%2Fj.nbd.2006.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=16750377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=329-341&author=E.+Greggioauthor=S.+Jainauthor=A.+Kingsburyauthor=R.+Bandopadhyayauthor=P.+Lewisauthor=A.+Kaganovichauthor=M.+P.+van+der+Brugauthor=A.+Beilinaauthor=J.+Blackintonauthor=K.+J.+Thomasauthor=R.+Ahmadauthor=D.+W.+Millerauthor=S.+Kesavapanyauthor=A.+Singletonauthor=A.+Leesauthor=R.+J.+Harveyauthor=K.+Harveyauthor=M.+R.+Cookson&title=Kinase+activity+is+required+for+the+toxic+effects+of+mutant+LRRK2%2Fdardarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span></div><div class="casAuthors">Greggio, Elisa; Jain, Shushant; Kingsbury, Ann; Bandopadhyay, Rina; Lewis, Patrick; Kaganovich, Alice; van der Brug, Marcel P.; Beilina, Alexandra; Blackinton, Jeff; Thomas, Kelly Jean; Ahmad, Rili; Miller, David W.; Kesavapany, Sashi; Singleton, Andrew; Lees, Andrew; Harvey, Robert J.; Harvey, Kirsten; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-341</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).  Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain.  However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations.  In this study, we noted two cellular phenotypes assocd. with mutant dardarin.  First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies.  Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.  Manipulating activity by replacing the kinase domain with a kinase-dead' version blocks inclusion body formation and strongly delays cell death.  This predicts that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD.  We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Hag6uVnmkLVg90H21EOLACvtfcHk0lixl2iAJx5Oow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D&md5=52b400fe2f04c2cdeae2a2aa0be67ece</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKingsbury%26aufirst%3DA.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DKaganovich%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DBlackinton%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DK.%2BJ.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BW.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DKinase%2520activity%2520is%2520required%2520for%2520the%2520toxic%2520effects%2520of%2520mutant%2520LRRK2%252Fdardarin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D23%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnrn2935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=21088684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=791-797&author=M.+R.+Cookson&title=The+role+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</span></div><div class="casAuthors">Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">791-797</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component.  Here, I discuss how mutations in a large complex gene - leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau.  These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ6sTeax7vLVg90H21EOLACvtfcHk0ljaZp306SkigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO&md5=1600eaee5fea809aa325e2d7a7963b35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrn2935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2935%26sid%3Dliteratum%253Aachs%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DThe%2520role%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D791%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rudenko, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson’s disease?</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1186%2F1741-7015-10-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=22361010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=20-27&author=I.+N.+Rudenkoauthor=R.+Chiaauthor=M.+R.+Cookson&title=Is+inhibition+of+kinase+activity+the+only+therapeutic+strategy+for+LRRK2-associated+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?</span></div><div class="casAuthors">Rudenko, Iakov N.; Chia, Ruth; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20</span>CODEN:
                <span class="NLM_cas:coden">BMMECZ</span>;
        ISSN:<span class="NLM_cas:issn">1741-7015</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of familial Parkinson's disease (PD).  Variation around the LRRK2 locus also contributes to the risk of sporadic PD.  The LRRK2 protein contains a central catalytic region, and pathogenic mutations cluster in the Ras of complex protein C terminus of Ras of complex protein (mutations N1437H, R1441G/C and Y1699C) and kinase (G2019S and I2020T) domains.  Much attention has been focused on the kinase domain, because kinase-dead versions of mutant LRRK2 are less toxic than kinase-active versions of the same proteins.  Furthermore, kinase inhibitors may be able to mimic this effect in mouse models, although the currently tested inhibitors are not completely specific.  In this review, we discuss the recent progress in the development of specific LRRK2 kinase inhibitors.  We also discuss non-kinase-based therapeutic strategies for LRRK2-assocd. PD as it is possible that different approaches may be needed for different mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArNzblopm1bVg90H21EOLACvtfcHk0ljaZp306SkigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D&md5=e1de091de6b38b8a1138327f7292ae48</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-10-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-10-20%26sid%3Dliteratum%253Aachs%26aulast%3DRudenko%26aufirst%3DI.%2BN.%26aulast%3DChia%26aufirst%3DR.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DIs%2520inhibition%2520of%2520kinase%2520activity%2520the%2520only%2520therapeutic%2520strategy%2520for%2520LRRK2-associated%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DBMC%2520Med.%26date%3D2012%26volume%3D10%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamichi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in <i>Caenorhabditis elegans</i> and <i>Drosophila</i> Parkinson’s disease models</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1093%2Fhmg%2Fddr312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=21768216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=3933-3942&author=Z.+Liuauthor=S.+Hamamichiauthor=B.+D.+Leeauthor=D.+Yangauthor=A.+Rayauthor=G.+A.+Caldwellauthor=K.+A.+Caldwellauthor=T.+M.+Dawsonauthor=W.+W.+Smithauthor=V.+L.+Dawson&title=Inhibitors+of+LRRK2+kinase+attenuate+neurodegeneration+and+Parkinson-like+phenotypes+in+Caenorhabditis+elegans+and+Drosophila+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models</span></div><div class="casAuthors">Liu, Zhao-Hui; Hamamichi, Shusei; Lee, Byoung-Dae; Yang, De-Jun; Ray, Arpita; Caldwell, Guy A.; Caldwell, Kim A.; Dawson, Ted M.; Smith, Wanli W.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3933-3942</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) have been identified as a genetic cause of familial Parkinson's disease (PD) and have also been found in the more common sporadic form of PD, thus positioning LRRK2 as important in the pathogenesis of PD.  Biochem. studies of the disease-causing mutants of LRRK2 implicates an enhancement of kinase activity as the basis of neuronal toxicity and thus possibly the pathogenesis of PD due to LRRK2 mutations.  Previously, a chem. library screen identified inhibitors of LRRK2 kinase activity.  Here, two of these inhibitors, GW5074 and sorafenib, are shown to protect against G2019S LRRK2-induced neurodegeneration in vivo in Caenorhabditis elegans and in Drosophila.  These findings indicate that increased kinase activity of LRRK2 is neurotoxic and that inhibition of LRRK2 activity can have a disease-modifying effect.  This suggests that inhibition of LRRK2 holds promise as a treatment for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUI1BJ-I2FnrVg90H21EOLACvtfcHk0ljaZp306SkigA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL&md5=53f130209a8364ac8c8c1f553ab4cd63</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr312%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHamamichi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DCaldwell%26aufirst%3DK.%2BA.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DInhibitors%2520of%2520LRRK2%2520kinase%2520attenuate%2520neurodegeneration%2520and%2520Parkinson-like%2520phenotypes%2520in%2520Caenorhabditis%2520elegans%2520and%2520Drosophila%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D3933%26epage%3D3942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanKampen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire-Zeiss, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnm.2199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20729864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=998-1000&author=B.+D.+Leeauthor=J.-H.+Shinauthor=J.+VanKampenauthor=L.+Petrucelliauthor=A.+B.+Westauthor=H.+S.+Koauthor=Y.-I.+Leeauthor=K.+A.+Maguire-Zeissauthor=W.+J.+Bowersauthor=H.+J.+Federoffauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Inhibitors+of+leucine-rich+repeat+kinase-2+protect+against+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease</span></div><div class="casAuthors">Lee, Byoung Dae; Shin, Joo-Ho; Van Kampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1000</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease.  Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration.  These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78Hm84uiebVg90H21EOLACvtfcHk0lgTMEVFRGihnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE&md5=d6c5df67511a2f154b21a523af408f65</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnm.2199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2199%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DShin%26aufirst%3DJ.-H.%26aulast%3DVanKampen%26aufirst%3DJ.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DKo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DY.-I.%26aulast%3DMaguire-Zeiss%26aufirst%3DK.%2BA.%26aulast%3DBowers%26aufirst%3DW.%2BJ.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DInhibitors%2520of%2520leucine-rich%2520repeat%2520kinase-2%2520protect%2520against%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D998%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><div class="note"><p class="first last">For a recent review on LRRK2 small molecule kinase inhibitors, see the following: </p></div><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göring, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amombo, G. M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for LRRK2 and their application to Parkinson’s disease models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200117j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=151-160&author=T.+Kramerauthor=F.+Lo+Monteauthor=S.+G%C3%B6ringauthor=G.+M.+O.+Amomboauthor=B.+Schmidt&title=Small+molecule+kinase+inhibitors+for+LRRK2+and+their+application+to+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models</span></div><div class="casAuthors">Kramer, Thomas; Lo Monte, Fabio; Goering, Stefan; Okala Amombo, Ghislaine Marlyse; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder.  Several single gene mutations have been linked to this disease.  Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) indicate LRRK2 as promising therapeutic target for the treatment of PD.  LRRK2 mutations were obsd. in sporadic as well as familial PD patients and have been investigated intensively.  LRRK2 is a large and complex protein, with multiple enzymic and protein-interaction domains, each of which is effected by mutations.  The most common mutation in PD patients is G2019S.  Several LRRK2 inhibitors have been reported already, although the crystal structure of LRRK2 has not yet been detd.  This review provides a summary of known LRRK2 inhibitors and will discuss recent in vitro and in vivo results of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUiu7gx3NxLVg90H21EOLACvtfcHk0lgTMEVFRGihnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D&md5=bda078bde5e0b515ca9d6f183d8b06f8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn200117j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200117j%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26aulast%3DG%25C3%25B6ring%26aufirst%3DS.%26aulast%3DAmombo%26aufirst%3DG.%2BM.%2BO.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520LRRK2%2520and%2520their%2520application%2520to%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson’s disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=365-373&author=B.+D.+Leeauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+as+a+potential+therapeutic+target+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520as%2520a%2520potential%2520therapeutic%2520target%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+selective+inhibitor+of+the+Parkinson%E2%80%99s+disease+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0ljScMpUkQMnKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren., Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span> </span><span class="NLM_article-title">Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson’s disease-related toxicity in human neurons</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb2002413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1021-1028&author=N.+Ramsdenauthor=J.+Perrinauthor=Z.+Ren.author=B.+D.+Leeauthor=N.+Zinnauthor=V.+L.+Dawsonauthor=D.+Tamauthor=M.+Bovaauthor=M.+Langauthor=G.+Drewesauthor=M.+Bantscheffauthor=F.+Bardauthor=T.+M.+Dawsonauthor=C.+Hopf&title=Chemoproteomics-based+design+of+potent+LRRK2-selective+lead+compounds+that+attenuate+Parkinson%E2%80%99s+disease-related+toxicity+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcb2002413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb2002413%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRen.%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DBova%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHopf%26aufirst%3DC.%26atitle%3DChemoproteomics-based%2520design%2520of%2520potent%2520LRRK2-selective%2520lead%2520compounds%2520that%2520attenuate%2520Parkinson%25E2%2580%2599s%2520disease-related%2520toxicity%2520in%2520human%2520neurons%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1021%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Nichols, P. L.; Eatherton, A. J.; Bamborough, P.; Jandu, K. S.; Philps, O. J.; Andreotti, D.</span><span> </span><span class="NLM_article-title">Novel Compounds</span>. WO 2011/038572 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+L.+Nichols&author=A.+J.+Eatherton&author=P.+Bamborough&author=K.+S.+Jandu&author=O.+J.+Philps&author=D.+Andreotti&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzoni, C.</span><span> </span><span class="NLM_article-title">LRRK2 and human disease: a complicated question or a question of complexes?</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">pe2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1126%2Fscisignal.2002680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=22253261" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=pe2&author=P.+A.+Lewisauthor=C.+Manzoni&title=LRRK2+and+human+disease%3A+a+complicated+question+or+a+question+of+complexes%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.2002680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.2002680%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DManzoni%26aufirst%3DC.%26atitle%3DLRRK2%2520and%2520human%2520disease%253A%2520a%2520complicated%2520question%2520or%2520a%2520question%2520of%2520complexes%253F%26jtitle%3DSci.%2520Signaling%26date%3D2012%26volume%3D5%26spage%3Dpe2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.3109%2F01677063.2011.627072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=22077787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=140-151&author=R.+E.+Droletauthor=J.+M.+Sandersauthor=J.+T.+Kern&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+cellular+biology%3A+a+review+of+recent+advances+in+identifying+physiological+substrates+and+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions</span></div><div class="casAuthors">Drolet, Robert E.; Sanders, John M.; Kern, Jonathan T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">140-151</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common forms of inheritable Parkinson's disease and likely play a role in sporadic disease as well.  LRRK2 is a large multidomain protein contg. two key groups, a Ras-like GTP binding domain and a serine, threonine kinase domain.  Mutations in the LRRK2 gene that assoc. with Parkinson's disease reside primarily within the two functional domains of the protein, suggesting that LRRK2 function is crit. to the pathogenesis of the disease.  The most common LRRK2 mutation increases kinase activity, making LRRK2 kinase inhibition an attractive target for small mol. drug development.  However, the physiol. function of LRRK2 kinase as well as its endogenous protein substrates remains poorly understood and has hindered drug development efforts.  Recent advances in LRRK2 biol. have revealed several potential cellular roles, interacting proteins, and putative physiol. substrates.  Together, a picture emerges of a complex multifunctional protein that exists in multiple cellular compartments.  Through unclear mechanisms, LRRK2 kinase regulates cytoskeleton architecture through control of protein translation, phosphorylation of cytoskeletal proteins, and response to cellular stressors.  This article will briefly cover some interesting recent studies in LRRK2 cellular biol. and highlight emerging cellular models of LRRK2 kinase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIaZnsxyLANrVg90H21EOLACvtfcHk0liFPhTvbMqhdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL&md5=b4b40ac3ccfa45091410f59e1401587c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627072%26sid%3Dliteratum%253Aachs%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520cellular%2520biology%253A%2520a%2520review%2520of%2520recent%2520advances%2520in%2520identifying%2520physiological%2520substrates%2520and%2520cellular%2520functions%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D140%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a potent LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+potent+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520potent%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Sheng, Z.; Zhang, S.; Bustos, D.; Kleinheinz, T.; Le Pichon, C. E.; Dominguez, S. L.; Solanoy, H. O.; Drummond, J.; Zhang, X.; Ding, X.; Cai, F.; Song, Q.; Li, X.; Yue, Z.; van der Brug, M. P.; Burdick, D. J.; Gunzner-Toste, J.; Chen, H.; Liu, X.; Estrada, A. A.; Sweeney, Z. K.; Scearce-Levie, K.; Moffat, J. G.; Kirkpatrick, D. S.; Zhu, H.</span><span> </span><span class="NLM_article-title">Ser1292 autophosphorylation is a biomarker of LRRK2 kinase activity and mediates cellular effects of PD mutations</span>.  <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=Z.+Sheng&author=S.+Zhang&author=D.+Bustos&author=T.+Kleinheinz&author=C.+E.+Le+Pichon&author=S.+L.+Dominguez&author=H.+O.+Solanoy&author=J.+Drummond&author=X.+Zhang&author=X.+Ding&author=F.+Cai&author=Q.+Song&author=X.+Li&author=Z.+Yue&author=M.+P.+van+der+Brug&author=D.+J.+Burdick&author=J.+Gunzner-Toste&author=H.+Chen&author=X.+Liu&author=A.+A.+Estrada&author=Z.+K.+Sweeney&author=K.+Scearce-Levie&author=J.+G.+Moffat&author=D.+S.+Kirkpatrick&author=H.+Zhu&title=Ser1292+autophosphorylation+is+a+biomarker+of+LRRK2+kinase+activity+and+mediates+cellular+effects+of+PD+mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26atitle%3DSer1292%2520autophosphorylation%2520is%2520a%2520biomarker%2520of%2520LRRK2%2520kinase%2520activity%2520and%2520mediates%2520cellular%2520effects%2520of%2520PD%2520mutations%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5545</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5536-5545&author=H.+Chenauthor=B.+K.+Chanauthor=J.+Drummondauthor=A.+A.+Estradaauthor=J.+Gunzner-Tosteauthor=X.+Liuauthor=Y.+Liuauthor=J.+G.+Moffatauthor=D.+Shoreauthor=Z.+K.+Sweeneyauthor=T.+Tranauthor=S.+Wangauthor=G.+Zhaoauthor=H.+Zhuauthor=D.+J.+Burdick&title=Discovery+of+selective+LRRK2+inhibitors+guided+by+computational+analysis+and+molecular+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span></div><div class="casAuthors">Chen, Huifen; Chan, Bryan K.; Drummond, Jason; Estrada, Anthony A.; Gunzner-Toste, Janet; Liu, Xingrong; Liu, Yichin; Moffat, John; Shore, Daniel; Sweeney, Zachary K.; Tran, Thuy; Wang, Shumei; Zhao, Guiling; Zhu, Haitao; Burdick, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5536-5545</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson's disease (PD).  Potent and selective small mols. capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD.  In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homol. model was developed that provided robust guidance in the hit-to-lead optimization of small mol. LRRK2 inhibitors.  Through a combination of mol. modeling, sequence anal., and matched mol. pair (MMP) activity cliff anal., a potent and selective lead inhibitor was discovered.  The selectivity of this compd. could be understood using the LRRK2 homol. model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YrcBmeoRILVg90H21EOLACvtfcHk0liFPhTvbMqhdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D&md5=fe4d3a709a35f94e3c092b73bdb09936</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300452p%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DShore%26aufirst%3DD.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520selective%2520LRRK2%2520inhibitors%2520guided%2520by%2520computational%2520analysis%2520and%2520molecular%2520modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5536%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-ref125_1"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avshalumov, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, Z.</span><span> </span><span class="NLM_article-title">Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson’s disease mutation G2019S</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/ref125_1&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1523%2FJNEUROSCI.5604-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/ref125_1&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20130188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/ref125_1&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2jurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=1788-1797&author=X.+Liauthor=J.+C.+Patelauthor=J.+Wangauthor=M.+V.+Avshalumovauthor=C.+Nicholsonauthor=J.+D.+Buxbaumauthor=G.+A.+Elderauthor=M.+E.+Riceauthor=Z.+Yue&title=Enhanced+striatal+dopamine+transmission+and+motor+performance+with+LRRK2+overexpression+in+mice+is+eliminated+by+familial+Parkinson%E2%80%99s+disease+mutation+G2019S"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref125_1R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S</span></div><div class="casAuthors">Li, Xianting; Patel, Jyoti C.; Wang, Jing; Avshalumov, Marat V.; Nicholson, Charles; Buxbaum, Joseph D.; Elder, Gregory A.; Rice, Margaret E.; Yue, Zhenyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1788-1797</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">PARK8/LRRK2 (leucine-rich repeat kinase 2) was recently identified as a causative gene for autosomal dominant Parkinson's disease (PD), with LRRK2 mutation G2019S linked to the most frequent familial form of PD.  Emerging in vitro evidence indicates that aberrant enzymic activity of LRRK2 protein carrying this mutation can cause neurotoxicity.  However, the physiol. and pathophysiol. functions of LRRK2 in vivo remain elusive.  Here we characterize two bacterial artificial chromosome (BAC) transgenic mouse strains overexpressing LRRK2 wild-type (Wt) or mutant G2019S.  Transgenic LRRK2-Wt mice had elevated striatal dopamine (DA) release with unaltered DA uptake or tissue content.  Consistent with this result, LRRK2-Wt mice were hyperactive and showed enhanced performance in motor function tests.  These results suggest a role for LRRK2 in striatal DA transmission and the consequent motor function.  In contrast, LRRK2-G2019S mice showed an age-dependent decrease in striatal DA content, as well as decreased striatal DA release and uptake.  Despite increased brain kinase activity, LRRK2-G2019S overexpression was not assocd. with loss of DAergic neurons in substantia nigra or degeneration of nigrostriatal terminals at 12 mo.  Our results thus reveal a pivotal role for LRRK2 in regulating striatal DA transmission and consequent control of motor function.  The PD-assocd. mutation G2019S may exert pathogenic effects by impairing these functions of LRRK2.  Our LRRK2 BAC transgenic mice, therefore, could provide a useful model for understanding early PD pathol. events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqebY5-NeADCLVg90H21EOLACvtfcHk0ljAYjlfGMw-Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2jurY%253D&md5=3c547266dea53eb88779e765dfcf1e7d</span></div><a href="/servlet/linkout?suffix=ref125_1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5604-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5604-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPatel%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAvshalumov%26aufirst%3DM.%2BV.%26aulast%3DNicholson%26aufirst%3DC.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26aulast%3DElder%26aufirst%3DG.%2BA.%26aulast%3DRice%26aufirst%3DM.%2BE.%26aulast%3DYue%26aufirst%3DZ.%26atitle%3DEnhanced%2520striatal%2520dopamine%2520transmission%2520and%2520motor%2520performance%2520with%2520LRRK2%2520overexpression%2520in%2520mice%2520is%2520eliminated%2520by%2520familial%2520Parkinson%25E2%2580%2599s%2520disease%2520mutation%2520G2019S%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D1788%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci3001138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=1138-1145&author=X.+Huauthor=Y.+Huauthor=M.+Vogtauthor=D.+Stumpfeauthor=J.+Bajorath&title=MMP-Cliffs%3A+systematic+identification+of+activity+cliffs+on+the+basis+of+matched+molecular+pairs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-Cliffs: Systematic Identification of Activity Cliffs on the Basis of Matched Molecular Pairs</span></div><div class="casAuthors">Hu, Xiaoying; Hu, Ye; Vogt, Martin; Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1145</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activity cliffs are generally defined as pairs of structurally similar compds. having large differences in potency.  The anal. of activity cliffs is of general interest because structure-activity relationship (SAR) determinants can often be deduced from them.  Crit. questions for the study of activity cliffs include how similar compds. should be to qualify as cliff partners, how similarity should be assessed, and how large potency differences between participating compds. should be.  Thus far, activity cliffs have mostly been defined on the basis of calcd. Tanimoto similarity values using structural descriptors, esp. 2D fingerprints.  As any theor. assessment of mol. similarity, this approach has its limitations.  For example, calcd. Tanimoto similarities might often be difficult to reconcile and interpret from a chem. perspective, a point of critique frequently raised in medicinal chem.  Herein, we have explored activity cliffs by considering well-defined substructure replacements instead of calcd. similarity values.  For this purpose, the matched mol. pair (MMP) formalism has been applied.  MMPs were systematically derived from public domain compds., and activity cliffs were extd. from them, termed MMP-cliffs.  The frequency of cliff formation was detd. for compds. active against different targets, MMP-cliffs were analyzed in detail, and re-evaluated on the basis of Tanimoto similarity.  In many instances, chem. intuitive activity cliffs were only detected on the basis of MMPs, but not Tanimoto similarity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCYSOxNqPjGbVg90H21EOLACvtfcHk0ljAYjlfGMw-Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1GgtLg%253D&md5=958a76d85d0a06424b43eb1b694cf3ca</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fci3001138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci3001138%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DVogt%26aufirst%3DM.%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DMMP-Cliffs%253A%2520systematic%2520identification%2520of%2520activity%2520cliffs%2520on%2520the%2520basis%2520of%2520matched%2520molecular%2520pairs%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D1138%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">The power of MMPA and a teaching lesson in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1815</span><span class="NLM_x">–</span> <span class="NLM_lpage">1816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300163y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1815-1816&author=K.+Muller&title=The+power+of+MMPA+and+a+teaching+lesson+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300163y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300163y%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DThe%2520power%2520of%2520MMPA%2520and%2520a%2520teaching%2520lesson%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1815%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Stumpfe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Exploring activity cliffs in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2932</span><span class="NLM_x">–</span> <span class="NLM_lpage">2942</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201706b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2932-2942&author=D.+Stumpfeauthor=J.+Bajorath&title=Exploring+activity+cliffs+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring Activity Cliffs in Medicinal Chemistry</span></div><div class="casAuthors">Stumpfe, Dagmar; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2932-2942</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, structure-activity relationships (SARs) have increasingly been studied through mining of large compd. data sets, leading to a renaissance of the activity landscape concept.  In general terms, an activity landscape is defined as any graphical representation that integrates similarity and potency relationships between compds. sharing a specific activity.  From activity landscape representations of different design, both global and local SAR features present in compd. data sets can be extd.  Modeling and rationalizing activity landscapes require the application of computational methods.  As such, the activity landscape concept is of comparable relevance for chemoinformatics (having a strong focus on data mining and representation) and medicinal chem. (given its immediate relevance for SAR anal.).  Herein, we describe in detail the multifaceted nature of activity cliffs, discuss underlying scientific concepts, and explain how their individual or systematic anal. might (or might not) provide useful information for medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql1wydp65qQLVg90H21EOLACvtfcHk0lhIpUFSjZWxCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFajsQ%253D%253D&md5=ceddd1de5798b585d6381ac18ba67fc9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm201706b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201706b%26sid%3Dliteratum%253Aachs%26aulast%3DStumpfe%26aufirst%3DD.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DExploring%2520activity%2520cliffs%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2932%26epage%3D2942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0lhIpUFSjZWxCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Chemical transformations that yield compounds with distinct activity profiles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml2000609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=523-527&author=Y.+Huauthor=J.+Bajorath&title=Chemical+transformations+that+yield+compounds+with+distinct+activity+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fml2000609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000609%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DChemical%2520transformations%2520that%2520yield%2520compounds%2520with%2520distinct%2520activity%2520profiles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D523%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, J. C.</span><span> </span><span class="NLM_article-title">Targeted kinase selectivity from kinase profiling data</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300012r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=383-386&author=F.+Millettiauthor=J.+C.+Hermann&title=Targeted+kinase+selectivity+from+kinase+profiling+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fml300012r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300012r%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26atitle%3DTargeted%2520kinase%2520selectivity%2520from%2520kinase%2520profiling%2520data%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D383%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32a1"><span>Erratum in Proc. Natl. Acad. Sci. U.S.A.<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span>. </span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Proc.+Natl.+Acad.+Sci.+U.S.A.+2007%2C+104%2C+2025.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase+activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase%2520activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Baker-Glenn, C.; Burdick, D. J.; Chambers, M.; Chan, B. K.; Chen, H.; Estrada, A.; Gunzner, J. L.; Shore, D.; Sweeney, Z. K.; Wang, S.; Zhao, G.</span><span> </span><span class="NLM_article-title">Aminopyrimidine derivatives as LRRK2 modulators and their preparation and use for the treatment of Parkinson’s disease</span>. WO2011151360A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Baker-Glenn&author=D.+J.+Burdick&author=M.+Chambers&author=B.+K.+Chan&author=H.+Chen&author=A.+Estrada&author=J.+L.+Gunzner&author=D.+Shore&author=Z.+K.+Sweeney&author=S.+Wang&author=G.+Zhao&title=Aminopyrimidine+derivatives+as+LRRK2+modulators+and+their+preparation+and+use+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaker-Glenn%26aufirst%3DC.%26atitle%3DAminopyrimidine%2520derivatives%2520as%2520LRRK2%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Brain penetrant LRRK2 inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300123a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=658-662&author=H.+G.+Choiauthor=J.+Zhangauthor=X.+Dengauthor=J.+M.+Hatcherauthor=M.+P.+Patricelliauthor=Z.+Zhaoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Brain+penetrant+LRRK2+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fml300123a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300123a%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DBrain%2520penetrant%2520LRRK2%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D658%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond the rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+the+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0li9OCXHxEmYhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520the%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0li9OCXHxEmYhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Keserű, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C5%B1author=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C5%25B1%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">40</a></strong><div class="note"><p class="first last">For impact of lipophilic efficiency parameters on compound quality, see the following: </p></div><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_contrib-group">Tarcsay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyíri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keserű, G. M.</span><span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Ny%C3%ADriauthor=G.+M.+Keser%C5%B1&title=Impact+of+lipophilic+efficiency+on+compound+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0li9OCXHxEmYhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNy%25C3%25ADri%26aufirst%3DK.%26aulast%3DKeser%25C5%25B1%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><div class="note"><p class="first last">For impact on CNS drugs and candidates, see the following: </p></div><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lg-_77yIVfxUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liederer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span> </span><span class="NLM_article-title">Use of cassette dosing approach to assess brain penetration in drug discovery</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=963-969&author=X.+Liuauthor=X.+Dingauthor=G.+Deshmukhauthor=B.+M.+Liedererauthor=C.+E.+C.+A.+Hop&title=Use+of+cassette+dosing+approach+to+assess+brain+penetration+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26atitle%3DUse%2520of%2520cassette%2520dosing%2520approach%2520to%2520assess%2520brain%2520penetration%2520in%2520drug%2520discovery%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D963%26epage%3D969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hennig, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala-Leon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Cornejo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, L.</span><span> </span><span class="NLM_article-title">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span> <span class="citation_source-journal">J. Fluorine Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1016%2Fj.jfluchem.2009.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2009&pages=453-460&author=L.+Hennigauthor=K.+Ayala-Leonauthor=J.+Angulo-Cornejoauthor=R.+Richterauthor=L.+Beyer&title=Fluorine+hydrogen+short+contacts+and+hydrogen+bonds+in+substituted+benzamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine hydrogen short contacts and hydrogen bonds in substituted benzamides</span></div><div class="casAuthors">Hennig, Lothar; Ayala-Leon, Ketty; Angulo-Cornejo, Jorge; Richter, Rainer; Beyer, Lothar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">453-460</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Ten Fluorine substituted benzamides were synthesized and studied by spectroscopic methods (NMR, IR, MS) and x-ray structure anal.  The configuration of these compds. strongly depends on solvent, temp. and substitution pattern.  Unexpectedly, some of these compds. form weak intramol. hydrogen bonds/short N-H···F-C contacts in CDCl3 soln. and in the solid state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO1miRde9jnbVg90H21EOLACvtfcHk0lg-_77yIVfxUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltl2nuro%253D&md5=2abb3e0d14e81fe2adda68b51bd6b6b8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2009.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2009.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DHennig%26aufirst%3DL.%26aulast%3DAyala-Leon%26aufirst%3DK.%26aulast%3DAngulo-Cornejo%26aufirst%3DJ.%26aulast%3DRichter%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DL.%26atitle%3DFluorine%2520hydrogen%2520short%2520contacts%2520and%2520hydrogen%2520bonds%2520in%2520substituted%2520benzamides%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2009%26volume%3D130%26spage%3D453%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Fritz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, T.</span><span> </span><span class="NLM_article-title">Weitreichende kopplung zwischen protonen und fluor in 2-fluorbenzamiden</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">836</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1974&pages=836-839&author=H.+Fritzauthor=T.+Winkler&title=Weitreichende+kopplung+zwischen+protonen+und+fluor+in+2-fluorbenzamiden"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DH.%26aulast%3DWinkler%26aufirst%3DT.%26atitle%3DWeitreichende%2520kopplung%2520zwischen%2520protonen%2520und%2520fluor%2520in%25202-fluorbenzamiden%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1974%26volume%3D57%26spage%3D836%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural modifications that alter the P-glycoprotein efflux properties of a compound</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-glycoprotein+efflux+properties+of+a+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-glycoprotein%2520efflux%2520properties%2520of%2520a%2520compound%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Lovering, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Escape from Flatland: increasing saturation as an approach to improving clinical success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6756</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+increasing+saturation+as+an+approach+to+improving+clinical+success"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lhel2koXYV03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520increasing%2520saturation%2520as%2520an%2520approach%2520to%2520improving%2520clinical%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span> </span><span class="NLM_article-title">Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1554</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101356p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1539-1554&author=M.+Ishikawaauthor=Y.+Hashimoto&title=Improvement+in+aqueous+solubility+in+small+molecule+drug+discovery+programs+by+disruption+of+molecular+planarity+and+symmetry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Improvement in Aqueous Solubility in Small Molecule Drug Discovery Programs by Disruption of Molecular Planarity and Symmetry</span></div><div class="casAuthors">Ishikawa, Minoru; Hashimoto, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1539-1554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKbtbfvqKZjrVg90H21EOLACvtfcHk0lhel2koXYV03w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWltLw%253D&md5=a88804b3850625ef9c3f7424366acb91</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm101356p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101356p%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DImprovement%2520in%2520aqueous%2520solubility%2520in%2520small%2520molecule%2520drug%2520discovery%2520programs%2520by%2520disruption%2520of%2520molecular%2520planarity%2520and%2520symmetry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1539%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfronga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J.</span><span> </span><span class="NLM_article-title">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">–</span> <span class="NLM_lpage">1447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1124%2Fdmd.105.008201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=16760229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1443-1447&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrongaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+R.+Nelsonauthor=M.+A.+Szewcauthor=J.+Van+Deusen&title=Evaluation+of+cerebrospinal+fluid+concentration+and+plasma+free+concentration+as+a+surrogate+measurement+for+brain+free+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the use of cerebrospinal fluid (CSF) drug concn. and plasma unbound concn. (Cu,plasma) to predict brain unbound concn. (Cu,brain).  The concn.-time profiles in CSF, plasma, and brain of seven model compds. were detd. after s.c. administration in rats.  The Cu,brain was estd. from the product of total brain concns. and unbound fractions, which were detd. using brain tissue slice and brain homogenate methods.  For theobromine, theophylline, caffeine, fluoxetine, and propranolol, which represent rapid brain penetration compds. with a simple diffusion mechanism, the ratios of the area under the curve of Cu,brain/CCSF and Cu,brain/Cu,plasma were 0.27 to 1.5 and 0.29 to 2.1, resp., using the brain slice method, and were 0.27 to 2.9 and 0.36 to 3.9, resp., using the brain homogenate method.  A P-glycoprotein substrate, CP-141938 (methoxy-3-[(2-phenyl-piperidinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.57 and 0.066, using the brain slice method, and 1.1 and 0.13, using the brain homogenate method, resp.  The slow brain-penetrating compd., N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine, had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.94 and 0.12 using the brain slice method and 0.15 and 0.018 using the brain homogenate method, resp.  Therefore, for quick brain penetration with simple diffusion mechanism compds., CCSF and Cu,plasma represent Cu,brain equally well; for efflux substrates or slow brain penetration compds., CCSF appears to be equiv. to or more accurate than Cu,plasma to represent Cu,brain.  Thus, we hypothesize that CCSF is equiv. to or better than Cu,plasma to predict Cu,brain.  This hypothesis is supported by the literature data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43dRkq9lx7Vg90H21EOLACvtfcHk0lhIiSm_Or0eGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D&md5=cef079e1a667dbddf9d5a2f7d01889e8</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.008201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.008201%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfronga%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520cerebrospinal%2520fluid%2520concentration%2520and%2520plasma%2520free%2520concentration%2520as%2520a%2520surrogate%2520measurement%2520for%2520brain%2520free%2520concentration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1443%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+an+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0lhIiSm_Or0eGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520an%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>Invitrogen Lanthascreen Eu kinase binding assay kit for TTK.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Invitrogen+Lanthascreen+Eu+kinase+binding+assay+kit+for+TTK."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelluma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manak, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deveraux, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+P.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+Mps1+cell+cycle+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0lhBxuVkxsmJWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520Mps1%2520cell%2520cycle%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Olaharski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzaludo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span> </span><span class="NLM_article-title">Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000446&author=A.+J.+Olaharskiauthor=N.+Gonzaludoauthor=H.+Bitterauthor=D.+Goldsteinauthor=S.+Kirchnerauthor=H.+Uppalauthor=K.+Kolaja&title=Identification+of+a+kinase+profile+that+predicts+chromosome+damage+induced+by+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlaharski%26aufirst%3DA.%2BJ.%26aulast%3DGonzaludo%26aufirst%3DN.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DUppal%26aufirst%3DH.%26aulast%3DKolaja%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520kinase%2520profile%2520that%2520predicts%2520chromosome%2520damage%2520induced%2520by%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3De1000446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Lan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">A chemical tool box defines mitotic and interphase roles for Mps1 kinase</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=21-24&author=W.+Lanauthor=D.+W.+Cleveland&title=A+chemical+tool+box+defines+mitotic+and+interphase+roles+for+Mps1+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DW.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DA%2520chemical%2520tool%2520box%2520defines%2520mitotic%2520and%2520interphase%2520roles%2520for%2520Mps1%2520kinase%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D21%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wilberg, K. B.</span><span> </span><span class="NLM_article-title">The deuterium isotope effect</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1955&pages=713&author=K.+B.+Wilberg&title=The+deuterium+isotope+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilberg%26aufirst%3DK.%2BB.%26atitle%3DThe%2520deuterium%2520isotope%2520effect%26jtitle%3DChem.%2520Rev.%26date%3D1955%26volume%3D55%26spage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lélias, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule–kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.-M.+L%C3%A9liasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule%E2%80%93kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DL%25C3%25A9lias%26aufirst%3DJ.-M.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule%25E2%2580%2593kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Porter, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revell, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheardown, M. J.</span><span> </span><span class="NLM_article-title">Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1038%2Fsj.bjp.0702751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=10498829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=1999&pages=13-20&author=R.+H.+Porterauthor=K.+R.+Benwellauthor=H.+Lambauthor=C.+S.+Malcolmauthor=N.+H.+Allenauthor=D.+F.+Revellauthor=D.+R.+Adamsauthor=M.+J.+Sheardown&title=Functional+characterization+of+agonists+at+recombinant+human+5-HT2A%2C+5-HT2B+and+5-HT2C+receptors+in+CHO-K1+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells</span></div><div class="casAuthors">Porter, R. H. P.; Benwell, K. R.; Lamb, H.; Malcolm, C. S.; Allen, N. H.; Revell, D. F.; Adams, D. R.; Sheardown, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The goal of this study was to characterize the agonist pharmacol. of human 5-HT2A, 5-HT2B and 5-HT2C (VSV) receptors expressed in CHO-K1 (Chinese hamster ovary) cells.  We used a fluorometric imaging plate reader (FLIPR) which allows rapid detection of rises in intracellular calcium levels upon the addn. of agonists.  Stimulation of all three receptors by 5-HT caused a robust concn. dependent increase in intracellular calcium levels.  No such effect was obsd. from non-transfected control CHO-K1 cells.  The rank order of potency of agonists at the different receptor subtypes varied.  Tryptamines, BW-723C86, d-norfenfluramine, Ro 60-0175 and LSD exhibited the following rank order of potency; 5-HT2B>5-HT2C>5-HT2A.  Piperazines such as m-chlorophenylpiperazine (mCPP), ORG-12962, MK-212 and also ORG-37684 exhibited a rank order of potency of 5-HT2C>5-HT2B>5-HT2A.  The phenylisopropylamines DOI and DOB had a rank order of 5-HT2A>5-HT2B>5-HT2C.  Many agonists tested had partial agonist actions when compared to 5-HT, and a wide range of relative efficacies were exhibited, which was cell line dependent.  For example, mCPP had a relative efficacy of 65% at 5-HT2C receptors but <25% at either 5-HT2A or 5-HT2B receptors.  Interpretation of literature values of functional assays using different cell lines, different receptor expression levels and different receptor isoforms, is complex.  Species differences and the previous use of antagonist radioligands to characterize agonist potency in binding assays emphasizes the importance of studying agonists in the same expt. using the same assay conditions and parental cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgNDFqRrlEtbVg90H21EOLACvtfcHk0lhQ7uWWsifoqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmt1Squrg%253D&md5=ff33f4122999f10960865e75161179ca</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702751%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DBenwell%26aufirst%3DK.%2BR.%26aulast%3DLamb%26aufirst%3DH.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DAllen%26aufirst%3DN.%2BH.%26aulast%3DRevell%26aufirst%3DD.%2BF.%26aulast%3DAdams%26aufirst%3DD.%2BR.%26aulast%3DSheardown%26aufirst%3DM.%2BJ.%26atitle%3DFunctional%2520characterization%2520of%2520agonists%2520at%2520recombinant%2520human%25205-HT2A%252C%25205-HT2B%2520and%25205-HT2C%2520receptors%2520in%2520CHO-K1%2520cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D128%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Zhou, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.-P.</span><span> </span><span class="NLM_article-title">Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.3109%2F03602530903286476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19961320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFehsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=268-354&author=S.-F.+Zhouauthor=B.+Wangauthor=L.-P.+Yangauthor=J.-P.+Liu&title=Structure%2C+function%2C+regulation+and+polymorphism+and+the+clinical+significance+of+human+cytochrome+P450+1A2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2</span></div><div class="casAuthors">Zhou, Shu-Feng; Wang, Bo; Yang, Li-Ping; Liu, Jun-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-354</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Human CYP1A2 is one of the major CYPs in human liver and metabolizes a no. of clin. drugs (e.g., clozapine, tacrine, tizanidine, and theophylline; n > 110), a no. of procarcinogens (e.g., benzo[a]pyrene and arom. amines), and several important endogenous compds. (e.g., steroids).  CYP1A2 is subject to reversible and/or irreversible inhibition by a no. of drugs, natural substances, and other compds.  The CYP1A gene cluster has been mapped on to chromosome 15q24.1, with close link between CYP1A1 and 1A2 sharing a common 5'-flanking region.  The human CYP1A2 gene spans almost 7.8 kb comprising seven exons and six introns and codes a 515-residue protein with a mol. mass of 58,294 Da.  The recently resolved CYP1A2 structure has a relatively compact, planar active site cavity that is highly adapted for the size and shape of its substrates.  The architecture of the active site of 1A2 is characterized by multiple residues on helixes F and I that constitutes two parallel substrate binding platforms on either side of the cavity.  A large interindividual variability in the expression and activity of CYP1A2 has been obsd., which is largely caused by genetic, epigenetic and environmental factors (e.g., smoking).  CYP1A2 is primarily regulated by the arom. hydrocarbon receptor (AhR) and CYP1A2 is induced through AhR-mediated transactivation following ligand binding and nuclear translocation.  Induction or inhibition of CYP1A2 may provide partial explanation for some clin. drug interactions.  To date, more than 15 variant alleles and a series of subvariants of the CYP1A2 gene have been identified and some of them have been assocd. with altered drug clearance and response and disease susceptibility.  Further studies are warranted to explore the clin. and toxicol. significance of altered CYP1A2 expression and activity caused by genetic, epigenetic, and environmental factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwfCc84BYyO7Vg90H21EOLACvtfcHk0lhQ7uWWsifoqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFehsL0%253D&md5=808977d5168454cc990a5a5daa167cc0</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.3109%2F03602530903286476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03602530903286476%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.-F.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DL.-P.%26aulast%3DLiu%26aufirst%3DJ.-P.%26atitle%3DStructure%252C%2520function%252C%2520regulation%2520and%2520polymorphism%2520and%2520the%2520clinical%2520significance%2520of%2520human%2520cytochrome%2520P450%25201A2%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2010%26volume%3D42%26spage%3D268%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Zhou, S.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span> </span><span class="NLM_article-title">Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=481-494&author=S.-F.+Zhouauthor=L.-P.+Yangauthor=Z.-W.+Zhouauthor=Y.-H.+Liuauthor=E.+Chan&title=Insights+into+the+substrate+specificity%2C+inhibitors%2C+regulation%2C+and+polymorphisms+and+the+clinical+impact+of+human+cytochrome+P450+1A2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.-F.%26aulast%3DYang%26aufirst%3DL.-P.%26aulast%3DZhou%26aufirst%3DZ.-W.%26aulast%3DLiu%26aufirst%3DY.-H.%26aulast%3DChan%26aufirst%3DE.%26atitle%3DInsights%2520into%2520the%2520substrate%2520specificity%252C%2520inhibitors%252C%2520regulation%252C%2520and%2520polymorphisms%2520and%2520the%2520clinical%2520impact%2520of%2520human%2520cytochrome%2520P450%25201A2%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D481%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">59</a></strong><div class="note"><p class="first last">Cellular assay is triple mutant LRRK2 (R1441G/Y1699C/G2019S), and BAC transgenic mice are G2019S mutant LRRK2.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Akabane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teramura, T.</span><span> </span><span class="NLM_article-title">A comparison of pharmacokinetics between humans and monkeys</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=308-316&author=T.+Akabaneauthor=K.+Tabataauthor=K.+Kadonoauthor=S.+Sakudaauthor=S.+Terashitaauthor=T.+Teramura&title=A+comparison+of+pharmacokinetics+between+humans+and+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkabane%26aufirst%3DT.%26aulast%3DTabata%26aufirst%3DK.%26aulast%3DKadono%26aufirst%3DK.%26aulast%3DSakuda%26aufirst%3DS.%26aulast%3DTerashita%26aufirst%3DS.%26aulast%3DTeramura%26aufirst%3DT.%26atitle%3DA%2520comparison%2520of%2520pharmacokinetics%2520between%2520humans%2520and%2520monkeys%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D308%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Roller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laspina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller-Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1080%2F00498250802546861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=19219746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=33-45&author=S.+Rollerauthor=D.+Cuiauthor=C.+Laspinaauthor=C.+Miller-Steinauthor=J.+Roweauthor=B+Wongauthor=T.+Prueksaritanont&title=Preclinical+pharmacokinetics+of+MK-0974%2C+an+orally+active+calcitonin-gene+related+peptide+%28CGRP%29-receptor+antagonist%2C+mechanism+of+dose+dependency+and+species+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences</span></div><div class="casAuthors">Roller, S.; Cui, D.; Laspina, C.; Miller-Stein, C.; Rowe, J.; Wong, B.; Prueksaritanont, T.</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The underlying mechanism for low oral bioavailability of MK-0974, a potent calcitonin-gene related peptide (CGRP)-receptor antagonist, in monkeys and for species-dependent non-linear pharmacokinetics in monkeys and rats were investigated.  In monkeys, MK-0974 displayed moderate clearance (14-20 mL min-1 kg-1), while oral bioavailability was 6%.  The pharmacokinetics of MK-0974 remained linear across 0.5-10 mg kg-1 i.v. dose in monkeys, but the oral area under the blood plasma concn.-time curve (AUC) increase (5-30 mg kg-1) was 15-fold over dose-proportional.  Based on a comparison of AUC following hepatic portal vein administration and cephalic vein infusion, MK-0974 exhibited a low-to-moderate hepatic extn. ratio (36%) in monkeys.  Following oral dose of [14C]MK-0974 to monkeys, the hepatic portal AUC ratio of MK-0974 vs. total radioactivity was 0.32, and the total radioactivity recovered in bile and urine was 45-83%.  MK-0974 undergoes significant oxidative metab. (cytochrome P 450 (CYP) 3A) in monkey intestinal microsomes.  In contrast, oral AUC of MK-0974 in rats was near dose-proportional (15-100 mg kg-1).  Following oral administration of [14C]MK-0974 to rats, the hepatic portal AUC ratio of MK-0974 to total radioactivity (0.67) was higher than in monkeys.  Addnl., the metabolic rate of MK-0974 was slower in rat than in monkey intestinal microsomes.  Collectively, intestinal 1st-pass metab. played a significant role in the low oral bioavailability in monkeys and contributed to the species-dependent non-linear oral pharmacokinetics in rats and monkeys of MK-0974.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSGwTRkl7ECrVg90H21EOLACvtfcHk0lgX5Zf_XWCN2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFaqsLw%253D&md5=4b3039fc4abdf2cfca46a7e0f1fceb53</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1080%2F00498250802546861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250802546861%26sid%3Dliteratum%253Aachs%26aulast%3DRoller%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DLaspina%26aufirst%3DC.%26aulast%3DMiller-Stein%26aufirst%3DC.%26aulast%3DRowe%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DB%26aulast%3DPrueksaritanont%26aufirst%3DT.%26atitle%3DPreclinical%2520pharmacokinetics%2520of%2520MK-0974%252C%2520an%2520orally%2520active%2520calcitonin-gene%2520related%2520peptide%2520%2528CGRP%2529-receptor%2520antagonist%252C%2520mechanism%2520of%2520dose%2520dependency%2520and%2520species%2520differences%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26spage%3D33%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit61"><span> <span class="citation_source-book">MOE</span>, version <span class="NLM_edition">2009.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal, Quebec, Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE%2C+version+2009.10%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C+Quebec%2C+Canada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMOE%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0lgX5Zf_XWCN2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26spage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, E.</span><span> </span><span class="NLM_article-title">Swiss-Prot: juggling between evolution and stability</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm301020q&amp;key=10.1093%2Fbib%2F5.1.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm301020q&amp;key=15153305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm301020q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=39-55&author=A.+Bairochauthor=B.+Boeckmannauthor=S.+Ferroauthor=E.+Gasteiger&title=Swiss-Prot%3A+juggling+between+evolution+and+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Swiss-Prot: juggling between evolution and stability</span></div><div class="casAuthors">Bairoch, Amos; Boeckmann, Brigitte; Ferro, Serenella; Gasteiger, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-55</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">Some of the aspects of Swiss-Prot that make it unique are described and the developments that are necessary for the database to continue to play its role as a focal point of protein knowledge are discussed.  Advices pertinent to the development of high-quality knowledge resources on one aspect or the other of the life sciences are provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEgdtQ3E4iD7Vg90H21EOLACvtfcHk0liSljIA2um0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D&md5=20bac4d8d69b26959f71a271299fd233</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Fbib%2F5.1.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252F5.1.39%26sid%3Dliteratum%253Aachs%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DBoeckmann%26aufirst%3DB.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DGasteiger%26aufirst%3DE.%26atitle%3DSwiss-Prot%253A%2520juggling%2520between%2520evolution%2520and%2520stability%26jtitle%3DBriefings%2520Bioinf.%26date%3D2004%26volume%3D5%26spage%3D39%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position+specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position%2520specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit65"><span> <span class="citation_source-book">Maestro Suites</span>, version <span class="NLM_edition">2009</span>; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro+Suites%2C+version+2009%3B+Schr%C3%B6dinger%2C+Inc.%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%2520Suites%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3GFW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3GFW','PDB','3GFW'); return false;">PDB: 3GFW</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i74"><a href="/doi/suppl/10.1021/jm301020q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40175"></div></div></div></div></div><hr /></hr><p class="last">Spleen PK/PD graphs for <b>14</b>, <b>18</b>, and <b>19</b> and additional experimental procedures. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301020q/suppl_file/jm301020q_si_001.pdf">jm301020q_si_001.pdf (191.84 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301020q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm301020q%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301020q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667988757a92d1cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
